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Boc tert-Butyloxycarbonyl
BOP  Benzotriazol-1-yl-oxy-tris dimethylaminophosphonium hexafluorophosphate
CD Circular dichroism
CuAAC Cu(I)-catalyzed azide-alkyne cycloaddition
DCM Dichloromethane
DIPCDI N,N’-diisopropylcarbodiimide
DiPEA N,N-diisopropylethylamine
DLS Dynamic light scattering
DMEM  Dulbecco’s Modified Eagle Medium
DMF Dimethylformamide
DMSO Dimethylsulfoxide
DOPA 3,4-dihydroxyphenylalanine
DHPA 3,4-dihydroxyphenylacetic acid
DMPC 1,2-dimyristoyl-sn-glycero-3-phosphocholine
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
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LC-MS Liquid chromatography-Mass Spectrometry
MALDI-TOF Matrix-assisted laser desorption/ionization – time of flight
MAS Magic-angle spinning
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MeOH Methanol
MMP Matrix metalloproteinase
MS Mass Spectrometry
MT Mushroom Tyrosinase
MW Molecular weight
NaIO4 Sodium periodate
NHS N-hydroxy succinimide
NMR Nuclear Magnetic Resonance
OSu N-hydroxysuccinimide 
PBS Phosphate buffered saline
PEG Poly(ethylene)glycol
PyBOP Benzotriazol-1-yl-oxy-tripyrrolidinophosphonium hexafluorophosphate
PyBrOP Bromotripyrrolidinophosphonium hexafluorophosphate
r.t. Room temperature
Rt Retention time
SEC Size-exclusion chromatography
SPAAC Strain-promoted azide-alkyne cycloaddition
SPOCQ Strain-promoted oxidation-controlled cyclooctyne–1,2-quinone cycloaddition
SPPS Solid phase peptide synthesis
TEM Transmission electron microscopy
TFA Trifluoroacetic acid
TFE Trifluoroethanol
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TLC Thin-layer chromatography
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Peptide- and protein based hydrogels
Temperature, pH 
changes in the body
Solution Hydrogel formation
Part of this chapter has been published as: 
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11.1. Introduction
Hydrogels are three-dimensional, hydrophilic polymer networks, capable of absorbing large 
amounts of water or biological fluids, up to thousand times their dry weight. They are insoluble 
due to the presence of cross-links between the constituents that form the polymeric network. 
They are often made of homopolymers or copolymers, but can also consist of small molecules 
that self-assemble into high molecular weight structures.1,2 The first hydrogel report dates back 
to the study by Wichterle and Lim (1960), who polymerized and cross-linked 2-hydroxyethyl 
methacrylate into a transparent gel, which showed promising results in the manufacturing 
of contact lenses.3 Since this pioneering work, the number of publications on hydrogels has 
increased every year.4,5 Hydrogels can be classified in a number of ways. They can for example 
be categorized based on the nature of their building blocks, being either neutral or ionic, or 
natural or synthetic in origin. Furthermore, hydrogels are often distinguished based on their 
mechanical and structural characteristics, such as the degree of cross-linking and the integrity 
of the gels. Finally, an important classification is the way in which cross-linking occurs, which can 
be either chemical or physical.2 Hydrogels formed by chemical cross-links undergo significant 
volume changes during the transition from solution (sol) to gel state. These chemical cross-links 
can be formed in many different ways, such as disulfide formation, (photo)polymerisation or 
the reaction between thiols and acrylates or sulfones. The density of cross-linking can easily be 
varied and with this also the mechanical properties of the final material. Physically cross-linked 
hydrogels, on the other hand, do not undergo significant volume changes during the sol-gel 
transition. They can be prepared via the self-assembly of polymers, which occurs in response 
to external stimuli such as pH and temperature. The polymers generally provide relatively low 
viscous solutions that can rapidly form a gel when an external trigger is applied. Often physical 
cross-linking leads to weaker gels than chemical cross-linking; therefore these gels are more 
susceptible to mechanical forces such as shear. This can also be used to its advantage, as it makes 
physical hydrogels suitable as injectable materials (Figure 1.1). Another advantage of physical 
cross-linking is that it mostly does not depend on the addition of organic solvents or cross-
linking reagents, offering possibilities for these hydrogels in biomedical applications such as the 
controlled delivery of drugs and cells and in tissue engineering.6
Tissue engineering is an important research field, since every year millions of people suffer 
from the loss or failure of organs or tissues. These patients are treated by organ or tissue 
transplantations. Since there is a huge shortage of donors, new treatments such as tissue 
engineering gain increasing attention.7-10 In this research field, man-made organs or tissues are 
developed to restore, improve or maintain tissue function.9 These materials are usually made by 
incorporation of the patient’s own cells into polymer scaffolds, such as poly(glycolic acid) (PGA) 
and poly(lactic acid) (PLA). These scaffolds are capable of delivering the cells into the body, 
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thereby providing a site for new tissue formation. Administration of these polymer scaffolds 
into the body occurs via cuts or incisions. In addition, polymer scaffolds can also be used as a 
substrate for the attachment and migration of cell populations.7,8 As an alternative, hydrogels are 
thought to constitute an excellent starting point as a matrix to grow new tissue in. The gels can 
be designed to be biodegradable and their mechanical and structural properties to resemble 
those of many tissues. Importantly, hydrogels can be designed to be able to transplant the cells 
into the body by simple injection, thereby minimizing the invasive manner (Figure 1.1).11 
Temperature, pH 
changes in the body
Solution Hydrogel formation
Figure 1.1. A schematic representation of an injectable hydrogel. At low temperatures, these hydrogels 
are soluble. Cells or drugs (represented by the black dots) are mixed with the solvent. After injection, 
temperature or pH changes in the body are responsible for hydrogel formation, resulting in the delivery 
of the cells or drugs to the body.
In the design of these hydrogels, several criteria have to be taken into account. A highly important 
factor is the biocompatibility. The injectable materials should be biocompatible, in the sense that 
they do not damage adjacent cells or in some other way induce undesired responses. Another 
issue that needs to be addressed is cell adhesion; hydrogels should interact favourably with the 
type of cells they want to deliver. Inappropriate interaction might lead to undesirable tissue 
formation. Furthermore, the degradation behaviour of the hydrogels is important for tissue 
engineering applications. The rate of degradation should be in line with the tissue development, 
since the degradation of the hydrogels may influence the mechanical properties. Importantly, 
the degradation products should be biocompatible as well.7 
An important guide in the design of hydrogels for tissue engineering is the extracellular matrix 
(ECM). The ECM is the biological material that surrounds cells in tissues. It is furthermore 
responsible for mechanical support and provides an environment for new tissue formation.12 
The ECM itself consists mainly of proteoglycan filaments, collagen fibres and elastin. The collagen 
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1fibres provide tensile strength and durability to the surrounding tissue. Elastin enables the stretch and recoil of the ECM network. The proteoglycan filaments are built up from proteins 
and hyaluronic acid to form coiled structures. Proteoglycan binds water, sequesters growth 
factors and supplies compression resistance. At low protein concentrations, the ECM structure 
can be considered gel-like.13,14 Hence, mimicking the ECM is an important goal in the design of 
hydrogels for tissue engineering and is considered as a good way to develop biomaterials with 
control over cell adhesion, proliferation, migration and differentiation.15
Peptides and proteins are often used in the development of hydrogels, since they exhibit some 
advantageous characteristics, such as biocompatibility and biodegradability. The incorporation 
of peptides into biomaterials can be performed using several chemical reactions including click 
chemistry, Michael addition of cysteine residues to vinyl sulfones or maleimides, UV-initiated 
cross-linking and native chemical ligation. These reactions all take place with a high level of 
chemical specificity. This is often not possible for proteins, since the exact composition of the 
interaction region is not precisely known. Incorporation of proteins into biomaterials is therefore 
often performed via non-specific amine-carboxylic acid couplings. Peptides can be incorporated 
into biomaterials to infer a number of functions. This includes cell-binding, growth factor binding, 
surface binding and/or proteolytic susceptibility.16 The most frequently used peptide sequence 
in this respect is the arginine-glycine-aspartic acid (RGD) sequence.17 The incorporation of 
this cell adhesion motif into biomaterials has already been reviewed extensively in literature. 
8,18-21 Efforts are being made to introduce combinations of peptides during the synthesis of 
biomaterials, in order to integrate multiple functions.16
On the other hand, peptides and proteins can also be employed as moieties that provide 
structural integrity to a gel, e.g. via self-assembly or aggregation. In this chapter an overview 
is given of hydrogels in which peptides and proteins are structural elements of the polymer 
network. Starting from hydrogels which are derived from naturally occurring structural proteins, 
we will gradually move from all-protein and peptide-based synthetic systems to hybrid hydrogels 
which are composed of synthetic polymeric and peptide structural elements. We will illustrate 
the potential of these hydrogels with applications which are mainly derived from the field 
of tissue engineering. Finally, an overview of chemical cross-linking methods is described. For 
articles which give a broader overview of biomaterials used in hydrogel formation or which 
discuss in more detail the mechanical properties of peptide-based hydrogels one is referred to 
excellent reviews by Schacht et al. and Pochan et al.4,22 
In summary, hydrogels are promising materials for use as biomaterials, since they have high water 
content, have a tuneable viscoelasticity, are biocompatible and can be made injectable. Both 
peptides and proteins have advantageous features for use as building blocks in the synthesis of 
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biomaterials and hydrogels in particular. As mentioned above, an important requirement for the 
design of hydrogels is the biocompatibility. Hydrogels based on peptides or proteins often fulfil 
this prerequisite and are easily degraded by the body. 
1.2. Natural protein-based hydrogels
As described above, proteins display interesting properties for use in the synthesis of hydrogels. 
Especially their excellent biocompatibility and biodegradability make them promising candidates 
in biomedical applications. A concise description of proteins derived from natural sources which 
are used for the preparation of biomaterials is provided. Since usually biosynthetic procedures 
are used to mimic the sequences of natural proteins, these are more extensively described in 
Paragraph 1.3. One is referred to excellent reviews for more information about elastin23,24, 
collagen and gelatin.25,26 
1.2.1. Elastin
Elastin is a major structural protein of the extracellular matrix (ECM) that regulates the cell/cell 
interactions and the cell/ECM interactions. Elastin provides the ECM with tensile strength and 
elasticity, required for proper functioning.27 Typically, natural elastin hardly has been used as a 
biomaterial in tissue engineering. An important requirement when using proteins as biomaterial 
is the purity. In the synthesis of elastin, elastic fibres are formed on microfibrillar components 
acting as scaffold. Elastin then has to be purified from the elastic fibres. Contaminations from 
the preparation, like calcium-binding microfibrillar components, can lead to immunological 
responses in the human body. Moreover, elastin is insoluble and has a strong tendency to calcify, 
making purification even more difficult.28 
1.2.2. Collagen and gelatin
Most of the collagens are fibrous proteins, responsible for important mechanical functions 
throughout the body. Collagens are particularly present in articular and bone tissues, where 
they provide most of the biochemical properties essential for proper functioning. Furthermore, 
collagens can bind and release cellular mediators such as cytokines and growth factors.29 The 
structural element of collagen is the triple helix, consisting of a -Gly-Xaa-Yaa- repeat. The amino 
acids Xaa and Yaa are usually proline and hydroxyproline (Hyp).30 Collagen is widely used as 
biomaterial in tissue engineering. It is used in its native fibrillar form, as well as after denaturation. 
Denaturation offers the possibility to fabricate several collagen forms, including sheets, tablets, 
pellets and sponges.31 Collagen has for example been used to repair tendon defects in rabbits32, 
for curing of chronic wounds caused by diabetes33 and as delivery system for proteins, drugs 
and genes.34 When the triple-helix structure of collagen is broken into single-strand molecules, 
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1gelatin is obtained. Gelation of a gelatin solution occurs easily by a change in temperature. Gelatin gels have shown to be non-immunogenic, biodegradable and biocompatible, making 
them suitable candidates for biomedical applications. However, the thermal and mechanical 
stability of the gelatin gels is rather low. For long term biomedical applications, the stability 
of gelatin gels is improved by chemical modifications such as cross-linking.7,35 Gelatin-based 
materials have already been used in several tissue engineering applications, for example in 
adipose tissue repair36 and as bone tissue engineering material.37 
1.2.3. Silk fibroin
Silks are natural structural proteins produced by insects such as spiders and worms. Silk 
produced by the silkworm Bombyx mori is called silk fibroin. This fibrous protein contains two 
protein components: fibroin and sericin. Fibroin consists of light (~26 kDa) and heavy chain 
(~390 kDa) polypeptides, which are present in a 1:1 ratio and are connected by a disulfide 
bridge. Silk fibroin forms β-sheets, due to the presence of the highly repetitive amino acid motif 
GAGAGS (Figure 1.2).38,39 
H
N
O
N
H O
H
N
O
N
H O
H
N
O
N
H O
OH
n
Figure 1.2. The ubiquitous GAGAGS motif present in silk fibroin induces the formation of β-sheets.
These β-sheets are responsible for the formation of silk fibroin hydrogels. Due to the formation 
of the β-sheets, the silk fibroin becomes insoluble in water. Hydrophobic interactions among 
the protein chains in fibroin lead to the assembly of the material into hydrogels. Gelation can be 
enhanced by an increase in temperature or fibroin concentration. Furthermore, gelation can be 
promoted by a decrease in pH or by addition of a hydrophilic polymer. Both factors stimulate 
desorption of water and decrease the repulsion between the protein chains. Addition of Ca2+ 
ions also accelerates the formation of hydrophobic interactions, presumably because the pH is 
lowered by ionic interactions with the COO- ions of the amino acid side chains.40 Silk fibroin 
hydrogels are biocompatible, have unique mechanical properties, are biodegradable and display 
cellular interactions.41 For example, in vitro and in vivo tests on rabbits with cancellous bone 
defects showed bone healing and stimulated cell proliferation.42 
1.2.4. Globular proteins
Many studies have been performed on the gelation processes of globular proteins such as 
bovine serum albumin, β-lactoglobulin and ovalbumin. From these proteins, β-lactoglobulin is 
the one most intensively studied. This protein, with a molecular mass of 18.6 kDa, is widely used 
in the food industry. This globular protein denatures when heated, leading to either large linear 
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aggregates or small primary aggregates, both consisting of peptide fragments.43,44 The small 
aggregates can further grow into larger aggregates and at a certain concentration self-assemble 
into gels. Alternatively, the large linear aggregates can phase separate, leading to protein-rich 
domains. These can also further aggregate and form gels.43
1.3. Biosynthetic polypeptide-based hydrogels
Natural protein-based hydrogels also display some disadvantages for use as biomaterials. 
As outlined above, their purification and low stability might be problematic. Furthermore, 
when using samples from natural sources, it is difficult to obtain identical compositions. As 
an alternative, synthetic polypeptide-based hydrogels have been investigated. These materials 
are prepared using methods such as gene expression in bacteria, via recombinant technology 
and solid phase peptide synthesis. Synthetic hydrogels can contain sequences mimicking those 
of natural proteins. Functionalities to increase the biological or mechanical properties of the 
hydrogels can easily be incorporated. Moreover, modifications in the peptide sequences can 
simply be made, in order to improve the features of the hydrogels. The following part of this 
chapter gives an overview of biosynthetic polypeptide-based hydrogels.
1.3.1. Collagen-based synthetic hydrogels 
Hydrogels based on collagen have been designed for the purpose of tissue engineering. As an 
example of the solid phase peptide synthesis approach, a small library of Nap-Gly-Phe-Phe-Tyr-
Gly-Gly-Xaa-Hyp was synthesized (Figure 1.3). The repeating collagen sequence Gly-Xaa-Hyp 
was used, in which amino acid Xaa was Lys, Glu, Ser, Ala or Pro. This sequence was connected 
to Nap-Gly-Phe-Phe-Tyr, a peptide with an N-terminal naphthyl (Nap) moiety that is able to 
form gels.
O
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H
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COOH
Figure 1.3. Nap-Gly-Phe-Phe-Tyr-Gly-Gly-Xaa-Hyp. Residue Xaa can be Lys, Glu, Ser, Ala or Pro. Due to 
the naphthyl moiety (Nap), all 5 members are capable of forming hydrogels.
All five members were capable of forming hydrogels in phosphate buffered saline. The construct 
with lysine proved to give the strongest hydrogel. A construct without the collagen domain 
Gly-Xaa-Hyp was also prepared. This compound also formed a hydrogel, but more extensive 
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1hydrogen bonds between the peptides were found in the other, collagen-based constructs. In order to test the biocompatibility of the gels, in vitro cell culture experiments were performed. 
Mouse embryonic fibroblast cells (3T3) were placed on top of the hydrogels. After 72 h, most 
cells on the surface of the Lys-, Glu- and Ser-containing constructs were still alive. Fewer 3T3 
cells were observed on the surface of Ala- and Pro-containing hydrogels and, if present, many 
of them were dead. These two hydrogels are thus not suitable for 3T3 cell culture, possibly due 
to the less polar side chains of Ala and Pro. The gel with lysine proved to be the most suitable in 
these tests, probably because the positively charged lysine increases the binding to the negative 
cell surface.45 
E. coli cannot be used for the synthesis of hydroxyproline containing collagens, since this bacterial 
host lacks the ability to perform the post-translational modification of proline to hydroxyproline. 
In order to broaden the applications of collagen as injectable biomaterial, hydroxyproline-free 
collagen mimetic peptides (CMP) were synthesized. An example is the (GPP)3 GPR GEK GER 
GPR (GPP)3 GPCCG peptide, containing a (GPP)3 triplet, that stabilizes the formation of a 
triple-helix. Analysis of the CMP indeed revealed the formation of stable triple helices, the 
important structural feature of collagen. The observed assembly behaviour suggests that these 
hydroxyproline-free peptides can be used as collagen mimetics, with the advantageous possibility 
to use E. coli for their production.46 An application of collagen-based hydrogels as delivery 
system was recently reported. CMPs were used to create DNA polyplex-modified collagens. 
The release of the DNA polyplexes was demonstrated and could also be tuned by varying 
the CMP content.47 In another example, the release of green fluorescent protein and human 
epidermal growth factor was shown from a highly cross-linked CMP-based 3-D matrix. After 
release of the growth factor, it remained active, which was shown by its ability to stimulate cell 
growth. When cell binding motif RGDS was incorporated in the CMP constructs, encapsulated 
epithelial cells formed spheroid structures. This result shows the potential of collagen-based 
hydrogels for mimicking the ECM.48
Collagen was also taken as a basis for the preparation of triblock thermo-reversible gels as 
shown by Skrzeszewska and co-workers via a protein engineering approach.49 The end 
blocks consisted of the (Pro-Gly-Pro)9 sequence, which forms collagen-like triple helices. The 
middle block was a 399 amino acid long sequence containing the (Gly-Xaa-Yaa)n structure 
and, besides proline, only hydrophilic residues such as asparagine and glutamine.49,50 This highly 
hydrophilic sequence is not able to form secondary structures and hence maintains a random 
coil conformation. Stable gels were only obtained when three of the collagen-like sequences 
form a triple helix, since double helices are not stable. The triblock construct was present as 
a viscous solution at temperatures above 50°C, but formed a gel at room temperature. This 
thermo-responsive behaviour was shown to be reversible, hence an increase in temperature 
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led to the soluble form. The gelation process of the triblock construct was used to develop a 
theoretical model that is able to predict the viscoelastic behaviour of polymer gels.49 In a later 
study rheology, light scattering and atomic force microscopy were conducted to investigate the 
pH-dependent fibre- and gel formation of the triblock constructs. Monomers were found at 
low pH, but with a pH value above 6, these self-assembled into fibres and then hydrogels. At 
physiological pH, gels appeared to have the highest moduli, although gel strength was found 
to be dependent on the purification and preparation method of the gels.51 As a first test, 
rat bone marrow cells were cultured in the presence of the triblock hydrogels. These cells 
remained viable, but comparison with collagen controls showed lower cell proliferation and 
mineralization.52 Possibly these results could be employed in the design of novel collagen-based 
gels with predictable and controllable properties.49 
1.3.2. Elastin-like polypeptides
As indicated above, elastin has important biological functions but is very difficult to be used in 
biomedical applications. Therefore, elastin-like polypeptides (ELPs) have been designed, inspired 
by natural elastin. These ELPs contain a pentapeptide repeat VPGXG, in which X can be any 
natural amino acid, except proline (Figure 1.4).53
N
H
O
N
O
H
N
O
N
H O
H
N
O
n
R
Figure 1.4. The ELP pentapeptide repeat VPGXG. Residue X can be every natural amino acid, except 
proline.
The gelation behaviour of ELPs is temperature-dependent. At low temperatures, the hydrophobic 
residues are surrounded by ordered water from hydrophobic hydration, resulting in a soluble 
aqueous ELP. Above a certain transition temperature, the surrounding water becomes less-
ordered and bulky, leading to the collapse of the polymer. This gives rise to folding and self-
assembly of the ELP, hence gelation occurs.54 The stimulus responsive behaviour of ELPs has 
extensively been described by the Chilkoti and the Urry groups.55-58
Since the immune system does not differentiate between ELPs and natural elastin, these materials 
hold great promise as drug deliverers or in tissue engineering. Additionally, the degradation 
products of ELPs only contain natural amino acids, making them perfectly biocompatible. 
Poly(VPAVG) is a member of the elastin-like polymers, in which the central glycine has been 
replaced by an alanine. Poly(VPAVG) shows a similar self-assembly process. It has been studied 
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1whether poly(VPAVG) is suitable as carrier for the delivery of bone morphogenetic proteins (BMPs). These BMPs are responsible for triggering the differentiation of stem cells during bone 
formation. BMP-2 and BMP-14 were successfully released from the elastin-like polymers and 
proved to increase the mineralization of C2C12 cells. Poly(VPAVG) thus has potential to be 
used in tissue engineering applications in bone.53
Apart from changes in temperature, the ordering of ELPs into hydrogels can also be initiated by 
performing chemical cross-linking. A variety of cross-linking strategies is known, but in order to use 
the ELPs for tissue engineering, the choice is limited. Many methods cannot be used because the 
cross-linking reagents are toxic to cells. Cross-linking reactions that require organic solvents are 
also not suitable, since this eliminates the possibility of encapsulating cells before cross-linking.56 
Lim et al. therefore developed a new cross-linking strategy for ELPs.59 Lysine-containing ELPs 
in aqueous solution were reacted with the amine reactive cross-linker β[tris(hydroxymethyl)
phosphino] propionic acid (THPP), resulting in the rapid formation of hydrogels (Figure 1.5). 
The mechanical properties of the cross-linked ELP gels can be controlled by the number of 
lysine residues and by the pH at which the cross-linking reaction takes place. Cell viability studies 
after encapsulation of mouse fibroblasts in these ELP hydrogels revealed that cross-linking with 
THPP is not cytotoxic.59
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Figure 1.5. Hydrogel formation by the cross-linking between the ELP Lys-residues and THPP.
The THPP cross-linking strategy has been used by Nettles et al. to develop an ELP hydrogel for 
repair of the cartilage matrix in goats.60 For this purpose, the knees of goats with osteochondral 
defects were filled by injecting the THPP-cross-linked ELP gel. After 3 months, a significant 
increase in integration was observed for the ELP filled knees, compared to the unfilled knees. 
However, after 6 months this increase was not maintained, due to degradation of the ELP-
hydrogel. Optimizations of these hydrogels should make them useful for long-term benefits in 
cartilage repair applications.60 Lim et al. further optimized ELP gels for biological applications.61 
ELP triblock copolymers were synthesized with an ABA structure. The central B-block was 
hydrophilic and surrounded by hydrophobic cross-linkable A domains. Gel formation occurred 
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rapidly with THPP as cross-linking agent. It was shown that the presence of the non-cross-
linkable B block and the variation of its length influenced the swelling, structure and mechanical 
properties of the gels. Cell viability of fibroblasts was also proven; it was actually found that 
the ELP triblock copolymers led to a greater cell proliferation than a monoblock ELP hydrogel 
(containing only the A block). Since the mechanical properties of ELP hydrogels can be tuned, 
gels can be designed in such a way that they support cell viability and that they are suitable for 
tissue repair applications.61 
Another chemical cross-linking method used in combination with ELPs is the formation of 
disulfide linkages. Asai et al. used this method to form hydrogels via intramolecular disulfide 
cross-links between cysteine containing ELPs. Hydrogen peroxide (0.3%) was used to accelerate 
the gelation process, leading to gels formed within 2.5 min.62 Cysteine containing ELPs were also 
used by the Chaikof group for functionalization with an RGD peptide utilizing maleimide-thiol 
chemistry.63 The properties of ELPs can furthermore be modified with chemical cross-linkers. 
Genipin, glutaraldehyde and disulfide formation can all be used to cross-link ELP polymer films. 
Varying the cross-linking method and strategy enables tailoring of mechanical and physical 
properties as well as drug release profiles of ELP hydrogels.64 The porous ELP materials offer 
space for transplanted cells to grow in, to generate their own extracellular matrix. Rodríguez-
Cabello and co-workers developed a method to synthesize macroporous ELP hydrogels as 
polymeric scaffolds, because they anticipated that materials containing (VPGIG)n would display 
elastin-like properties such as elasticity and biocompatibility.65 Some lysine residues were 
incorporated in the elastin blocks for cross-linking purposes. The second block contained 
the cell adhesive motive REDV, specific for endothelial cells. The final block consisted of a 
hexapeptide sequence for elastase-proteolytic action. Cross-linking of this ELP triblock material 
was performed using a so-called salt-leaching/gas-foaming technique, in which the amount of 
salt and the particle size control porosity and pore size of the material. This technique allowed 
the authors to prepare macroporous ELP hydrogels with tuneable pore size. It was found that 
HUVEC cells were present both on the surface and in the inner layers of the ELP hydrogel, 
showing that this type of ELP hydrogels indeed has potential for use as an artificial extracellular 
matrix.65 
1.3.3. Silk-like polypeptides
Schacht et al. examined hydrogels made from β-sheet forming silk proteins.66 To this purpose, 
a spider silk protein called eADF4 (C16) was produced, consisting of 16 repeats of molecule 
C. Its sequence is GSSAAAAAAAASGPGGYGPENQGPSGPGGYGPGGP and mimics the silk 
protein ADF4 of the garden cross spider. Hydrogelation of the eADF4 (C16) protein took place 
at increasing concentration, invoked by dialysis. Gelation occurred via the transition of random 
coil conformations and α-helices into β-sheets. In order to increase the stability, the hydrogels 
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1that formed were chemically cross-linked. The tyrosine residue side chains of the eADF4 (C16) protein were connected using ammonium peroxodisulfate and tris(2,2’-bipyridyl)dichloro-
ruthenium(II). The cross-linking resulted in a higher mechanical strength for the hydrogels. The 
mechanical properties of the eADF4 (C16) hydrogels were furthermore influenced by addition 
of fluorescein. This interfered with the assembly into β-sheets resulting in less stable gels.66 
1.3.4. Silk-elastin-like polypeptides
Silk-elastin-like polypeptides (SELPs) are composed of elastin-like and silk-like peptide 
components. The silk-like blocks provide chemical and thermal stability, since they have the 
ability to form hydrogen-bonded β-sheet crystals. The degree of crystallization is reduced by 
the elastin-like blocks, thereby introducing flexibility and aqueous solubility to the SELPs. These 
silk-elastin-like materials are liquid at room temperature, but form gels at elevated temperature. 
It appeared that the gel formation was caused by the crystallization of the silk-like components. 
This hypothesis was tested by the addition of urea, which prevents the formation of hydrogen 
bonding. Gelation was indeed not observed, since the silk-like blocks were unable to form 
the hydrogen-bonded β-sheet crystals. The addition of seed crystals enhanced the rate of 
gelation, further proving that the crystal formation of the silk-like blocks is responsible for the 
gelation. In a further study, the gelation of SELPs was found to be a two-step process. In the 
first step, it indeed is the hydrogen bonding between the silk blocks which causes spontaneous 
self-assembly. In this first step, micellar-like particles are formed. In the second step, the SELP 
molecules are ordered by hydrophobic interactions between the elastin blocks, leading to 
hydrogel or nanoparticle formation. 67-69 The ratio of elastin-like and silk-like components 
can be varied, as well as the block lengths and the sequence. This influences the biological, 
physicochemical and material properties of the formed hydrogels.67 Successful diffusion out 
of the SELP hydrogels was demonstrated for small molecules like vitamin B12, cytochrome 
c and theophylline70, for DNA71 and for adenoviruses.72 This shows that SELP hydrogels are 
already applied as biomaterials. Since their gelation is dependent on both elastin-like and silk-like 
proteins, a high level of control is possible. This makes SELP hydrogels very suitable for more 
applications in the controlled release of therapeutics. 
By introducing stimulus sensitivity, more applications of SELPs are foreseen, including use as 
sensors and drug delivery devices. Nagarsekar et al. synthesized protein polymers, aiming for pH 
and temperature sensitivity.73,74 These SELPs were composed of repeating silk-like (GAGAGS) 
and elastin-like (VPGVG) sequences. The general structure of the synthesized SELPs is [(Gly-Val-
Gly-Val-Pro)4-Gly-X-Gly-Val-Pro-(Gly-Val-Gly-Val-Pro)4-Gly-Ala-Gly-Ala-Gly-Ser]11, in which 
residue X can be either glutamic acid or valine. A transition from a solution state to a turbid 
state was observed for these protein polymers upon increasing temperature. Increasing ionic 
strength leads to less hydration of the polymer by water molecules, meaning that precipitation 
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of the polymer occurs at lower temperatures. Furthermore, a decrease in transition values was 
also shown with increasing protein polymer concentrations. Altogether, these results show that 
mutations of neutral into ionic residues and changes in polymer length, gives the possibility to 
control the sensitivity of SELPs towards pH, temperature and ionic strength.73,74 
1.3.5. Hydrogels based on a coiled-coil motif
A natural way of self-assembly of biological systems is the formation of an α-helical coiled-coil. 
Most of these coiled-coil sequences contain the characteristic heptad repeat abcdefg, with 
hydrophobic residues at positions a and d and with charged amino acids usually located at 
positions e and g (Figure 1.6). These peptides form a helical conformation, with the hydrophobic 
amino acids located at one side of the helix. The hydrophobic interhelical interfaces thus 
obtained, promote the aggregation into coiled-coil dimers. These aggregates are stabilized by 
the pH-dependent interactions between the charged residues.75 In the Woolfson group, two 
28-residue peptides were designed to yield hydrogel materials. To ensure the formation of 
coiled-coil dimers, each peptide contained heptad repeats with isoleucines at position a and 
leucines at position d. To form a dimer with sticky ends, oppositely charged glutamate and lysine 
residues were placed on positions e and g. The complementary sticky ends promoted the 
assembly of the two peptides in α-helical coiled-coil fibrils.76
a
g
e
d
c
f
b
a
e
g
a
d
b
f
c
Figure 1.6. The coiled-coil dimer based on the heptad repeat (abcdefg). Positions a and d are usually 
occupied by hydrophobic amino acids, whereas charged residues are often found at positions e and g. The 
residues located at positions b, c and f are exposed on the surface of the coiled coil. 
By choosing the right amino acids for position b, c and f, the interactions between the fibres might 
increase, resulting in a further assembly into hydrogels. It was chosen to make combinations of 
alanine and glutamine, since alanine can enhance the weak hydrophobic interactions between 
the fibrils and glutamine has the tendency to make hydrogen bonds. The constructs containing 
three alanines and the one with three glutamines on positions b,c and f were shown to form a 
gel. The possibility to use the three alanine- containing hydrogels as a substrate for cell growth 
was tested using rat adrenal pheochromocytoma cells. It was shown that the two peptide 
component hydrogel supports cell differentiation and cell growth.77 
In another study, the coiled-coil domain of the cartilage oligomeric matrix protein was used to 
design hydrogels. This polypeptide is able to self-assemble into pentamers. After functionalization 
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1with a cysteine residue, linkage to polymer PEGDA was performed using a Michael-type addition reaction. These polypeptide-polymers formed hydrogels upon exposure with UV-
light. Fibroblasts encapsulated in the hydrogels showed spreading and migration, making these 
materials suitable for tissue engineering applications.78 
The Tirrell group studied a protein containing six heptad repeats to make up a leucine zipper 
helix.75 The design of the peptide was based on the sequence of the Jun oncogene product 
and on a database containing naturally occurring coiled-coil proteins. A triblock copolymer 
was designed with the leucine zipper domains flanking the central polyelectrolyte domain. This 
central region was based on the Ala-Gly-rich sequence [(AG)3PEG]10 and was water soluble. The 
triblock copolymer formed a switchable hydrogel. Gelation was lost at pH values above 9.5 and 
at temperatures above 55°C, due to dissociation of the coiled-coil domains. The biosynthetic 
approach allowed controlling the characteristics of both the leucine zipper domains and the 
polyelectrolyte region. This gives the possibility to design hydrogels with specific features, aiming 
at the controlled release of therapeutics.75 
Another series of triblock polypeptides were designed by Xu and co-workers based on the 
coiled-coil domain.79 Polypeptides ABA, CBA, ABC and CBC all contained two terminal coiled-
coil motifs, A and C. The sequence of block A was (VSSLESK)6 and the C block sequence 
was (VSSLESK)2-VSKLESK-KSKLESK-VSKLESK-VSSLESK. Block C was obtained by changing 
one valine and three serine residues from block A in lysine residues. The central B block was 
the water-soluble random coil polyelectrolyte segment [(AG)3PEG]10. The balance between 
oligomerisation of blocks A and C and the swelling of block B should result in self-assembly of 
the triblocks. The thermal stability of the four triblocks was measured. The difference between 
the constructs containing block C, is the presence of four more lysine residues compared to 
block A. The introduced lysine amino acids disrupted hydrophobic interactions and introduced 
electrostatic repulsive forces. As a consequence, the thermal stability decreased, resulting in a 
lower temperature needed for coiled coil association. Triblock CBC indeed gave the lowest 
temperature (45°C) for unfolding of the polymer, whereas ABA was thermally stable even at 
temperatures as high as 95°C. All four constructs formed viscoelastic hydrogels at sufficiently 
high concentrations. The concentration to obtain elastic gels was the lowest for triblock CBC. 
When the same concentration range was taken for all constructs, it was found that the solution 
of ABA only contained monomers and dimers. In contrast, dimer to tetramer association was 
shown for triblock CBC. This explains why lower concentrations of CBC already form gels and 
furthermore indicates that gelation is related to the association of the coiled coil blocks. The 
triblocks were also shown to be pH sensitive. Finally, the reversibility of secondary structure 
formation was tested for polymer CBC. Addition of denaturant GdnHCl resulted in unfolding 
of the α-helical structure. After removal of the denaturant, the polymer folded back to its 
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original structure and hydrogels were formed again. Since these triblocks are stimuli responsive 
and hydrogelation is reversible, applications in the biomedical field are foreseen.79 
In contrast to these examples where the coiled-coil motif was essential for hydrogel formation, 
Mehl et al. designed a protein hydrogel not forming a coiled-coil. This gel was based on the four-
helix bundle of the E. coli protein GrpE. This protein contained an amphipathic helix at each end 
and a random coil as the middle domain. The domain in between these two was an α-helix, not 
able to form a coiled coil structure. The amphipathic helices of the protein dimer were able to 
form a four-helix bundle. Instead of coiled-coil driven gelation, hydrogels were formed by simple 
hydrophilic and hydrophobic interactions forming the four-helix bundle.80 
1.3.6. Two-component hydrogels 
Two-component protein-engineered hydrogels have been designed by the Heilshorn group.81 
For the synthesis of the two components, two protein association domains were chosen. The 
first was domain WW, consisting of conserved tryptophan residues. This WW domain is known 
to fold into antiparallel β-sheets. Secondly, a proline-rich protein domain was chosen. The 
first component consisted of multiple WW domains, linked together by hydrophilic spacers 
containing the cell adhesion motif RGDS. These spacers were designed to introduce flexibility 
and biofunctionality. The second component contained the proline-rich proteins, also linked by 
hydrophilic spacers. Upon mixing of the two components, physical cross-linking occurred, leading 
to the formation of a hydrogel. This type of material is therefore called a mixing-induced two-
component hydrogel (MITCH). The viscoelasticity of the hydrogels can be altered, by adjusting 
the binding strength between the two domains and by changing the frequency of the repeated 
domains per component. This type of gels could be advantageous for use in the encapsulation 
of cells and proteins. Since gelation is not induced upon a change in temperature, pH or ionic 
strength, these cells and proteins can be kept under constant physiological conditions. The 
three cell types PC-12, HUVEC and NSC were encapsulated in these hydrogels. In all cases, 
the cells were distributed throughout the gels and were highly viable. Moreover, the two-
component hydrogels showed complete self-healing after shear-thinning and can thus be useful 
as injectable materials for clinical use.81 In a follow-up study, the proline-rich protein was linked 
to 8-armed PEG. Upon mixing with the WW domain, a MITCH-PEG construct was obtained. 
In this way, multiple weak interactions were combined to get a stronger binding. This system 
allows altering the cross-linking density of hydrogels both by changing the PEG content as well 
as by peptide avidity. When endothelial cells were cultured in the MITCH-PEG hydrogels, a well-
spread morphology was found.82 
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1Two-component hydrogels were also investigated by Kiick et al.
83 In their research, a PEG star 
polymer was modified with heparin (PEG-LMWH), since this is known to sequester and stabilize 
growth factors. The second component consisted of the heparin-binding growth factor VEGF. 
Hydrogels were formed by mixing the PEG-LMWH and the VEGF component in phosphate 
buffered saline. Gelation was induced by the effective cross-linking between VEGF and LMWH. 
VEGF-receptors were shown to selectively remove VEGF, which thereby causes gel erosion 
(Figure 1.7). These results demonstrate that therapeutically relevant growth factors can be 
used as cross-linkers in hydrogel formation and can afterwards selectively be released in the 
body upon action of receptors.83 Another two-component hydrogel with heparin was studied 
by Wieduwild and co-workers. Star-PEG was functionalized with several heparin-binding peptide 
motifs. These peptides form α-helices upon interaction with heparin, leading to assembly and 
thus hydrogel formation. The peptide-star-PEG / heparin hydrogels could encapsulate cells 
which remained metabolically active.84 
Figure 1.7. The two-component hydrogel PEG-LMWH/VEGF and the receptor-mediated gel erosion. 
Reproduced with permission from ref 83.83
1.4. Oligopeptides
1.4.1. Hydrogels based on β-sheet forming peptides
Another type of hydrogels is based on the β-sheet motif of peptides. The peptides used to 
make this type of hydrogels are designed to be soluble in aqueous solutions, displaying a random 
coil conformation. Only after addition of an external stimulus, the peptides form a β-hairpin 
conformation. After rapid self-assembly, a cross-linked, β-sheet rich hydrogel is obtained. External 
stimuli used to induce gel formation include heat, light and changes in pH or ionic strength.85 In 
the Messersmith group, the 16 residues containing peptide (FEFEFKFK)2 (FEK16) was studied.86 
This peptide consists of alternating hydrophilic and hydrophobic amino acids and is able to 
self-assemble into β-sheet structures. The self-assembly was induced by the addition of salts. 
This resulted in shielding of the repulsive electrostatic interactions, thereby favouring attractive 
hydrophobic and Van der Waals forces. Peptide FEK16 is fully soluble in water and was shown 
to form β-sheets when the salts NaCl, CaCl2 and KCl were added in mM concentrations. It 
was investigated whether this assembly could be triggered by the addition of stimuli-responsive 
liposomes. Both temperature- and light-sensitive liposomes containing CaCl2 were prepared 
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and added to a FEK16 solution. CaCl2 was released after applying the thermal or photochemical 
trigger, resulting in the formation of highly cross-linked β-sheet hydrogels. This peptide hydrogel 
was suggested to have potential in drug delivery, tissue engineering and wound healing.86 
In the Schneider and Pochan groups, the 20 amino acid containing peptide MAX1 was 
synthesized.87 This peptide (VKVKVKVK-VDPPT-KVKVKVKV-NH2) contains a tetra-peptide 
surrounded by hydrophobic valine and hydrophilic lysine residues. MAX1 formed an amphiphilic 
β-hairpin at high pH (9.0) or after addition of salt at physiological pH. Addition of the cell culture 
growth media DMEM (Dulbecco’s Modified Eagle Medium) to the aqueous peptide solution 
resulted in β-hairpin folding, followed by self-assembly into a gel (Figure 1.8). Studies performed 
on model fibroblasts revealed that MAX1 hydrogels are cytocompatible and maintain their 
rigidity during cell proliferation.87 
+ DMEM 
(cell culture 
media) Self-Assembly
Unfolded peptide Folded β-hairpin
Hydrogel 
nano-structure
Figure 1.8. Hydrogelation of the MAX1 peptide. Addition of cell culture medium results in folding of the 
peptide in a β-hairpin, followed by self-assembly into a gel. Reproduced with permission from ref 87.87
The same researchers also synthesized peptide MAX8, in which one lysine was replaced by a 
glutamic acid (VKVKVKVK-VDPPT-KVEVKVKV-NH2). This lowered the overall positive charge 
of the peptide, which should make folding and self-assembly faster in the same cell culture 
conditions. It was indeed shown that the MAX8 hydrogel was formed faster than MAX1, 
thereby maintaining the way of folding and self-assembly. The MAX8 hydrogels were used for the 
encapsulation of C3H10t1/2 mesenchymal stem cells, resulting in a homogeneous distribution. To 
be able to deliver the gel-cell constructs by syringe, the gels must show shear-thinning behaviour. 
The MAX8 hydrogel became a low-viscosity gel after shear stress was applied. When the stress 
was no longer applied, the gel quickly recovered its initial rigidity. These properties make MAX8 
hydrogels useful for the delivery of cells in tissue-regeneration applications.85 MAX8 hydrogels 
are more rigid and contain more cross-links than MAX1 gels, leading to smaller mesh sizes. 
Dextran macromolecules and protein probes encapsulated in the MAX gels were released 
in rates varying from days till a month. Fastest release rates were recorded for MAX1, due to 
the larger mesh size.88 An additional study further demonstrated that electrostatic interactions 
have an influence on the release rate. Positively charged proteins encapsulated in the MAX8 
hydrogel experience repulsive electrostatic interactions, which enhanced the protein release 
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1from the gel. On the other hand, less than 10% of the initially loaded amount of negatively charged proteins is released from these gels. Since the peptide hydrogel is positively charged, 
the strong attraction with the negatively charged proteins reduces the release.89 Furthermore, 
electrostatic interactions are also known to play a role in cell adhesion, cell viability and cell 
proliferation. Therefore, the MAX8 alternative HLT2 was designed, with a lower overall charge 
state (+5 compared to +7) and thus a less electropositive character. These constructs showed 
comparable gel formation and could both be used for cell encapsulation and syringe delivery of 
cells. However, when primary bovine chondrocytes were encapsulated, the less electropositive 
HLT2 showed higher cell viability and better supported maintenance of morphology.90 Further 
research on MAX1 and the more hydrophobic analogue MAX35 focussed on the lytic 
behaviour. Both constructs bound to negatively charged liposomes and induced release of their 
content by pore formation.91
1.4.2. Short aromatic peptides
Short aromatic peptide derivatives also have the ability to form hydrogels.92,93 Dipeptides 
protected with the fluorenylmethoxycarbonyl (Fmoc) group can self-assemble through the 
formation of hydrogen bonds and π-π interactions. The latter involves the attractions between 
the π-electrons in the aromatic fluorenyl rings of Fmoc. The gel formation of dipeptide Fmoc-
Phe2 was tested, by dissolving the peptide in a basic solution (pH > 8.0). The drop wise addition 
of hydrochloric acid, to lower the pH, resulted in gel formation (Figure 1.9).94 Gelation of the 
dipeptide was also possible in cell culture medium DMEM. Fmoc-Phe2 dipeptides were also 
mixed in a 1:1 ratio with Fmoc-Ser, Fmoc-Lys and Fmoc-Asp. All four resulting hydrogels were 
shown to support the viability of chondrocytes. Cell viability of human dermal fibroblasts was 
increased by the Fmoc-Phe2/Ser and Fmoc-Phe2/Asp gels. The Fmoc-Phe2/Ser gels furthermore 
also supported viability of 3T3 fibroblasts and retention of cell morphology of chondrocytes.95 
In another study, the effect of Fmoc-Phe2 and Fmoc-RGD gels on dermal fibroblasts was further 
investigated. The fibroblasts were encapsulated in a gel containing both Fmoc-Phe2 and Fmoc-
RGD. Adhesion of the fibroblasts was promoted and cell spreading was observed, through 
specific binding of the RGD-motif to integrins. These results show that short aromatic peptide 
derivatives might be used as scaffolds for in vitro tissue regeneration.96 Inspired by the results 
obtained for the natural amino acid phenylalanine, a short peptide sequence containing the non-
proteinogenic amino acid taurine was developed. This motif also proved to be a hydrogelator, 
resulting in gels containing up to 98% water.97 
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Figure 1.9. Hydrogelation of short aromatic peptides. Upon applying an external trigger, the peptides 
associate with each other, leading to self-assembly into hydrogels. Adapted from ref. 92.92
The gelation of short peptide sequences was further investigated by utilizing different aromatic 
capping groups. Peptide sequence Gly-Phe-Phe-Tyr was capped with naphthalene, phenothiazine, 
benzyloxycarbonyl (Cbz) and with Fmoc. All constructs formed nanofibres, which entangled with 
each other to form the hydrogel network. The peptide with capping group phenothiazine was 
the most efficient gelator, as it already could form hydrogels at a very low concentration (0.01 
wt%).98 Analogous to this, pyrene and Fmoc were used as capping group for tyrosine-leucine 
hydrogelators. Both constructs were assembled and co-assembled with serine surfactants, also 
capped with both pyrene and Fmoc. This allows variation in peptide and aromatic content. 
In all cases self-assembly behaviour was found, caused by aromatic interactions as wells as by 
β-sheet-type arrangements.99 In another research, the Phe-Phe sequence was capped with 
indole, resulting in gels with a high storage modulus.100 Constructs with only one amino acid 
were also able to form hydrogels, for example Fmoc-Phe-OH101,102 and Fmoc-Tyr-OH.102 Even 
without the Fmoc group, but with the aromatic pyrene moiety as capping group, gelation of the 
single amino acid Phe was possible.103 
 
1.4.3. Peptide amphiphiles 
An important driving force for self-assembly is amphiphilicity. There are three types of 
amphiphilic peptides distinguished in literature.104 One type of peptide-amphiphiles is composed 
of a hydrophobic aliphatic tail and a hydrophilic peptide sequence, linked to each other via an 
amide bond. Amphiphiles have the ability to self-assemble in aqueous solution, in such a way 
that the hydrophilic domains are exposed to the water, while the hydrophobic regions are 
hidden from the aqueous environment. Amphiphiles can self-assemble in several organizations, 
including spheres, rods, disks, channels and sheets. With the introduction of peptide elements 
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1in amphiphilic molecules, chemical functionalities can be introduced. Peptide amphiphiles often self-assemble in cylindrical micelles, called nanofibres. The core of these nanofibres is formed 
by the aliphatic tail, while the peptide sequence is displayed on the outer surface. This self-
assembly can be controlled by adjustment of the pH or by addition of divalent cations such as 
Ca2+ and Mg2+. When the peptide-amphiphile concentration is sufficient, the nanofibres further 
assemble into a gel.15,105 Since the pioneering work of Stupp et al., peptide amphiphile nanofibre 
gels have been applied in the field of tissue engineering.106 One example is the use of peptide-
amphiphiles containing the cell adhesion motif RGDS. These constructs were tested as scaffolds 
for the delivery of bone marrow derived stem and progenitor cells. In vitro tests showed that the 
cells are viable and proliferative. In vivo tests revealed an increase in the relative bioluminescent 
signal intensity coming from viable cells, indicating cell proliferation. Furthermore, the nanofibre 
gel showed only a mild tissue reaction, suggesting biocompatibility and biodegradability of the 
peptide amphiphiles. These results demonstrate the use of peptide-amphiphiles as injectable 
materials for bone marrow cell therapies.107
Another application of peptide-amphiphiles has been demonstrated by the Kokkoli group.108 
They developed a fibronectin-mimetic peptide amphiphile containing the peptide sequences 
GRGDSP and PHSRN. The sequence GRGDSP contains the tripeptide RGD, which is 
naturally present in the cell binding domain of natural extracellular matrix (ECM) proteins, 
like fibronectin. Peptide sequence PHSRN was incorporated to enhance the activity and 
specificity of the fibronectin-mimetic. These two peptide domains were connected by a linker 
to mimic the natural distance between the respective domains and the overall hydrophobicity/ 
hydrophilicity. The thus designed PR_b peptide [KSSPHSRN(SG)5RGDSP] was linked to a C16 
double hydrocarbon tail, to form the peptide-amphiphile.108 This construct showed excellent 
cell adhesion properties compared to other fibronectin-mimetic peptides, but was unable 
to form hydrogels.108,109 For this purpose, peptide PR_g [GGGSSPHSRN(SG)5RGDSP] was 
synthesized, containing the spacer GGGSS. In contrast to KSS, this spacer was able to promote 
nanofibre formation. Peptide-amphiphiles were created by linkage of peptide PR_g to a C16 
hydrocarbon tail. The PR_g construct self-assembled into nanofibres, followed by a further 
aggregation into hydrogels. In order to test their biological properties, HUVECs (human umbilical 
vein endothelial cells) were adhered on the surface on the gels. A comparison with PEG gels, 
fibronectin-functionalized PEG and commercially available peptide hydrogels (PuraMatrix) 
showed that PR_g hydrogels support cell adhesion and proliferation and thereby outperforms 
the comparison gels. Peptide-amphiphile nanofibre hydrogels are therefore promising as ECM 
mimetic scaffolds in tissue engineering.109 
Several small peptides have been synthesized by the Zhang group as another kind of amphiphilic 
biomaterials.110 These peptides contain alternating hydrophobic and hydrophilic amino acids. 
The charged residues used have an alternating positive or negative charge. Solutions of these 
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peptides in deionized water formed stable β-sheets. After exposure to electrolytes, self-
assembly into nanofibres took place. These fibres further self-assembled into stable hydrogels. 
Peptide concentrations of 0.1-1% were sufficient for gelation to occur. Oligopeptide KLD-12 
was synthesized, aiming for cartilage tissue repair (Figure 1.10).
Figure 1.10. Oligopeptide KLD-12. The peptide contains alternating positive and negative charges, leading 
to the formation of ß-sheets and assembly into nanofibres and gels. Reproduced with permission from 
ref 110.110
An efficient encapsulation of chondrocytes into the hydrogels was achieved. It was shown that 
the chondrocytes were evenly distributed over the hydrogel and maintained a high cell viability 
(>80%). Furthermore, the chondrocytes retained their morphology. The peptide hydrogels 
formed a cartilage-like ECM, showing their potential as scaffold for cartilage tissue repair.110 
Apart from the chondrocytes, other cell interactions with these hydrogels have also been 
investigated, including osteoblasts,111 neural cells112 and endothelial cells.113
Another example of a small amphiphilic peptide for hydrogel formation was recently given by 
the Arosio group. Model peptide RADA 16-1 (RADARADARADARADA) was chosen as it 
is known to self-assemble into fibrils and higher ordered structures. The peptide first formed 
short rigid fibrils with a length of approximately 100 nm. Strong hydrophobic interactions led to 
the formation of longer fibrils and aggregates. At higher peptide concentrations hydrogels were 
formed, which were broken down upon dilution.114
Also peptide-based amphiphilic block copolymers have been designed for hydrogel formation. 
This category contains polymers prepared entirely from amino acids, as well as hybrid systems 
in which polypeptides are combined with synthetic polymers.104 The hydrogelation of diblock 
copolypeptide amphiphiles was investigated by Deming and coworkers. One part of these 
amphiphiles was built up from the polyelectrolytes (poly-L-lysine) or poly(L-glutamate). Both of 
these polyelectrolytes are soluble in water and are highly charged at pH 7. The other part of 
the diblock amphiphiles contained the hydrophobic domains poly(L-leucine) or poly(L-valine), 
which adopt an α-helical or a β-sheet conformation, respectively. Rigid hydrogels were formed 
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1at low concentrations of the diblock amphiphiles in water. These hydrogels were thermally stable, even at temperatures as high as 90°C. When the hydrophobic part was short in length, 
hydrogels could not be formed. This is caused by the fact that the peptides are unable to 
adopt their desired conformation. A slightly better gelation was found for amphiphiles with 
the α-helical conformation. Gelation was furthermore influenced by the balance between the 
hydrophobic and the hydrophilic blocks. The hydrophobic interactions need to be strong enough, 
to stop the swelling caused by the electrostatic repulsion in the polyelectrolyte part of the gel. 
The hydrogels were broken down by applying large-amplitude oscillations, to test their shear 
thinning behaviour. An 80-90% recovery of the mechanical strength was observed within the 
short time period of 10 s. A slower reorganization process then led to the complete recovery 
of hydrogel strength.115 Several variations in the compositions of the diblock amphiphiles have 
been made, to optimize the hydrogel strength in ionic media. This type of hydrogels has shown 
to be stable in cell growth media, salt concentrations up to 0.5 M and in aqueous media of 
varying pH. These features, together with the ability to rapidly recover after shear thinning, make 
these hydrogels promising candidates in biomedical applications such as drug delivery and tissue 
regeneration.116
1.4.4. Multidomain peptides 
Besides relatively simple peptide amphiphiles, coiled-coil and β-sheet forming peptides, also 
multidomain peptides have been designed to form gels. In these peptides, factors favouring 
assembly and factors disfavouring assembly are both present. Mostly, these multidomain peptides 
have an ABA structure. The central B domain contains both hydrophilic and hydrophobic amino 
acids, creating an amphiphile that has the ability to self-assemble. The A domains surrounding 
the B domain consist of charged residues, causing electrostatic repulsion at neutral pH, thereby 
working against the assembly. When these forces are properly balanced, multidomain peptides 
self-assemble into nanofibres and further into hydrogels. Several multidomain peptides have 
been synthesized and compared with respect to their ability to control gelation. Peptides 
containing the positively charged lysine in domain A, self-assemble in the presence of negatively 
charged ions such as phosphate. On the other hand, positively charged ions are required for 
gelation of peptides with glutamic acid in domain A. When hydrophilic glutamines in domain 
B were replaced for serines, a large increase in mechanical strength of the gels was obtained. 
More importantly, these serine-containing peptides were able to undergo shear-thinning and 
recovery of their mechanical strength after shear. Peptides containing both serine and cysteine 
residues in domain B showed a further increase in strength, due to the possibility to make 
cysteine disulfide bonds.117 In a follow-up study, the aromatic residues phenylalanine, tryptophan 
and tyrosine were incorporated in domain B. All multidomain peptides retained their ability to 
form nanofibres, but the presence of aromatic residues influenced the ability to form hydrogels. 
Constructs containing the motif QFQL or QF in the B-block still formed good hydrogels, while 
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constructs with QW or QY only formed short fibres and therefore also poor hydrogels.118 
These results show that gelation of multidomain peptides can be controlled through changes 
in chemical functionalities.117,118 As mentioned, an important goal in tissue engineering is to 
generate materials providing an ECM-like environment for cells. Matrix metalloproteinases 
(MMPs) are used by cells to degrade the matrix, so that it can be replaced by newly synthesized 
ECM proteins. With this in mind, a peptide was synthesized containing the MMP specific cleavage 
motif LRG in domain B and the adhesion motif RGD in one of the A domains. Compared 
to a multidomain peptide without these motifs, increased cell viability, cell spreading and an 
improved cell migration into the hydrogel was observed.14
Peptide-based photo-responsive hydrogels have been synthesized by Huang and co-workers.119 
Their materials contained an azobenzene moiety, which was used as a conformational switch. 
Upon UV-irradiation, a conformational change from (E) to (Z) took place, which changed the 
position of the phenylalanine residues and thereby led to less effective π-π stacking (Figure 
1.11). The azobenzene moiety was coupled to the N-terminus of dipeptides using (E)-2-(4-
(phenyldiazenyl)phenyl) acetic acid. Self-assembly of these azo-dipeptides was thought to occur 
via intermolecular π-π stacking of the phenyl rings from azobenzene and via hydrogen bonding 
of the peptides. A series of azo-dipeptides was synthesized. Constructs containing aromatic 
residues such as phenylalanine and tyrosine easily formed hydrogels. Poor gelation behaviour 
was observed for dipeptides with the cationic residues Arg and Lys. Insertion of phenylalanine or 
tyrosine into these dipeptides (azo-Arg-Ala, azo-Lys-Ala) facilitated gelation. Salt concentration 
and pH also had an effect on the hydrogelation behaviour. Azo-dipeptide hydrogels collapsed 
upon UV-irradiation, due to the expected less effective π-π stacking. The gel reformed after an 
average of two days under ambient visible light. To test the biological applications of these gels, 
vitamin B12 was trapped into azo-Gln-Phe-Ala. Release of B12 took more than two days, but 
was greatly enhanced upon UV-irradiation (4h).119 Velema et al. incorporated the azobenzene 
moiety into the structure of dichromyl molecules. Upon triggering with light, these compounds 
self-assembled into fibres, resulting in gel formation. Another trigger for assembly was NaCl, 
addition of this salt enhanced aggregate formation.120 Recently, constructs were synthesized 
containing an azobenzene motif, as well as alkyl chains and a polyether moiety. These constructs 
readily formed nanofibres in water and displayed multistimuli responsive behaviour. Apart from 
light, changes in temperature, pH and mechanical stress also initiated hydrogel formation.121 
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Figure 1.11. Balanced (A) and disturbed (B) interactions between the azo-dipeptides. Conformation A 
leads to the formation of hydrogels. Adapted from ref 119.119
1.5. Hybrid hydrogels with a polymeric scaffold
Poly(ethylene glycol) (PEG) has widely been used as a component in the synthesis of biomaterials. 
This polymer has good water solubility, lacks toxicity and has a low immunogenicity.122 The 
conjugation of PEG to proteins, known as PEGylation, increases the protein solubility and 
stability. Immunogenicity caused by proteins is reduced by incorporation of the PEG polymer. 
PEGylation prevents receptor-mediated protein uptake by the reticuloendothelial system and 
avoids the rapid renal clearance of small proteins. Therefore, PEGylation can be used as a 
method to prolong the plasma half-life of proteins.123 Furthermore, the PEG chain is flexible and 
is able to associate with water molecules.124 Due to its interesting features, PEG has attracted 
much attention for use in biomedical applications. In 1990, this led to the first FDA approval 
of the PEG-based compound ADAGEN. This compound is used for the treatment of severe 
combined immunodeficiency disease.125-127 Altogether, PEG is very suitable for use as basis in 
the design of hydrogels. 
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Figure 1.12. Structures of the commonly used polymeric scaffolds for hydrogel formation. In this thesis, 
the focus will be on poly(ethylene)glycol (PEG) based hydrogels, as this polymer has good water solubility, 
lacks toxicity, has low immunogenicity and is widely used for the preparation of hydrogels.
Apart from PEG, several other polymers can be used, including poly(propylene oxide) (PPO), 
poly(ethylene oxide) diacrylate (PEODA) and N-(2-hydroxypropyl)methacrylamide (HPMA) 
(Figure 1.12). This section will focus on peptide-based hydrogels with synthetic polymeric 
building blocks.
In the Kiick and Jia group, the synthetic polymer PEG was used in the synthesis of elastin-based 
hydrogels.124 PEG was used to replace the dynamic, entropic peptide segments of elastin. In 
order to maintain the cross-linking properties of natural elastin, a peptide sequence was coupled 
to the polymer using copper (I) catalyzed azide-alkyne cycloaddition (aka ‘click reaction’). 
For this purpose, PEG was functionalized with azides. Based on the hydrophilic cross-linking 
domains of elastin, peptide [X(AKAAAKA)2X] was prepared. X stands for the non-natural 
amino acid L-propargylglycine, containing the desired alkyne functionality. The peptide-PEG 
multiblock contained three to five repeats of PEG and the peptide. A cross-linking procedure 
with hexamethylene diisocyanate was carried out to form urea linkages through the lysine side 
chains of the peptide domain (Figure 1.13).
Hydrogels were afforded, which showed softening behaviour after hydration, similar to natural 
elastin. In vitro toxicity studies with the soluble peptide-PEG product showed some toxicity 
to primary porcine vocal fold fibroblasts. After cross-linking, however, the hydrogel allowed 
fibroblasts to grow and proliferate, showing that the gel does not leach toxic impurities during 
cell culture. The elastin-based PEG-hydrogels are thus promising for use as elastomeric scaffolds 
in tissue engineering applications.124 Further studies performed by the same researchers focused 
on a more straightforward approach to synthesize the (AKAAAKA)2 containing hydrogels. For 
this purpose, PEG was replaced by Pluronics: a PEG- poly(propylene oxide) (PPO)-PEG block 
copolymer. This polymer self-assembles into micelles. To be able to couple the copolymer to 
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1the peptide, a vinyl sulfone end group was incorporated in Pluronics. The lysine amines in the (AKAAAKA)2 peptide showed a high reactivity towards vinyl sulfones, when deprotonated. The 
peptide and copolymer were coupled at a temperature of 60°C, under formation of stable, 
viscoelastic hydrogels.128 
Figure 1.13. Synthesis of the elastin-based polymeric hydrogels. Adapted from ref 124.124
1.5.1. Collagen-based hydrogels with a polymeric scaffold 
Lee et al. combined collagen with poly(ethylene glycol) (PEG) for tissue engineering applications.129 
In their study, poly(ethylene oxide) diacrylate (PEODA) was used. This compound polymerizes 
after exposure with UV light to form a cross-linked PEG gel. The collagen mimetic peptide 
(CMP) (Pro–Hyp–Gly)7–Tyr was incorporated in the backbone of PEODA. The utility of these 
CMP/PEODA hydrogels as tissue engineering scaffolds was examined by the encapsulation of 
chondrocytes. Since the extracellular matrix of chondrocytes is mainly composed of fibrous 
type II collagen, the collagen content in the hydrogels was measured. A 103% increase in 
collagen content was observed compared to non-CMP containing hydrogels, showing that 
CMP enhanced the tissue production of encapsulated cells.129 
1.5.2. Fibroin- and collagen-based hydrogels
Rizzi and co-workers developed a PEG-based material containing protein polymers to support 
tissue repair.130,131 The monomers of the protein polymers were built up from several components. 
One of them was a 15-amino acid sequence based on human fibrinogen, containing a plasmin 
degradation site and the cell adhesion motif RGD. The second component was adopted from 
human collagen and was a matrix metalloproteinase (MMP) cleavage sequence. A block of 
negatively charged amino acids (glutamic acid) was also present, in order to improve the 
solubility of the protein. Finally, the end termini of the proteins contained cysteine residues, used 
as cross-linking sites for the linkage to PEG. The PEG molecule used was functionalized with 
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vinyl sulfone groups, able to react with the cysteine thiol groups. After polymerization of the 
protein monomers, the protein solution was mixed with the PEG solution, resulting in hydrogel 
formation.130 Biochemical analysis revealed that the hydrogels promote cellular adhesion. The 
RGD motif proved to be responsible for this binding, since the mutant with the RGG sequence 
did not support cellular adhesion.131 In another research, fibrinogen was PEGylated in order 
to prepare hydrogels by making use of free radical polymerization. These gels were implanted 
into segmental rat defects to promote new bone formation. After 5 weeks, histology and X-ray 
studies confirmed the formation of new bone tissue.132,133 
1.5.3. Coiled coil based hydrogels 
The coiled coil motif has been used by the Kopeček group as cross-links for synthetic polymers 
to create hybrid hydrogels.134 A linear copolymer was synthesized by radical copolymerization 
of N-(2-hydroxypropyl)-methacrylamide (HPMA) and the metal-chelating monomer 
N-(N’,N’-dicarboxymethylaminopropyl)-methacrylamide (DAMA). The produced polymer had 
iminodiacetate groups in its side-chains. Two His-tagged peptides (CC1 and CC2) containing 
the characteristic coiled-coil motif were also synthesized (Figure 1.14). Peptides CC1 and 
CC2 were separately mixed with the HPMA-DAMA polymer, in the presence of Ni2+. The 
iminodiacetate groups formed complexes with Ni2+, to which the histidines of the coiled-
coil peptides were attached. This process leads to the formation of temperature-responsive 
hydrogels.134,135
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Figure 1.14. A schematic representation of the HPMA-DAMA copolymer and the His-tagged coiled-coil 
peptides. In the presence of Ni2+, complexes with the iminodiacetate groups are formed, to which the 
His-tag is attached. This process leads to hydrogel formation. 
Further research by the Kopeček group focussed on two pentaheptad peptides (CCE and 
CCK), that were grafted onto a maleimide-functionalized N-(2-hydroxypropyl) methacrylamide 
(HPMA) polymer.136 It was found that the peptide should contain at least four heptad repeats to 
ascertain gelation of the HPMA-peptide copolymer.137 The two peptides CCE and CCK were 
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1built up from valine and leucine residues at positions a and d of the heptad repeat (Figure 1.6). The charged amino acid glutamic acid occupied positions e and g for CCE, while CCK 
contained lysine residues at these places. These oppositely charged peptides were designed, to 
act as cross-linkers in the hydrogel formation. In order to improve the solubility of the peptides, 
CCE contained a lysine residue at position f, whereas this was a glutamic acid for CCK. The 
uncharged amino acids serine and alanine occupied the remaining b and c positions. Both 
peptides were functionalized with the tetrapeptide Cys-Tyr-Gly-Gly on the N-terminus. The 
peptides were attached to HPMA via a thioether linkage formed between the N-terminal Cys 
and the maleimide groups of HPMA. Gelation was observed when solutions of CCE-HPMA 
and CCK-HPMA were mixed in a 1:1 ratio. Circular dichroism spectroscopy confirmed the 
formation of the expected two-stranded α-helical coiled-coil between CCE and CCK, which 
appeared to be reversible.136 To investigate the role of the coiled-coil motif in the hydrogel 
formation, mutants of CCE and CCK were synthesized. In both mutants, a single amino acid 
modification resulted in a random coil conformation, showing the importance of the coiled-coil 
motif for gelation.138
A more native design using the coiled coil motif was described by Jing and co-workers.139 
The peptide used in their peptide-polymer system was based on the coiled-coil region of 
human fibrin. The solvent-exposed amino acids b, c and f of the heptad repeat were kept intact. 
Substitutions of the residues at positions a, d and g were made, in order to design a peptide that 
readily oligomerises. Their designed peptide γ52-88KI was functionalized with a terminal cysteine 
residue, to conjugate it to maleimide-containing PEG and thereby create a PEG-peptide 
diblock and a peptide-PEG-peptide triblock. CD analysis showed that PEG did not influence 
the secondary structure, since both constructs still formed coiled-coils. The triblock formed 
transparent, elastic hydrogels, in contrast to the diblock which formed nonviscous solutions. 
This suggests that gelation occurs via the cross-linking of PEG by the coiled-coil motifs.139 In 
a more recent study, the immunogenicity of these triblocks was investigated. Since these tests 
use mouse models, a new triblock was synthesized, in which the peptide (γ-KEI) was based on 
mouse fibrin rather than on human fibrin. The newly synthesized γ-KEI – PEG - γ-KEI triblock 
formed coiled-coil bundles as well as higher-order supramolecular structures such as 12-, 18-, 
30- and 50-mers. This construct did not cause peptide-specific T-cell responses, which was 
shown by the absence of the cytokines IL-2 and interferon-gamma. The triblock provoked 
moderate antibody response in mice, while this was not observed for the native mouse fibrin 
peptide or γ-KEI. The question arises whether the measured moderate antibody response in 
mice influences the application of self-assembling materials for biomedical applications.140 
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1.5.4. β-sheet based hydrogels
Tzokova et al. used the oligomer PEO7 functionalized with a terminal azide.141 Tetraphenylalanine 
was coupled to 4-pentynoic acid in order to introduce an alkyne functionality. Click chemistry 
was then performed to obtain the peptide-polymer construct mPEO7-Phe4-OEt (Figure 1.15). 
Self-assembly of this diblock in water was not possible due to its low solubility. Instead water 
was added to solutions of the construct in THF to prepare a series of varying mPEO7-Phe4-OEt 
concentrations. After removal of THF by dialysis against water, viscous solutions were obtained 
at low polymer-peptide concentrations. At higher concentrations, transparent hydrogels were 
formed. After addition of water, π-π-stacking became dominant, providing a platform for self-
assembly. The self-assembly was also driven by the formation of antiparallel β-sheets. The formed 
hydrogels were shown to be sufficiently strong to make biomedical applications possible.141 
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Figure 1.15. The mPEO7-F4-OEt construct, in which click chemistry was used to link the peptide and the 
polymer. Self-assembly was triggered by addition of THF to aqueous solutions, after which dialysis resulted 
in transparent hydrogels.
In a further study, the effect of mPEO length on the self-assembly behaviour was investigated. 
Circular dichroism spectroscopy was used to measure the amount of π-π-stacking for constructs 
with mPEO molecular weights of 350, 1200 and 1800 Da. For the shortest mPEO length, 
some π-π-stacking was observed as well as β-sheet formation. For the largest mPEO-Phe4-
OEt construct, π-π-stacking was clearly dominant. This indicates that a longer polymer length 
disrupts the formation of the preferred β-sheet conformation of the peptide. The structures 
that were obtained for the mPEO-Phe4-OEt constructs varied from nanotubes and fibres to 
micelles for the longer mPEO blocks. Apart from tetra-phenylalanine, tetra-valine was also 
clicked to the mPEO polymers of the three different lengths. For all these three mPEO-Val4-OEt 
constructs, a mixture of β-sheets and random coils was observed. Valine is more hydrophobic 
than phenylalanine and has a great tendency to form β-sheets. These valine-containing diblocks 
formed wide, plank-like structures after dialysis. Due to the dominance of β-sheet formation, 
self-assembled structures were obtained that closely resemble those formed by the peptides 
alone. The length of the PEO polymer did not seem to influence this self-assembly behaviour. 
These results show that both the choice of peptides and the length of the polymer influences 
the self-assembly behaviour of these peptide-PEO constructs.142 The β-sheet forming principle 
was also used by Castelletto and co-workers. Peptide DGRFFF was chosen as it has a β-sheet 
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1secondary structure and contains the cell-binding motif RGD. This peptide was linked to PEG and at sufficiently high concentrations β-sheet aggregates were formed. Films of the peptide-
polymer construct were prepared on tissue culture plate. Fibroblasts cultured on these films 
remained viable and showed cell proliferation.143
1.6. Chemical cross-linking methods
As described before, hydrogels retain their stability through cross-links between the polymeric 
constituents. These cross-links are chemical or physical in nature and prevent the uncontrolled 
dissolution of the polymer chains in an aqueous environment. Chemical cross-linking allows 
control over the cross-linking density, as well as over the final mechanical properties of the 
hydrogel. Numerous chemical cross-linking methods have been utilized for gel formation. Many 
of these methods are termed ‘click’ reactions. Requirements to be classified as click reaction 
are a near quantitative conversion, biological compatibility and limited by-products.144 In the 
last part of this chapter, a number of prominent examples of chemical cross-linking methods 
for hydrogel formation are mentioned, all with PEG as the polymeric basis. Except for radical 
polymerization, they can all be classified as click reactions. For a more extensive overview of 
click reactions for hydrogel formation and other conjugates, one is referred to excellent recent 
reviews by Tang et al. and Jiang et al.144,145 
1.6.1. Radical polymerization
Radical polymerization involves the formation of free radicals by means of UV-light, visible light, 
redox reactions or temperature. Photopolymerization is a type of radical polymerization that 
mainly uses UV light.146 This chemistry was used by the Hubbell group for hydrogel formation 
using PEG as the central domain. PEG was modified with oligomeric α-hydroxy acid. After 
addition of a photoinitiator to the polymeric solution, UV irradiation resulted in the formation of 
hydrogels. These gels appeared to be useful for the controlled release of proteins.147 In another 
research, redox initiated free radical polymerization was used to make photodegradable PEG-
based gels. For this purpose, a photolabile nitrobenzyl ether-derived moiety was first linked 
to PDA (photodegradable acrylate). Hydrogels were formed after copolymerization of the 
photolabile acrylate to PEG. These hydrogels are degradable, as the PEG monomers are released 
upon irradiation. Complete degradation also releases the (poly)acrylate chains. Incorporation of 
cell-binding domain RGD allowed cell migration and differentiation.148 A disadvantage of using 
radical polymerization for hydrogel formation is the presence of free radicals. These radicals can 
be transferred to proteins, which might lead to degradation or a reduced bioactivity.146 
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1.6.2. CuAAC
The Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) as introduced by Meldal and 
Sharpless, is commonly known as the first click reaction (Figure 1.16). CuAAC has been 
widely used for many applications. A huge advantage of this chemistry is the orthogonality, 
since both the azide and alkyne are unreactive towards biological molecules.149-151 Hydrogels 
were also prepared with CuAAC as cross-linking method. Azide-functionalized 4-armed PEG 
and diacetylene-functionalized PEG gave a well-defined hydrogel network upon catalysis by 
copper.152 Enzyme degradable CuAAC hydrogels were also prepared by cross-linking 4-armed 
alkyne-functionalized PEG to a protease-sensitive bis-azido peptide.153
 
R1 N3 R2
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R2
R1
R2
R2
N
N
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+
+
Figure 1.16. CuAAC and SPAAC reaction
1.6.3. SPAAC
A disadvantage of CuAAC as cross-linking method is the need of the heavy metal catalyst. This 
hampers its use for in vivo applications as copper is cytotoxic to both bacterial and mammalian 
cells. As a solution to this problem, ring strain was introduced to activate alkynes for their 
reaction with azides. This copper-free click chemistry between a ring-strained alkyne and azide is 
named SPAAC (strain-promoted azide-alkyne cycloaddition) (Figure 1.16). Except from being 
orthogonal and efficient, the SPAAC reaction can also be applied in living sytems.154-156 The use 
of SPAAC for hydrogel formation was demonstrated by DeForest and coworkers, who cross-
linked azide-functionalized star-shaped PEG to cyclooctyne-containing peptides. This peptide 
sequence was composed of an enzyme degradable motif, which allowed the cells to spread 
and migrate through the hydrogel material. High cell viability (>90% after 24h) was observed 
after encapsulating fibroblasts, showing the potential of SPAAC cross-linked gels for biological 
applications. Moreover, by incorporation of the orthogonal thiol-ene photochemistry, the gels 
could be used for 3D patterning of biological functionalities.157 In other examples where SPAAC 
was utilized, high viability of human mesenchymal stem cells and bone marrow derived stromal 
cells was demonstrated.158,159 The tethering and tunable release of drugs from SPAAC cross-
linked PEG-gels has also been shown.160 Furthermore, the incorporation of labile ester linkages 
near the SPAAC cross-links gave rise to controlled degradation of the hydrogels.161
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11.6.4. Diels-Alder conjugationDiels-Alder chemistry is the [4+2] cycloaddition between a diene and a dienophile (Figure 
1.17). Since this reaction is highly accelerated in water and chemoselective, it is a useful 
cross-linking method for gelation.162 Wei et al. demonstrated the formation of hydrogels using 
Diels-Alder by coupling poly(N,N-dimethylacrylamide-co-furfuryl methacrylate (dienes) to 
maleimide-functionalized PEG.163 Nimmo et al. used the same chemistry to make hydrogels 
containing hyaluronic acid (HA), a natural polymer highly abundant in the extracellular matrix. 
HA was modified with furan groups and then cross-linked to bis-maleimide PEG. Hydrogels 
were formed with tuneable mechanical and degradation properties and were shown to be 
cytocompatible.164 The inverse electron demand Diel-Alder reaction between tetrazines and 
norbornene was used by the Anseth group to make cytocompatible hydrogels (Figure 1.17). 
Cross-linking of 4-armed PEG tetrazine to an ECM mimetic cell degradable dinorbornene 
peptide quickly resulted in hydrogel formation. Gels were shown to be suitable for cellular 
encapsulation as human mesenchymal stem cells retained high cell viability after being 
encapsulated for 72 h.165 
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Figure 1.17. Diels-Alder and thiol-ene chemistry.
1.6.5. Thiol-ene chemistry
Thiol-ene chemistry is the reaction between a thiol and unsaturated functional groups such 
as alkenes or norbornene (Figure 1.17). The orthogonality as well as high efficiency of this 
coupling procedure makes it suitable for hydrogel formation.151,166 Aimetti et al. showed that 
norbornene-functionalised four-armed PEG can form hydrogels with thiol-functionalised 
enzyme sensitive peptides (human neutrophil elastase) upon photo irradiation. The obtained 
hydrogels are degradable, which was shown through release of the model protein bovine 
serum albumin (BSA).167 The thiol-norbornene photopolymerization was also utilized to 
make hydrogels with matrix metalloproteinase (MMP) or chymotrypsin degradable cross-
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linkers. Human mesenchymal stem cells retained high cell viability upon encapsulation in these 
hydrogels.168 In another example, pancreatic β-cells were encapsulated in the hydrogel network 
and could be regained via chymotrypsin-mediated gel erosion.169 Further studies on hydrogels 
formed by thiol-ene chemistry revealed that degradation of the network is primarily caused 
by ester bond hydrolysis. Degradation was accelerated when network formation was less ideal, 
which allows tuning of the degradation process.170 
1.6.6. Michael-type additions
Michael-type additions are widely used as cross-linking method for hydrogel formation (Figure 
1.18). Vinyl sulfone functionalized multi-armed PEG was reacted with bis-cysteine peptides, 
yielding elastic hydrogels. When the RGD or MMP sequence was chosen as the peptide cross-
linker, cell adhesive and degradation properties were introduced, respectively.171 The same cross-
linking approach was also used to incorporate resilin-like polypeptides to mimic the elastomeric 
properties of natural resilin. Fibroblasts encapsulated in the formed hydrogels remained viable, 
thereby making these resilin-functionalized gels promising in cardiovascular tissue engineering.172 
Another Michael-type addition is the reaction between a maleimide and a thiol moiety. Phelps 
and co-workers prepared a maleimide-functionalized 4-armed PEG molecule, which was reacted 
with a thiol-modified RGD-containing peptide. The resulting hydrogels were efficiently formed, 
even at low polymer concentrations.173 Another type of Michael addition was recently reported 
between acrylate and amine groups. Eight-armed PEG molecules with acrylate end-groups 
were reacted with different amounts of cross-linker NH3 to yield a range of hydrogels. The 
excess of the small ammonia cross-linker could easily be removed by evaporation. By changing 
the amounts of NH3 the cross-linking density and thereby the final mechanical properties of 
the gels could be tuned.174 
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Figure 1.18. Michael type additions. 
1.6.7. Native chemical ligation
Native chemical ligation is the reaction between an N-terminal cysteine and a thioester. 
An S-acyl covalent intermediate is formed, which rapidly undergoes S- to N-acyl migration, 
thereby forming a new amide bond (Figure 1.19). The reaction can be performed in mild 
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1aqueous conditions and is highly efficient. Native chemical ligation was used for cross-linking by the Messersmith group. For this purpose several dipeptides were synthesized containing an 
N-terminal cysteine. Polymer 4-armed PEG was modified with either a dipeptide or a thioester 
moiety. Mixing of aqueous solutions of both polymers (10 – 20 wt%) resulted in hydrogel 
formation within minutes.175 
1.6.8. Oxime chemistry
Recently, oxime chemistry was introduced as a novel hydrogel cross-linking method. Oxime 
chemistry is the reaction between an aminooxy group and an aldehyde or ketone (Figure 1.19). 
Grover et al. demonstrated that this chemistry is suitable for gel formation as it allows control 
over the reaction kinetics and efficiency. Hydrogels were prepared using eight armed aminooxy 
functionalized PEG and glutaraldehyde. Introduction of cell binding domain RGD revealed that 
the oxime-formed gels supported mesenchymal stem cell incorporation.176 The Becker group 
further investigated oxime cross-linked hydrogels. The gelation time and mechanical properties 
of the gels can be tuned by pH and by addition of a catalyst. Gels formed faster and appeared 
to be much stiffer at pH 4.5 than at pH 7.6. Addition of catalyst aniline resulted in stronger gels, 
with shorter gelation times.177
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Figure 1.19. Oxime chemistry and native chemical ligation.
1.6.9. Combined click reactions
This paragraph clearly showed the potential of click reactions for hydrogel formation. Recently, 
the Dove group decided to combine two click reactions to create a double network gel. A 
dual cross-linking method was developed in which simultaneously a loose and a dense network 
were formed. The loose network was prepared by Diels-Alder norbornene-tetrazine chemistry. 
The nucleophilic thiol-alkyne addition was utilized for formation of the dense network. The 
hydrogels were formed rapidly under physiological conditions. Rheological analysis showed that 
gels had a high mechanical strength. Due to the bioorthogonality of the two click reactions, the 
gels were also suitable for encapsulation of human cells.178
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1.7. Outline
This introductory chapter showed that there are multiple ways to develop hydrogels, aiming 
for use in biomedical applications. Hydrogels show distinctly different properties when cross-
linked via physical or via chemical methods. The way in which cross-linking occurs determines 
the mechanical properties of the gel, the biocompatibility and has an influence on hydrogel 
administration. With control over the cross-linking method, the gel properties can also be 
controlled, which facilitates their clinical use. In this thesis, several bio-inspired cross-linking 
methods for hydrogel formation are studied, with the aim to develop adaptive scaffolds for 
bone tissue engineering. In Chapter 2, we investigate the possibilities to construct physically 
cross-linked hydrogels by adopting calcium-binding peptide motifs found in nature. These 
domains were conjugated to star shaped poly(ethylene)glycol (star-PEG). The hydrogel forming 
capacity was studied by addition of calcium ions, to induce ionic cross-links between the 
polymeric constituents. After studying this physical cross-linking method, we switched our focus 
to chemically cross-linked hydrogels. We employed the copper-free click reaction between a 
ring-strained alkyne (BCN) and an azide (SPAAC) for the formation of soft PEG hydrogels. 
The biocompatibility of these gels was investigated, by performing several cell adhesion studies 
(Chapter 3). A new type of chemical cross-linking method is reported in Chapter 4, in which 
we used the oxidation controlled reaction between alkyne BCN and a catechol (SPOCQ). The 
novelty of this method lies in the fact that for the first time a fast and activatable click chemistry 
approach is obtained. Both chemical cross-linking methods SPAAC and SPOCQ were further 
used in Chapter 5, where hydrogels were combined with peptide amphiphile fibres. By 
magnetic alignment of the fibres and entrapment of the aligned structures in a hydrogel matrix, 
we aimed for creating a scaffold to direct the growth of neuronal cells. In the final chapter, we 
focus on combining physical and chemical cross-linking methods to make dual cross-linked gels. 
For this purpose, we explored bisphosphonate moieties, which efficiently interact with Ca2+ to 
yield physically cross-linked gels and combined this methodology with chemical SPOCQ cross-
linked gels (Chapter 6). 
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Physical cross-linking of star-PEG polymers 
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2.1. Introduction
Bone tissue is composed of the two cell types osteoblasts and osteoclasts, responsible for 
bone mineralization and bone resorption, respectively. These cells are embedded in an organic 
matrix composed of collagen and hydroxyapatite. Collagen is the main structural component, 
which gives the bone its tensile strength. The inorganic part of bone tissue is made up of the 
calcium and phosphate-containing mineral hydroxyapatite: Ca5(PO4)3OH. Much research has 
been carried out in the field of bone tissue engineering, in order to find scaffolds for bone repair. 
Two important criteria in the development of these scaffolds are degradability and the ability 
to induce apatite formation.1 Materials that mineralize bone tissue are usually non-collagenous 
proteins, with strong calcium-binding features.1,2 These calcium-binding motifs are abundantly 
present in nature.
An important class of proteins with mineralizing capacity and strong calcium-binding features 
are the bone sialoproteins. These highly glycosylated proteins contain two glutamic acid-rich 
domains and a C-terminal RGD-integrin binding sequence. Sialoproteins can promote cell 
adhesion and provide hydroxyapatite nucleation. Important in the nucleating activity is the first 
glutamic acid-rich domain, in which 16 of the 46 residues are glutamic acid (Glu) amino acids. 
Apart from a block containing 8 glutamic acid residues in a row, this domain also contains a 
number of serine residues. The second glutamic acid-rich domain also has nucleating activity, but 
needs posttranslational modifications in order to be active.3 Another example of an apatite-
binding protein is osteonectin. This glycoprotein contains 4 domains and a total of 287 amino 
acids. N-terminal domain I is again rich in Glu, and appears to be responsible for hydroxyapatite 
binding, due to its high glutamic acid content, whereas domain II is rich in cysteine and contains 
N-glycosylation sites. Domains III and IV are made up of EF-hand motifs, which are helix-loop-
helix structural domains responsible for binding of calcium ions.4 A different type of apatite binder 
is the non-collagenous bone protein osteocalcin. Characteristic about this protein are the three 
γ-carboxyglutamic acid residues, formed by the posttranslational modification of glutamic acid. 
These modified Glu-residues are responsible for hydroxyapatite binding. The γ-carboxyglutamic 
acid binding motif is not capable of binding to amorphous calcium phosphate, which implies that 
the protein specifically binds to the surface of hydroxyapatite.2,5 The role of the Glu domains in 
hydroxyapatite binding was further supported by studies with Glu6 peptides as a model system. 
Moreover, studies with peptides containing fewer Glu residues showed lower binding affinity 
to hydroxyapatite.4 
In contrast to the previous examples, glutamic acid (or related) residues are not responsible for 
apatite binding in the last class of proteins, the phosphophoryns. This protein is mainly composed 
of phosphorylated serines and aspartic acid residues. Phosphophoryns precipitate upon binding 
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to calcium, but this feature is lost after dephosphorylation of the serine residues. Additionally, 
blocking of the acidic side chain of aspartic acid also results in loss of the calcium binding ability. 
Both residues are therefore important for binding to calcium as well as to hydroxyapatite.6,7 
As described above, calcium is important in the mineralization of bone tissue, but it also has 
a function in many other biological processes. Calcium is essential for the cell as it regulates 
several cellular processes, including cell metabolism, cell death, cell cycle, signal transduction and 
neurotransmission. A large number of calcium-binding proteins have been identified in nature. 
An important class of these are the EF-hand calcium-binding proteins, consisting of calcium-
buffering and calcium-sensing members. The difference between these two is that calcium-
sensing proteins undergo a conformational change upon Ca2+ binding, which does not occur 
for calcium-buffering proteins. The most prominent member of the calcium-sensing proteins 
is calmodulin, which is expressed in all eukaryotic cells. The important structural motif, the 
EF-hand domain, consists of an N-terminal and C-terminal helix (named E and F). The central 
Ca2+ coordinating loop is located between the two helices. Calmodulin consists of four EF-hand 
motifs, able to bind four calcium ions. Seven carboxylate ligands are responsible for coordinating 
Ca2+ in each binding loop. A conformational change occurs upon calcium binding leading to a 
more open conformation of calmodulin. As a result the hydrophobic methionine residues are 
exposed to the solvent, leading to release of free energy. This conformational change is the basis 
of action of calmodulin, as the released energy is used to transduce calcium signals (Figure 
2.1).8,9
A B
Figure 2.1.The conformational change of calmodulin (A) upon interaction with calcium (B). Calcium 
binding leads to a more open conformation, resulting in the exposure of hydrophobic residues (methionine, 
shown in purple).8
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Apart from proteins with calcium-binding properties, there are also natural polysaccharides 
with this ability. Alginate is the most commonly known calcium-binding polysaccharide, which 
is present in the cell wall of brown algae. It is composed of the two monomers α-L-guluronic 
acid (G) and β-D-mannuronic acid (M) (Figure 2.2). In the polymer, blocks of one of the 
monomers are present, as wells as regions with alternating units. Alginates from different 
natural sources are different in their proportion of M and G blocks. An important feature of 
alginate is its ability to form gels with divalent cations such as Ca2+, Ba2+ and Sr2+. Gelation is 
not induced by monovalent cations and by Mg2+.10-12 Gelation is mainly achieved by binding of 
the cation to the guluronic acid regions of alginate. A strong binding to calcium was observed 
in a cooperative manner for polyguluronic acid segments of at least 20 monomers. A similar 
polymannuronic acid segment of alternating MG blocks did not show cooperative binding to 
calcium. This suggests a mechanism in which binding of one ion facilitates binding of the next. 
The mode of gelation of alginate is called the egg-box model. The guluronic acid segments form 
two chains with a buckled shape, with cavities in between which can accommodate a calcium 
ion. This model also explains why alginate gels with a higher guluronic acid content have better 
mechanical properties.13 
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Figure 2.2. Alginate; G = guluronic acid, M = mannuronic acid.
In summary, nature has developed many calcium-binding motifs in different proteins, like 
bone sialoproteins and EF-hand proteins, but also in polysaccharides like alginate. Interestingly, 
calcium-binding in all of these examples depends on the electrostatic interactions between 
the positively charged calcium and negatively charged carboxylate groups, such as glutamic 
acid, aspartic acid or related residues. Only in the alginate example, calcium-binding has been 
utilized for hydrogel formation. Surprisingly, the strong calcium binding properties found in 
nature hardly have been translated to synthetic polymers. Our goal therefore is to develop 
synthetic calcium-cross-linkable polymers (Figure 2.3). For this purpose, we first synthesized 
several bio-inspired peptides and explored their calcium-binding features (Paragraph 2.2). 
The next step was the conjugation of these calcium-binding peptides to poly(ethylene)glycol 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
56    Chapter 2
(PEG), to obtain peptide-polymer constructs (Paragraph 2.3). It was envisaged that addition 
of calcium to these constructs should lead to physical cross-links between the polymers; hence 
the propensity to hydrogel formation of the constructs was investigated. 
Ca2+
Figure 2.3. Formation of a polymeric network, a hydrogel, upon addition of calcium (red) to calcium-
binding polymers (black)
2.2. Synthesis and analysis of Ca2+ binding peptides
2.2.1. GE7G 
As explained in the introduction, glutamate domains are responsible in most proteins for Ca2+ 
binding ability, as was for example seen for osteonectin. Our first choice for a calcium-binding 
peptide therefore was an oligo-glutamate to induce Ca2+ binding (Figure 2.4).14 
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Figure 2.4. Calcium binding peptides. A) Binding principle, physical interaction between anionic residue 
and positively charged calcium. B) Peptide GE7G (2).
Solid phase peptide synthesis (SPPS) was utilized as method for peptide synthesis. This method 
easily allows us to control the number of acidic moieties in the peptide. A 2-chlorotrityl resin 
was utilized for the synthesis of oligo-glutamates Glu6, Glu7 and Glu8. Although synthesis of all 
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three oligo-glutamates was successful, some solubility issues were encountered for Glu8, as it was 
hardly soluble in water. We therefore decided to continue our research with oligo-glutamate 
Glu7 (E7). In order to prevent racemization when either the N-terminus or C-terminus was 
utilized for further modifications, the Glu7 part was flanked by glycine residues yielding peptide 
GE7G (2). The next step was to investigate the calcium-binding features of the oligo-glutamate. 
As it was expected that Ca binding would lead to a conformational change in the peptide, 
circular dichroism (CD) spectroscopy was employed. 
A CD spectrometer measures the difference in absorbance between counter-clockwise 
rotating (left-handed, L) and clockwise rotating (right-handed, R) circularly polarized light. A 
CD signal will only be recorded if there is a chromophore which is optically active (chiral). In 
case of peptides, measurements will occur in the far UV region (190-250 nm), as the peptide 
bond functions as the chromophore. CD can be used as an analysis method for peptides to 
determine their secondary structure and also to determine whether ligand binding changes the 
conformation.15 CD spectra were recorded for a solution of peptide GE7G (2; 0.4 mg/mL) in 
Tris buffer (pH 8.9). The peptide adopted a random coil, indicated by the characteristic negative 
signal around 198 nm. Based on the number of carboxylic acid moieties in the peptide, up to 
16 equivalents CaCl2 were added, but this did not change the conformation of the peptide 
(Figure 2.5). 
Figure 2.5. Circular dichroism (CD) spectra of peptide GE7G (2) with several equivalents of Ca2+. A 
random coil conformation was measured prior and after addition of calcium.
However, this does not necessarily imply that Ca2+ binding to GE7G (2) does not occur. We 
therefore turned to isothermal calorimetry (ITC) analysis. This technique measures the heat 
generated or consumed upon interaction of two molecules. One of the molecules is loaded in 
the sample cell, which is maintained at a constant temperature. The other molecule, the ligand, 
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is loaded in the syringe. Small volumes of the ligand are titrated into the sample solution. The 
heat of the binding process (enthalpy ΔH) is measured for each injection. The heat is integrated 
as a function of the molar ratio between the two molecules to yield a titration curve. Since 
the binding sites become more saturated with the ligand over time, the heat signal diminishes 
progressively. The titration curve can be fitted in various binding models in order to obtain 
binding constants such as the stoichiometry of the interaction, the affinity constant (K), Gibbs 
free energy (ΔG) and entropy (ΔS) (Figure 2.6).16 
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Figure 2.6. A typical isothermal calorimetry (ITC) spectrum, showing the binding of 1-adamantylamine 
to β-cyclodextrin. A) Plot showing the exothermic heat release upon injection of the syringe solution into 
the cell solution. B). Plot showing the integrated heat data. A typical S-shaped differential binding curve is 
obtained, which can be fitted into a binding model to obtain the binding parameters.16
In order to estimate the calcium-binding features of the oligo-glutamate, a solution of GE7G (2; 
100 µM) in HEPES buffer was loaded in the sample cell. A solution of ligand CaCl2 in HEPES 
buffer was added to the syringe and titrated in the peptide solution. ITC analysis revealed 
an endothermic reaction, since the injection peaks were positive in value (Figure 2.7 A-C). 
A range of calcium concentrations (1.25, 2.5 and 5 mM) were added to the peptide (2), in 
order to get more insight in the binding process. The value for the heat generated per injection 
appeared to be twice as high when the calcium concentration was doubled from 1.25 mM 
to 2.5 mM. Furthermore, the peptide reached its saturation point at an earlier stage. These 
effects were more pronounced when a 5 mM calcium solution was titrated. We thus observed 
an injection pattern, but the high calcium concentrations used might lead to background heat 
signals, caused by the solubility effect. We therefore conducted a control experiment in which 
CaCl2 (5 mM) was titrated into HEPES buffer (Figure 2.7 D). 
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Figure 2.7. ITC spectra for the interaction between peptide GE7G (2; 100 µM) and varying amounts of 
CaCl2 (A-C) A) 1.25 mM CaCl2 B) 2.5 mM CaCl2 C) 5.0 mM CaCl2 D) Background spectrum of CaCl2 
(5 mM) in HEPES buffer. 
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A typical background spectrum was recorded, lacking the progressive change in heat signals 
upon injection. The plot of the enthalpy change (ΔH) against the molar ratio also gave randomly 
distributed signals. Now that we confirmed that the observed injection peaks for peptide GE7G 
(2) are not background signals, we attempted to estimate the binding parameters from the 
recorded ΔH spectrum. The data points did not follow the typical S-curve, usually seen in ITC 
graphs (compare Figure 2.6 with 2.7). We tried to fit the data but unfortunately, we were not 
able to find a model to fit all obtained data points. This might be caused by the large number 
of possible dependent binding sites (8) present in the peptide (7 Glu side chains and the C 
terminus), which might give rise to a more complicated binding event. As a consequence of the 
lack of a suitable binding model, we could not reliably estimate binding parameters for calcium 
to GE7G (2). An important point to mention is that the effect of binding of calcium to GE7G 
seems to be small. Values for the heat released upon interaction are significantly lower than 
for calcium-binding examples found in literature (for example: EDTA). A comparison with the 
example ITC curve (compare Figure 2.6 with 2.7) also shows this, which indicates that the 
binding between the peptide and calcium is weak.16-20
Our next step was to examine the interaction of peptide 2 with Ca2+ using dynamic light 
scattering (DLS). This analysis technique is based on the principle that molecules in solution 
experience Brownian motion. When light is passed through the solution, it will be scattered 
by the molecules. DLS measures the fluctuations in scattering intensity due to the Brownian 
motion. The scattering intensity will change faster, if particles move faster. Temperature, viscosity 
of the solvent and size can have an effect on the diffusion rate of molecules. In DLS, both 
temperature and solvent are constant, meaning that variation in scattering intensity can directly 
be related to the size of the molecule. DLS was used as a technique to measure calcium binding, 
since we expected calcium to make cross-links between peptides, leading to aggregation. DLS 
was performed on peptide GE7G (2) prior and after addition of several equivalents of calcium 
(Figure 2.8). In the presence of calcium, a small shift was observed towards molecules with a 
larger size, indicating the formation of small aggregates. In conclusion, it is likely that binding of 
calcium to peptide GE7G (2) takes places. This is based on the measured shift in DLS and on 
ITC analysis showing typical progressively decreasing signals of generated heat, and the fact that 
these signals change with changing calcium concentration. Although quantification of the effects 
and the mode of binding remained elusive, we still decided to continue with peptide GE7G 
in further steps in reaching our goal to develop peptide-polymer based calcium cross-linked 
hydrogels (see Paragraph 2.3.2). 
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Figure 2.8. Dynamic light scattering (DLS) spectra of peptide GE7G (2) with several equivalents of 
calcium.
2.2.2. Calmodulin binding domains
As a second binding motif, we focused on calmodulin, which, as described in the introduction, 
is a well-known calcium-binding protein, containing 4 EF-hand domains. The Ca2+ binding loop 
of these domains is composed of 12 amino acids. We decided to synthesize these four peptide 
segments by SPPS, whereby each fragment was flanked by an N-terminal and/or C-terminal 
glycine. Calmodulin domain 4 has the sequence DIDGDGQVNYEE (residues 130-141) and 
was obtained in high purity, but did contain a small fraction with an amino acid deletion (~10%). 
The same result was obtained for domain 1, peptide DKDGDGTITTKE (residues 21-32). Both 
domain 2 (4; DADGNGTIDFPE, residues 57-68) and domain 3 (6; DKDGNGYISAAE, residues 
94-105) were obtained in a pure form employing SPPS. Since these two peptides could directly 
be used without further purification, we decided to start with these for analysing the calcium-
binding features. ITC analysis was conducted on calmodulin domain 3 (6). When the sample cell 
was loaded with the peptide (6) in a concentration of 100 µM, spectra were obtained which 
very much resembled the background spectrum of Ca2+ in water (Figure 2.7 D, Figure 2.9 
A). The same measuring conditions were utilized for domain 2 (4), which also hardly gave any 
heat signals. We decided to increase the peptide concentration for domain 2 (4) to 500 µM and 
measured ITC again (Figure 2.9 B). For low calcium concentrations (1.25 mM and 2.5 mM) the 
same background resembling binding isotherms were obtained. We measured a certain trend 
with a further increased calcium concentration (5 mM), since the measured heat signals showed 
a progressive decrease. However, the intensity of these signals was very low, despite the high 
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peptide concentration. Moreover, the plot of ΔH showed a random distribution. The absence 
of the S-shaped binding curve can be caused by a buffer mismatch, the existence of more than 
one binding event or by the fact that binding does not occur. Since the buffer was kept constant 
in the experiment and only calcium binding was analysed, it is likely that the observed heat of 
injection (ΔH) is due to absence of binding.
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Figure 2.9. ITC spectra of the interaction between the calmodulin domains and CaCl2, in HEPES buffer. 
A) Calmodulin domain 3 (6; GDKDGNGYISAAEG, 100 µM) and 2.5 mM CaCl2. B) Calmodulin domain 2 
(4; GDADGNGTIDFPEG, 500 µM) and 5.0 mM CaCl2.
Based on the ITC results obtained for calmodulin domain 2 and 3 (4,6), we concluded that 
binding of Ca2+ to these peptides does not occur, or at least cannot be measured properly using 
ITC. As an alternative characterization technique, we performed DLS analysis on calmodulin 
domain 2 (4; 100 µM) with an excess of calcium (2.5 mM) (Figure 2.10). 
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Figure 2.10. DLS spectra of peptide calmodulin domain 2 (4; GDADGNGTIDFPE, 100 µM) prior and 
after addition of calcium (2.5 mM).
Upon addition of Ca2+ a shift in particle size was observed, indicating the formation of peptide 
aggregates. This result indicates that calmodulin domain 2 (4) has calcium-binding properties, 
which is therefore in contrast to the ITC analysis. Since these two analysis techniques did not 
lead to conclusive results, we decided not to discard these sequences, but still consider them 
as potential binding motifs in peptide-polymer constructs which can be physically cross-linked 
with Ca2+ (Paragraph 2.3.3). Analysis of another nature-inspired calcium-binding peptide 
sequence was less ambiguous. One of the two calcium binding domains of the intracellular 
calcium-binding protein parvalbumin (residues 52 – 63) was synthesized. Although solid phase 
synthesis of peptide DKDKSGFIEEDEG was successful, we did not find any effect upon addition 
of calcium ions with CD and DLS analysis (data not shown). 
2.2.3. G[LEELLEE]2G
Several metal ions have the ability to induce the assembly of peptides into α-helical coiled-
coils.21 An example was given for a peptide derived from a marine snail, which showed α-helix 
formation upon addition of calcium.18 As also outlined in Chapter 1, most of these coiled-
coil sequences contain the characteristic heptad repeat abcdefg, with hydrophobic residues 
located at one side of the helix (positions a and d). The thus obtained hydrophobic interhelical 
interfaces promote the aggregation into coiled-coil dimers. Recently, the Börner group utilized 
these design rules to develop a peptide with a calcium-dependent self-assembly into an 
α-helix.22 These researchers investigated peptide sequence LLEELLEELEELLEEFG and showed 
a clear shift from a random coil to an α-helix with CD spectroscopy upon addition of Ca2+. The 
abundance of glutamates in the peptide clearly indicates calcium-binding features. This inspired 
us to synthesize the closely resembling peptide G[LEELLEE]2G (8). Solid phase peptide synthesis 
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using the 2-chlorotrityl resin afforded the peptide in good purity. We adopted the measuring 
conditions of the Börner group to measure CD of peptide G[LEELLEE]2G (8) (Figure 2.11).22 
As seen for the characteristic minima around 208 nm and 220 nm, the peptide indeed adopts 
an α-helical conformation. Surprisingly, this secondary structure was already obtained prior to 
calcium addition. A calcium-induced assembly of the peptide was not measured. 
Figure 2.11. CD spectra of peptide G[LEELLEE]2G (8) with several equivalents of calcium, showing an 
α-helical conformation in all cases. 
Our peptide sequence only differed in the N-terminal amino acid, being a glycine instead 
of a leucine and in the absence of the phenylalanine residue. The latter one was added for 
spectroscopic purposes and the leucine was introduced to increase hydrophobicity. Both were 
not expected to have an influence on the secondary structure of the peptide. However, the 
authors indicate that there is a fragile balance between the two secondary structures. This 
might explain why we could not measure the conformational shift for our peptide. Since CD 
analysis did not answer the question whether peptide G[LEELLEE]2G (8) has calcium-binding 
properties, we continued our analysis with ITC. The sample cell was loaded with 100 µM 
peptide G[LEELLEE]2G (8) and the syringe was loaded with 1.25 mM calcium chloride. ITC 
analysis showed an exothermic reaction, as negative heat signals were measured. As expected, 
the intensity of these signals decreased over time. An almost straight line was seen in the plot 
of the enthalpy change ΔH which was impossible to fit into a model to obtain the binding 
parameters. Nevertheless, a trend was visible when looking at the heat signals, which indicates 
that calcium binding to G[LEELLEE]2G (8) occurs (Figure 2.12). 
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Figure 2.12. ITC spectrum of G[LEELLEE]2G (8; 100 µM) and CaCl2 (1.25 mM).
We continued our analysis by performing DLS with a calcium concentration range (0 - 10 eq). 
Upon addition of 7.5 eq Ca2+ or more a clear shift towards larger size molecules was observed 
(Figure 2.13). This shows that addition of calcium to the peptide results in aggregate formation. 
In conclusion, both ITC and DLS analysis of G[LEELLEE]2G (8) indicate that the peptide is a 
promising candidate for the synthesis of peptide-polymer constructs (see Paragraph 2.3.4). 
In order to improve the self-assembly properties and the stability of the peptide, we decided to 
modify the peptide by linkage of an alkyl tail to create a peptide amphiphile. Alkyl functionalized 
[LEELLEE]2G was obtained by coupling of palmitic acid to the C-terminus via SPPS. CD analysis 
showed an α-helical structure for peptide C15H31C(O)-[LEELLEE]2G (10), prior and after 
addition of calcium (data not shown). Addition of the alkyl tail did not significantly change the 
calcium-binding properties of the peptide. As for the unmodified peptide, ITC analysis gave 
negative heat signals (data not shown) and DLS showed aggregate formation upon addition of 
calcium ions (Figure 2.14). 
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Figure 2.13. DLS spectra of peptide G[LEELLEE]2G (8) and CaCl2, showing the formation of aggregates.
Figure 2.14. DLS spectra of peptide C15H31C(O)-[LEELLEE]2G (10), showing an increase in size (aggregate 
formation) after calcium addition. 
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To verify that the observed aggregate formation was caused by binding of calcium to the 
peptide, we decided to add the strong calcium binder ethylenediaminetetraacetic acid (EDTA). 
DLS measurements were performed on a solution of peptide C15H31C(O)-[LEELLEE]2G 
(10) with CaCl2 and EDTA. Upon addition of EDTA aggregate formation was not measured 
anymore, as the size shifted to values comparable to when the peptide solution without calcium 
was measured. This result confirms that Ca2+ actually causes aggregate formation of peptide 
C15H31C(O)-[LEELLEE]2G (10) (Figure 2.15). 
Figure 2.15. DLS spectra of peptide C15H31C(O)-[LEELLEE]2G (10) after addition of calcium and EDTA. 
Addition of strong calcium binder EDTA diminishes aggregate formation, giving sizes comparable to 
peptide only (0 eq). 
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Table 2.1. Overview of all calcium-binding peptides. Prot. stands for protected, meaning that the peptide 
is side-chain and N-terminally protected, leaving the C-terminus as the only functional group. Peptides 11-
19 will be discussed in Paragraph 2.4.
No. Peptide Full name
1 GE7G (protected) Boc-Gly-[Glu(OtBu)]7-Gly-OH
2 GE7G H-Gly-Glu7-Gly-OH
3 Calmodulin domain 2 (prot.)
GDADGNGTIDFPE 
Boc-Gly-Asp(OtBu)-Ala-Asp(OtBu)-Gly-Asn(Trt)-Gly-Thr(tBu)-
Ile-Asp(OtBu)-Phe-Pro-Glu(OtBu)-OH 
4 Calmodulin domain 2
GDADGNGTIDFPE
H-Gly-Asp-Ala-Asp-Gly-Asn-Gly-Thr-Ile-Asp-Phe-Pro-Glu-OH
5 Calmodulin domain 3 (prot.)
GDKDGNGYISAAEG 
Boc-Gly-Asp(OtBu)-Lys(Boc)-Asp(OtBu)-Gly-Asn(Trt)-Gly-
Tyr(tBu)-Ile-Ser(tBu)-Ala-Ala-Glu(OtBu)-Gly-OH
6 Calmodulin domain 3
GDKDGNGYISAAEG
Boc-Gly-Asp-Lys-Asp-Gly-Asn-Gly-Tyr-Ile-Ser-Ala-Ala-Glu-Gly-
OH
7 G[LEELLEE]2G (prot.) Boc-Gly-[Leu-Glu(OtBu)-Glu(OtBu)-Leu-Leu-Glu(OtBu)-
Glu(OtBu)]2-Gly-OH
8 G[LEELLEE]2G H-Gly-Leu-Glu-Glu-Leu-Leu-Glu-Glu-Leu-Glu-Glu-Leu-Leu-Glu-
Glu-Gly-OH
9 C15H31-G[LEELLEE]2G (prot.) C15H31C(O)-Gly-[Leu-Glu(OtBu)-Glu(OtBu)-Leu-Leu-Glu(OtBu)-
Glu(OtBu)]2-Gly-OH
10 C15H31-G[LEELLEE]2G C15H31C(O)-Gly-Leu-Glu-Glu-Leu-Leu-Glu-Glu-Leu-Glu-Glu-Leu-
Leu-Glu-Glu-Gly-OH
11 GEG (prot.) Boc-Gly-Glu(OtBu)-Gly-OH
12 GEG H-Gly-Glu-Gly-OH
13 LEL (prot.) Boc-Leu-Glu(OtBu)-Leu-OH
14 LEL H-Leu-Glu-Leu-OH
15 AEA (prot.) Boc-Ala-Glu(OtBu)-Ala-OH
16 AEA H-Ala-Glu-Ala-OH
17 FFE (prot.) Boc-Phe-Phe-Glu(OtBu)-OH
18 FEF (prot.) Boc-Phe-Glu(OtBu)-Phe-OH
19 EFF (prot.) Boc-Glu(OtBu)-Phe-Phe-OH
2.3. Synthesis and gelation of peptide-polymer constructs
2.3.1. General protocol for the synthesis of peptide-polymer constructs
Now that we analysed the binding properties of several peptides towards calcium (Table 2.1), 
we decided to continue with the synthesis of calcium cross-linkable hydrogels. Since hydrogels 
are polymeric networks, the next step was to couple the peptides to polymers. The addition 
of Ca2+ should then lead to physically cross-linked peptide-polymer constructs, and hence a 
hydrogel (Figure 2.16). 
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Figure 2.16. Hydrogel formation of a calcium-binding peptide-polymer construct using calcium as cross-
linker. 
We chose poly(ethylene)glycol (PEG) as the polymeric basis, because of its good water solubility, 
low immunogenicity and its lack of toxicity (see Chapter 1). Our starting compound was a star-
shaped 4-armed PEG (star-PEG), each arm end functionalized with an amino group. In order 
to obtain control over the site of coupling (namely the C-terminus of the peptide) peptide 
synthesis was performed on a 2-chlorotrityl resin, which enabled us to apply a mild procedure 
for cleavage. Treatment of the 2-chlorotrityl resin with a mixture of DCM: TFE: HOAc (6:1:1) 
only cleaves the peptide from the resin, but does not remove any other acid-labile groups. 
Hence, this mild cleavage procedure afforded a fully side-chain protected peptide. The peptide 
was also N-terminally modified with a Boc-group, resulting in the C-terminal carboxylic acid as 
the only available functional group. Linkage of the C-terminus to the amino-groups of star-PEG 
was performed with coupling reagents BOP and DiPEA as a base, forming the native amide 
bond (Figure 2.17). An excess of peptide was used in the coupling reaction, which was easily 
removed by column chromatography on basic aluminium oxide. The final step in obtaining 
the peptide-polymer construct was the deprotection of the amino-acid side-chain and the 
N-terminal Boc-group. This was easily done in one step by treatment of the construct with TFA 
(Figure 2.17). 
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Figure 2.17. Synthesis of peptide-polymer constructs. A fully protected peptide (PG = protecting group) 
is coupled via an amide bond to star-PEG-NH2 using BOP and DiPEA. TFA cleavage affords the final 
deprotected peptide-polymer construct. 
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2.3.2. GE7G-star-PEG
The coupling procedure was first followed to connect protected peptide Boc-Gly-[Glu(OtBu)]7-
Gly-OH (1) to star-PEG-NH2. Completion of the reaction was monitored with TLC analysis; 
staining with ninhydrin showed disappearance of the free amino groups. Analysis of the Boc-
Gly-[Glu(OtBu)]7-Gly-star-PEG construct (20) was performed with NMR and MALDI-TOF. 
The same techniques were used after TFA treatment and confirmed the synthesis of the final 
(unprotected) peptide-polymer construct (21). The next step was to add calcium to star-PEG-
GE7G (21) to investigate if a polymeric network could be formed, hence whether calcium 
functions as physical cross-linker. First, a 5 mg/mL solution of GE7G-star-PEG (21) was used 
in MilliQ. A cloudy solution was obtained which disrupted the visual analysis of the effect of 
calcium addition. Attempts to improve the solubility of construct 21 by changing the solvent to 
Tris buffer (pH 8.9), HEPES buffer (pH 7.1) or basic H2O (pH 10) failed. Finally, GE7G-star-PEG 
(21) appeared to be soluble in a 1M NaOH solution and also remained soluble upon further 
dilution in HEPES buffer. Via this method, a 1 wt% (10 mg/mL) clear solution was prepared to 
which stepwise increasing equivalents of calcium (0.5 – 10 eq) were added. Since gel formation 
was not observed after two days, we increased the concentration of peptide-polymer construct 
21 to 5 wt%. Addition of calcium ions quickly caused formation of a precipitate. Calcium was 
added up to 20 equivalents, but despite precipitate formation, we did not observe any gelation. 
These experiments were also performed at a temperature of 37°C and with 10 wt% GE7G-
star-PEG (21), but this gave the same results. Probably, precipitation is caused by the formation 
of Ca(OH)2. As a final attempt, a 10 wt% solution was prepared in concentrated ammonia 
(25%). A clear solution remained after addition of an aqueous solution of calcium. Unfortunately, 
addition of increasing amounts of calcium still did not result in gel formation. 
2.3.3. Calmodulin-star-PEG-constructs
The second series of peptide-polymer constructs were based on the calmodulin domains 2 and 
3 (GDADGNGTIDFPE and GDKDGNGYISAAEG) as these peptides were obtained in a pure 
form by solid phase peptide synthesis. The standard coupling procedure was used for linkage of 
protected domain 2 (3) to star-PEG-NH2. Problems were encountered during the work-up, as 
the construct appeared to be hardly soluble in DCM. Due to this solubility problem, purification 
of the peptide-polymer (22) conjugate via column chromatography on basic Al2O3 did not 
work, also not via pre-adsorption of the compound on celite. Unfortunately, these solubility 
problems also occurred for the polymer with calmodulin domain 3 (23). Since deprotection of 
the amino-acid side chains changes the solubility of the calmodulin 3-star-PEG construct (23), a 
cleavage procedure with TFA was carried out. After evaporation of TFA, dialysis was performed 
using a dialysis bag with a molecular weight cut off of 3500 Da. Unbound peptide has a lower 
molecular weight and was therefore expected to be removed from the sample. To check 
whether the pure material was obtained after dialysis, size-exclusion chromatography (SEC) 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Physical cross-linking of star-PEG polymers using calcium-binding peptides    71
2
was performed. In order to be able to analyse the spectra, first the deprotected calmodulin 
domain 3 (6) was analysed on SEC, which gave a clear peak at Rt = 9.05 min. As a reference, 
also the starting material star-PEG-NH2 was measured on SEC. Due to the absence of any UV-
active groups; it could not be visualized on SEC. A solution to this problem was found by linkage 
of the UV-active benzoyl chloride. Analysis of star-PEG-benzoyl gave a peak with Rt = 8.10 min. 
This retention time was used as reference point, as the larger peptide-polymer construct should 
have a faster elution. 
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Figure 2.18. Analytical size exclusion (SEC) chromatogram of the peptide-polymer construct with 
calmodulin domain 3. The product (23; Rt = 6.70 min) is contaminated with the excess of peptide (6; Rt 
= 9.00 min). Ch1 is the spectrum recorded at 214 nm, channel 2 is obtained at 254 nm. 
Analytical SEC of the dialysed calmodulin 3-star-PEG (23) gave peaks at 6.70, 9.00 and 17.264 
min (Figure 2.18). This clearly shows that dialysis was not successful for removal of the excess 
peptide. SEC also indicated formation of the product, as the peak at 6.70 min belongs to a 
compound that is larger in size than starting material star-PEG-NH2. Preparative use of the SEC 
column afforded the isolation of polymer-peptide construct 23 (Figure 2.19). MALDI-TOF 
analysis of this product resulted in a broad peak with a mass lower than calculated. This indicates 
that coupling of the peptide was less efficient than expected. Despite the lower mass, a gelation 
test was performed with calmodulin 3-star-PEG (23). Since the purification method afforded 
only little amounts of material, a 2 wt% solution was tested. The construct was readily soluble 
in water, but unfortunately addition of calcium did not result in gelation. Because purification of 
the calmodulin polymers was found to be tedious and time-consuming, we decided to abandon 
this approach.
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Figure 2.19. Preparative size exclusion (SEC) chromatography afforded the pure peptide-polymer 
construct with calmodulin domain 3 (23; Rt = 6.75 min). Ch1 is the spectrum recorded at 214 nm, 
channel 2 is obtained at 254 nm. 
2.3.4. G[LEELLEE]2G-star-PEG
Protected peptide Boc-G[LEELLEE]2G (7) was coupled to star-PEG-NH2 using the standard 
coupling reagents BOP and DiPEA in DMF. TLC analysis confirmed conversion to the peptide-
polymer construct (24). As for the calmodulin peptides, the obtained product was insoluble 
in DCM. The compound was therefore first deprotected using TFA. Dialysis was then carried 
out to try to remove the excess of peptide 8. SEC analysis revealed peaks at Rt = 7.09 min 
and Rt = 10.74 min. The deprotected peptide (8) gave the same retention time around 10.7 
min, implying that dialysis was not successful for purification. SEC analysis was performed using 
an isocratic flow composed of 55% MilliQ and 45% acetonitrile. In order to be able to use 
this method preparatively, the construct needs to soluble in the H2O/MeCN mixture. Polymer 
G[LEELLEE]2G-star-PEG (24) had very low solubility in the solvent mixture, making purification 
using preparative SEC impossible. Since peptide G[LEELLEE]2G (8) was found to have promising 
calcium binding properties, it was disappointing to see that the peptide-polymer construct (24) 
could not be purified and therefore gelation studies could not be carried out. Due to the severe 
solubility and purification problems with G[LEELLEE]2G, we decided not to continue with the 
synthesis of the polymer construct with alkyl functionalized peptide C15H31C(O)-[LEELLEE]2G 
(10). 
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2.3.5. Discussion
A range of calcium-binding peptides were selected based on motifs found in Ca2+-binding 
proteins (Table 2.1). The synthesis of these peptides was successfully accomplished. The 
calcium binding properties were measured using ITC, DLS and CD analysis. For some peptides, 
it was difficult to be conclusive about the ability to bind calcium, based on contradictory results 
obtained by the used techniques. On the other hand, for some peptides both aggregation upon 
calcium addition was measured (DLS) and Ca2+-binding was established via ITC. We decided 
to evaluate all peptides of which at least one technique showed interaction with Ca2+ for their 
ability to form Ca2+ cross-linked hydrogels. For this purpose, we started with the synthesis of 
peptide-polymer constructs. GE7G-star-PEG (21) was successfully obtained and was therefore 
used in gelation studies. Unfortunately, its solubility in aqueous solutions was problematic, 
and in the end addition of calcium did not result in gel formation. Synthesis of the peptide-
polymer constructs with the calmodulin peptides (22, 23) and with G[LEELLEE]2G (24) was 
troublesome. These constructs appeared to have a very low solubility, making purification 
difficult or even impossible. In conclusion, only the synthesis and purification of GE7G-star-PEG 
(21) was successful, but gelation did not occur. A possible explanation for the lack of gelation 
could be that calcium binding can occur both intermolecularly as well as intramolecularly. 
Gelation can only occur when a polymeric network is formed, hence when calcium makes 
intermolecular connections. A problem occurs when calcium makes intramolecular bonds, 
between the anionic groups within a peptide, or between peptides connected to two arms 
of one star-PEG molecule. In both cases, calcium binding occurs, but calcium does not provide 
the physical connection between two polymers. A second explanation for the lack of gelation 
could be that the tested conditions are not ideal, in terms of pH or polymer concentration. The 
final reason to explain that addition of calcium to GE7G-star-PEG (21) did not give a hydrogel, 
is that binding simply is not efficient enough to make sufficient physical cross-links to form a 
polymeric network. This seems to be the most likely explanation, since ITC data of peptide 
GE7G (2) with calcium indicated weak binding and only a small shift was recorded with DLS 
analysis. To confirm this hypothesis, we decided to gain further information on the gelation 
process, by studying short anionic peptides, aiming to prevent intramolecular cross-linking (see 
Paragraph 2.4).
2.4. Short anionic peptides
A new approach was taken by using short anionic peptides. This idea was inspired on research 
by the Ulijn group, who showed the gelation of the short aromatic peptide Fmoc-Phe2 (see 
Chapter 1).23,24 Despite the fact that intramolecular calcium binding between two arms of 
a star-PEG molecule cannot be prevented, this new approach eliminates the intramolecular 
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binding within a peptide. Hopefully, this approach forces intermolecular calcium binding, and 
thus the formation of a network. Moreover, solubility and purification problems are less likely 
to occur with smaller peptides. Based on the previous GE7G peptide (2), we first decided 
to synthesize short peptide Boc-Gly-Glu(OtBu)Gly (11; GEG). Since synthesis of these small 
peptides was easy using SPPS, protected analogues LEL and AEA (13, 15) were also prepared 
(Figure 2.20). This allows investigating whether introducing less or more hydrophobicity has an 
influence on the ability to bind calcium. Inspired by work of the Ulijn group, peptides containing 
both anionic and aromatic peptides were synthesized. Peptides Boc-Phe-Phe-Glu(OtBu) (17; 
FFE) and protected analogues FEF (18) and EFF (19) were afforded pure after SPPS (Figure 
2.20). 
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Figure 2.20. Overview of the protected short anionic (and aromatic) peptides.
The calcium binding properties of the first set of peptides GEG, LEL and AEA (12, 14, 16) was 
determined using ITC analysis. For all three peptides, the obtained spectra looked random, as 
if they were background samples (data not shown). Since these short peptides do not have a 
secondary structure and aggregation is not likely to occur, we did not measure CD and DLS, 
but instead directly continued with the synthesis of the peptide-polymer construct. All the 
protected short anionic (and aromatic) peptides (11, 13, 15, 17, 18 and 19) were linked to 
star-PEG-NH2 using standard coupling reagents (Py)BOP and DiPEA. Purification was readily 
performed using column chromatography, after which TFA treatment gave the final deprotected 
peptide-polymer constructs (26, 28, 30, 32, 34 and 36). Gelation studies with calcium were 
first performed for solutions of GEG-star-PEG (26), LEL-star-PEG (28) and AEA-star-PEG (30) 
in water. A high total polymer content, 15 wt%, was tested. Addition of calcium was performed 
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stepwise, first 1 equivalent CaCl2 and then stepwise to a total of 4 eq. With an excess of calcium 
(4 eq) precipitate formation was seen, however, the viscosity of the solution did not change. The 
same procedure was used for gelation studies with FFE-star-PEG (32), FEF-star-PEG (34) and 
EFF-star-PEG (36), and apart from MilliQ a 15 wt% solution was also prepared in Tris buffer (pH 
9.0). In all cases, no effects were seen after addition of up to 5 eq calcium. Gelation mediated 
by short (and aromatic) peptide polymers could therefore not be demonstrated using calcium 
as cross-linker. 
2.5. Conclusion
In this chapter, we aimed for the development of synthetic calcium-cross-linkable polymers. 
Several bio-inspired peptides were successfully synthesized and then analysed with circular 
dichroism (CD) spectroscopy, isothermal calorimetry (ITC) and dynamic light scattering (DLS) 
to determine their calcium-binding properties. Although it was difficult to be conclusive about 
the binding with Ca2+, we evaluated all peptides of which at least one technique showed 
interaction. These peptides were coupled to polymer star-poly(ethylene)glycol (PEG) to obtain 
peptide-polymer constructs. The constructs with the calmodulin peptide (22, 23) and with 
peptide G[LEELLEE]2G (24) could not be used in gelation studies due to purification problems. 
The peptide-polymers with oligo-glutamate GE7G (21) and with short anionic peptides (GEG 
26, LEL 28, AEA 30, FFE 32, EFF 34 and FEF 36) were successfully obtained. Their ability to make 
a physically cross-linked hydrogel was tested by addition of CaCl2 to a solution of the peptide-
polymers in water or in a basic solvent. None of the tested constructs formed a hydrogel. 
Based on our observations and the data obtained with CD, ITC and DLS analysis, we draw the 
conclusion that the interaction of calcium with GE7G (2) or with the short anionic peptides is 
not strong enough to make physical connections between the polymers. The calcium-binding 
ability of the peptide-polymer constructs is too weak to make a calcium cross-linked hydrogel. 
Therefore, we first decided to focus on chemically cross-linked hydrogels, as will be described 
in Chapters 3, 4 and 5. New insights in the field of hydrogels gave us reason to return to 
physically cross-linked systems, as explored in Chapter 6.
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2.7. Materials and methods
The 2-chlorotrityl resin was purchased from Bachem (Bubendorf, Switzerland) and Fmoc-
L-amino acids were purchased from Novabiochem (EMD Chemicals, Gibbstown, USA) 
or Bachem. 4-Armed poly(ethylene glycol)-NH2 (10 kDa) salt was obtained from JenKem 
Technology (USA). All other chemicals were purchased from Sigma-Aldrich, Baker or Fluka and 
utilized as received. Column chromatography was performed with Silica gel 60 (particle size 
0.040 – 0.063 mm Merck) or aluminum oxide (basic activated, pore size 58 Å, Sigma-Aldrich). 
Thin-layer chromatography (TLC) was performed on silica gel coated plates (Merck 60, F-254). 
Visualization was accomplished with UV-light and/or ninhydrin or permanganate staining. MilliQ 
water was purified using a WaterPro PS Polisher (Labconco), set to 18.2 MΩ/cm. 
1H NMR spectra were recorded on a Varian Mercury (400 MHz). As a solvent shift reference, 
we used CDCl3 (δ = 7.26 ppm), and D2O (δ = 4.79 ppm). Mass spectra were recorded on a 
Thermo Finnigan LCQ-Advantage MAX or on a Bruker Biflex MALDI-TOF (Bruker Daltronik, 
Bremen, Germany). As matrix, α-cyano-4-hydroxycinnamic acid or dithranol were used. LC-
MS was performed on a Thermo Finnigan LCQ-Fleet ESI-ion trap (Thermo Fischer, Breda, 
The Netherlands) equipped with a Phenomenex C18 column, 50 x 2.0 mm, particle size 3 
µM (Phenomenex, Utrecht, The Netherlands). An acetonitrile/water gradient containing 0.1% 
formic acid was used for elution (5-100%, 1-10 min, flow 0.2 mL/min). 
Analytic HPLC was performed on a Shimadzu LC-20A Prominence system (Shimadzu, ‘s 
Hertogenbosch, The Netherlands) equipped with a C18 Reprosil column, 150 x 3 mm, particle 
size 3 µm (Dr. Maisch GmbH, Screening Devices, Amersfoort, The Netherlands). Elution of 
the peptides was achieved using an acetonitrile/water gradient containing 0.1% trifluoroacetic 
acid (5-100% MeCN, 1-31 min, flow 0.4 mL/min). Preparative HPLC was performed on a 
Shimadzu LC-20A system equipped with a Reprosil C18 column, 250 x 20 mm (particle size: 
10 µm) or 250 x 10 mm (particle size: 5 µm) (both: Dr. Maisch GmbH). Elution was achieved 
using an acetonitrile/water gradient containing 0.1% trifluoroacetic acid (5-100% MeCN, 5-55 
min, flow 8 mL/min or 4 mL/min). Analytical and preparative SEC were performed on the 
Shimadzu HPLC systems, using a BioSep SEC-s2000 column (particle size 5 µm, pore size 150 
Å, Phenomenex). An isocratic elution was performed for 20 min with 45% acetonitrile and 55% 
water (containing 0.1% TFA).
CD spectra were recorded on a Jasco J-815 spectropolarimeter equipped with a Jasco PFD-
425S Peltier type temperature control system. ITC experiments were performed on a fully 
automated isothermal titration calorimeter (Microcal Auto-iTC200, GE Healthcare). DLS 
measurements were carried out on a Malvern instruments Zetasizer Nano-S (ZEN 1600). 
Lyophilization was achieved using an ilShin Freeze Dryer (ilShin, Ede, The Netherlands).
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General procedure 1: Peptide synthesis (SPPS)
Peptides were synthesized from 1.0 g 2-chloro-trityl resin using Fmoc solid-phase peptide 
synthesis (SPPS). The resin was swollen in DCM for 20 min prior to use. Functionalization of the 
resin with the first amino acid was performed for 60 min with 2.0 eq of the required amino acid 
and 3.0 eq N,N-diisoproylethylamine (DiPEA). After the coupling reaction, capping of the resin 
was performed with 2.0 eq DiPEA in methanol. Deprotection of the Fmoc-groups was carried 
out with piperidine in DMF (20%, v/v) for 20 min. Subsequent couplings were performed for 45 
min with 3.0 eq of the required amino acid, 3.3 eq of N,N’-diisopropylcarbodiimide (DIPCDI) 
and 3.6 eq of N-hydroxybenzotriazole (HOBt) in DMF. After each coupling and deprotection 
step, a Kaiser test was done to ensure completion of the reaction.25 Two different cleavage 
protocols were applied to remove peptides from the resin, a mild procedure using acetic acid 
and a TFA-cleavage protocol. The mild cleavage was performed in order to ensure that the 
acid-labile protecting groups remained intact. Mild cleavage was performed by treatment of the 
resin with a mixture of dichloromethane (DCM), trifluoroethanol (TFE) and acetic acid (HOAc) 
(6:1:1) for 3 h. The solvents were evaporated under reduced pressure and co-evaporation was 
performed with chloroform (3 x 40 mL). Peptides were afforded as white solids after freeze-
drying from dioxane. For the TFA-cleavage protocol, the resin was treated with a mixture of TFA: 
triisopropylsilane (TIS): H2O (95: 2.5: 2.5) for 3h at r.t. Peptides were afforded by precipitation 
in Et2O, followed by freeze-drying from water. 
General procedure 2A: Synthesis peptide-polymer constructs (column chromatography)
To star-poly(ethylene glycol)-NH2 HCl salt (200 mg, 20 µmol) in DCM (20 mL) was added 
subsequently BOP (53 mg, 6 eq, 120 µmol), protected peptide (6 eq, 120 µmol), and DiPEA 
82 µL, 24 eq, 0.48 mmol). The reaction mixture was stirred overnight at r.t. Extraction was 
performed with 1 M KHSO4 (3 x 40 mL) and brine (1 x 40 mL), after which the organic layer 
was dried over Na2SO4. Column chromatography on basic aluminum oxide (MeOH: DCM; 
10:90) afforded the protected peptide-polymer construct as a white powder after freeze-
drying from dioxane. 
General procedure 2B: Deprotection peptide-polymer constructs
Deprotection of the peptide-polymer construct (200 mg) was performed by treatment with 
TFA: H2O (95:5; 10 mL) for 4 h at r.t. The reaction mixture was concentrated and co-evaporated 
with toluene (3 x 30 mL). The product was dialysed against water using a membrane with a 
MW cut-off of 3500 Da. Dialysis was performed for 3 days under regular exchange of the water 
(twice a day). Freeze drying afforded the product as a white solid.
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General procedure 3: Synthesis peptide-polymer constructs (SEC)
To star-poly(ethylene glycol)-NH2 HCl salt (75 mg, 7.5 µmol) in DMF (10 mL) was added 
subsequently PyBrOP (21 mg, 6 eq, 45 µmol), protected peptide (6 eq, 45 µmol), and DiPEA 
31 µL, 24 eq, 180 µmol). The reaction mixture was stirred overnight at r.t. Evaporation of the 
DMF was performed under reduced pressure at 50°C. The residue was directly treated with a 
mixture of TFA: TIS: H2O (95: 2.5: 2.5; 5 mL) for 4 h at r.t. The product was dissolved in water : 
MeOH (1:1) and dialysed against 800 mL water using dialysis membranes with a MW cut-off 
of 3500 Da. Dialysis was performed for 2 days under regular exchange of the water/MeOH 
mixture (twice a day). After dialysis, the products were obtained as white solids by freeze-
drying. Analytical SEC was performed to check the purity of the peptide-polymer construct. If 
possible, purification was performed by preparative SEC using an isocratic elution (45% MeCN; 
55% H2O, containing 0.1% TFA). Samples were prepared in the same solvent mixture (20 mg 
in 5 mL). 
CD measurements
CD spectra were measured from 250 – 190 nm at 20°C using a 1 mm quartz cuvette. Peptide 
solutions were prepared in Tris buffer (0.17 mM, pH 8.9) at final concentrations of 0.2 mg/mL. 
To the peptide solution, varying amounts of calcium chloride were added. For peptide GE7G, a 
CaCl2 concentration range of 0 – 16 eq was added. For peptides [LEELLEE]2G and C15H31C(O)-
[LEELLEE]2G, 0 – 10 eq CaCl2 were added. Final spectra were obtained by subtracting the 
background spectrum obtained for the buffer.
ITC measurements
Prior to the ITC measurements, peptides were purified using preparative HPLC. All ITC 
experiments were carried out in HEPES buffer (20 mM, pH 7.1). Peptide solutions were loaded 
in the cell (400 µL), CaCl2 solutions in the syringe (200 µL) and the HEPES buffer was added 
to the reference cell. ITC measurements were carried out using a temperature of 25°C, a 
reference power of 10 µCal/sec, a scanning time of 150 s and a rotation speed of 1000 rpm. 
Titrations comprising 19 injections (2 µL) were carried out from the syringe into the cell. 
For peptides GE7G and calmodulin domain 3, a peptide solution of 100 µM was measured 
with CaCl2 concentrations of 1.25, 2.5 and 5.0 mM. Calmodulin domain 2 was measured in 
a concentration of 500 µM with 1.25, 2.5, 5.0 and 10 mM CaCl2. Peptide G[LEELLEE]2G was 
measured at 100 µM with 1.25 mM CaCl2. For the short anionic peptides GEG, LEL and AEA, 
peptide concentrations of 100 µM were measured with a CaCl2 range of 0.5, 1.0, 2.0 and 5.0 
mM. 
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DLS measurements
DLS measurements were performed in a 1 mL cuvette in HEPES buffer (20 mM, pH 7.1). 
Peptide solutions of 1 mM were measured with a calcium concentration range of 0 – 10 eq. 
For each experiment, three runs were performed with 10 measurements of 10 sec each. Final 
graphs were created based on the average of the three runs. For peptide C15H31-[LEELLEE]2G, 
EDTA was added to the peptide/calcium solution (5 eq, 10 eq). For peptide calmodulin domain 
2, a concentration of 100 µM was measured, with 2.5 mM CaCl2. 
Synthesis of the peptides
Boc-Gly-[Glu(OtBu)]7-Gly-OH (1)
The peptide was synthesized according to general procedure 1 using 4.60 g 2-chlorotrityl resin. 
Cleavage from the resin was performed using the mild procedure and afforded the peptide (1) 
as white powder after freeze-drying. 
LCQ: m/z: 1528.3 [M + H]+ (calculated [M + H]+ = 1528.8)
LC-MS: m/z: 1528.1 [M + H]+, Rt = 12.50 min
HPLC: Rt = 20.74 min
1H-NMR (400 MHz, CDCl3): δ = 1.24 – 1.50 (m, 72H, CH3), 1.94 – 2.63 (m, 28H, (CH2)2 OtBu), 
3.74 – 4.50 (m, 11H, 7 CH (Cα), BocHN-CH2, CH2COOH). 
H-Gly-Glu7-Gly-OH (2)
The peptide was synthesized using general procedure 1 and cleaved from the resin using a 
mixture of TFA: H2O (95:5) for 3h. The peptide could also be afforded by TFA-treatment of 
the protected peptide (Boc-Gly-[Glu(OtBu)]7-Gly-OH) (1). In both cases, precipitation in ether 
followed by freeze-drying from water provided the deprotected peptide (2).
LCQ: m/z: 1036.3[M + H]+ (calculated [M + H]+ = 1036.4)
LC-MS: m/z: 1036.28 [M + H]+, Rt = 2.55 min
LC-MS (MS/MS): MS2 m/z: 961.13 [M – G – H2O]+; 832.05 [M – EG – H2O]+; 702.99 [M – EEG 
– H2O]+. MS3 m/z: 574.00 [M – EEEG – H2O]+; 427.03 [M – EEEEG – 2H2O]+; 316.03 [M – 
EEEEEG – H2O]+
HPLC: Rt = 2.48 min
Calmodulin binding domain 2 – GDADGNGTIDFPE (protected) (3)
Boc-Gly-Asp(OtBu)-Ala-Asp(OtBu)-Gly-Asn(Tr t)-Gly-Thr(tBu)-Ile-Asp(OtBu)-Phe-Pro-
Glu(OtBu)-OH 
General procedure 1 was followed for synthesis of calmodulin binding domain 2, using the mild 
cleavage procedure. 
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LCQ: m/z: 1952.6 [M + Na]+ (calculated [M + H]+ = 1930.01)
LC-MS: m/z: 1930.00 [M + H]+, Rt = 12.44 min HPLC: Rt = 27.12 min
MALDI-TOF (dithranol): m/z: 1952.0 [M + Na]+
HPLC: Rt = 27.12 min
Calmodulin binding domain 2 – GDADGNGTIDFPE (4)
H-Gly-Asp-Ala-Asp-Gly-Asn-Gly-Thr-Ile-Asp-Phe-Pro-Glu-OH
Protected calmodulin domain 2 (3) was treated with a mixture of TFA: TIS: H2O (95: 2.5: 2.5) 
for 4h at r.t. The peptide was precipitated in diethyl ether and obtained as a white solid after 
drying (air).
LCQ: m/z: 1307.6 [M + H]+ (calculated [M + H]+ = 1307.53)
LC-MS: m/z: 1308.08 [M + H]+, Rt = 6.44 min
HPLC: Rt = 14.52 min
SEC: Rt = 9.71min
Calmodulin binding domain 3 – GDKDGNGYISAAEG (protected) (5)
Boc-Gly-Asp(OtBu)-Lys(Boc)-Asp(OtBu)-Gly-Asn(Trt)-Gly-Tyr(tBu)-Ile-Ser(tBu)-Ala-Ala-
Glu(OtBu)-Gly-OH
General procedure 1 was followed for synthesis of calmodulin binding domain 3, using the mild 
cleavage procedure. 
LCQ: m/z: 1038.8 [M + H]2+ (calculated [M + H]+ = 2076.11, [M + H]2+ = 1038.56)
LC-MS: m/z: 1038.84 [M + H]2+, Rt = 12.68 min
HPLC: Rt = 25.52 min
Calmodulin binding domain 3 – GDKDGNGYISAAEG (6)
Boc-Gly-Asp-Lys-Asp-Gly-Asn-Gly-Tyr-Ile-Ser-Ala-Ala-Glu-Gly-OH
Protected calmodulin domain 3 (5) was treated with a mixture of TFA: TIS: H2O (95: 2.5: 2.5) 
for 4h at r.t. The peptide was precipitated in diethyl ether and obtained as a white solid after 
drying (air).
LCQ: m/z: 1353.5 [M + H]+ (calculated [M + H]+ = 1353.58)
LC-MS: m/z: 1353.76 [M + H]+, Rt = 3.14 min
HPLC: Rt = 12.15 min
SEC: Rt = 9.05 min
Boc-Gly-[Leu-Glu(OtBu)-Glu(OtBu)-Leu-Leu-Glu(OtBu)-Glu(OtBu)]2-Gly-OH 
(protected) (7)
General procedure 1 was followed using 1.5 g 2-chlorotrityl resin. Cleavage was performed 
using the mild procedure.
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LCQ: m/z: 1196.9 [M + H]2+, calculated [M + H]2+ = 1196.73)
MALDI-TOF (dithranol): m/z: 2414.8 [M + Na]+, calculated [M + Na]+ = 2414.45
HPLC: Rt = 33.88 min
H-G[LEELLEE]2G-OH (8)
H-Gly-Leu-Glu-Glu-Leu-Leu-Glu-Glu-Leu-Glu-Glu-Leu-Leu-Glu-Glu-Gly-OH
General procedure 1 was used for peptide synthesis, followed by TFA cleavage. After 
precipitation, the peptide was further purified by prep-HPLC. 
LCQ: m/z: 1844.5 [M + H]+ (calculated [M + H]+ = 1843.90)
LC-MS: m/z: 1844.52 [M + H]+, 922.68 [M + H]2+, Rt = 9.11 min
HPLC: Rt = 22.01 min
C15H31C(O)-Gly-[Leu-Glu(OtBu)-Glu(OtBu)-Leu-Leu-Glu(OtBu)-Glu(OtBu)]2-Gly-
OH (protected) (9)
General procedure 1 was followed using 1.5 g 2-chlorotrityl resin. In the final step, palmitic acid 
(3.0 eq) was coupled using DIPCDI (3.3 eq) and HOBt (3.6 eq). Cleavage was performed using 
the mild procedure.
LCQ: m/z: 1237.5 [M + H]2+, 1260.4 [M + Na]2+ (calculated [M + H]2+ = 1237.31)
MALDI-TOF (dithranol): m/z: 2496.1 [M + Na]+, calculated [M + Na]+ = 2495.61
C15H31C(O)-Gly-[Leu-Glu-Glu-Leu-Leu-Glu-Glu]2-Gly-OH (10)
General procedure 1 was used for peptide synthesis. In the final step, palmitic acid (3.0 eq) was 
coupled using DIPCDI (3.3 eq) and HOBt (3.6 eq). Cleavage was performed using TFA. 
LCQ: m/z: 1013.4 [M + H]2+ (calculated [M + H]2+ = 1013.06)
HPLC: Rt = 31.69 min
Boc-Gly-Glu(OtBu)-Gly-OH (protected) (11)
General procedure 1 (1.0 g resin), followed by the mild cleavage procedure.
LCQ: m/z: 417.9 [M + H]+; 857.0 [2M + Na]+ (calculated [M + H]+ = 418.21)
LC-MS: m/z: 417.88 [M + H]+, 834.92 [2M + H]+, Rt = 7.92 min
HPLC: Rt = 17.11 min
1H-NMR (400 MHz, CD3OD): δ = 1.42 – 1.52 (m, 18H, CH3), 1.92 & 2.16 (2m, 2H, Cα-CH2-
CH2), 2.37 (m, 2H, Cα-CH2-CH2), 3.74 (s, 2H, BocHN-CH2), 3.92 (s, 2H, CH2COOH), 4.49 (m, 
1H, Cα)
H-Gly-Glu-Gly-OH (12)
General procedure 1 (1.0 g resin), followed by the TFA-cleavage procedure.
LCQ: m/z: 261.9 [M + H]+, 522.9 [2M + H]+ (calculated [M + H]+ =262.10)
HPLC: Rt = 2.53 min
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Boc-Leu-Glu(OtBu)-Leu-OH (protected) (13)
General procedure 1 (1.0 g resin), followed by the mild cleavage procedure.
LCQ: m/z: 529.9 [M + H]+, 1081.2 [2M + Na]+ (calculated [M + H]+ = 530.34)
LC-MS: m/z: 530.00 [M + H]+, 1059.08 [2M + H]+, Rt = 9.90 min
HPLC: Rt = 22.66 min
1H-NMR (400 MHz, CDCl3): δ = 0.84 – 1.00 (m, 12H, CH3 (Leu)), 1.36 – 1.53 (s, 18H, CH3 (Boc, 
OtBu)), 1.56 – 1.79 (m, 6H, CH2, CH (Leu)), 1.96 & 2.08 (2m, 2H, Cα-CH2-CH2 (Glu)), 2.40 (m, 
2H, Cα-CH2-CH2 (Glu)), 4.40 – 4.55 (m, 3H, 3 Cα).
H-Leu-Glu-Leu-OH (14)
General procedure 1 (1.0 g resin), followed by the TFA-cleavage procedure.
LCQ: m/z: 374.1 [M + H]+, 747.1 [2M + H]+ (calculated [M + H]+ =374.22)
HPLC: Rt = 12.95 min
Boc-Ala-Glu(OtBu)-Ala-OH (protected) (15)
General procedure 1 (1.0 g resin), followed by the mild cleavage procedure.
LCQ: m/z: 445.9 [M + H]+, 913.1 [2M + Na]+ (calculated [M + H]+ = 446.24)
LC-MS: m/z: 445.96 [M + H]+, 890.92 [2M + H]+ Rt = 8.18 min
HPLC: Rt = 17.88 min
1H-NMR (400 MHz, CDCl3): δ = 1.26 – 1.57 (m, 24H, CH3), 1.92 & 2.10 (2m, 2H, Cα-CH2-
CH2), 2.38 (m, 2H, Cα-CH2-CH2), 4.07 (m, 1H, Cα), 4.33 – 4.46 (m, 2H, 2 Cα).
H-Ala-Glu-Ala-OH (16)
General procedure 1 (1.0 g resin), followed by the TFA-cleavage procedure.
LCQ: m/z: 289.9 [M + H]+, 579.0 [2M + H]+ (calculated [M + H]+ = 290.13)
HPLC: Rt = 2.66 min
Boc-Phe-Phe-Glu(OtBu)-OH (protected) (17)
General procedure 1 (1.0 g resin), followed by the mild cleavage procedure.
LCQ: m/z: 597.9 [M + H]+, 1194.9 [2M + H]+ (calculated [M + H]+ = 598.31)
LC-MS: m/z: 598.08 [M + H]+, 1195.24 [2M + H]+, Rt = 10.02 min
HPLC: Rt = 22.69 min
Boc-Phe-Glu(OtBu)-Phe-OH (protected) (18)
General procedure 1 (1.0 g resin), followed by the mild cleavage procedure.
LCQ: m/z: 598.1 [M + H]+, 1194.9 [2M + H]+ (calculated [M + H]+ = 598.31)
LC-MS: m/z: 598.08 [M + H]+, 1195.20 [2M + H]+, Rt = 10.02 min
HPLC: Rt = 22.67 min
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Boc-Glu(OtBu)-Phe-Phe-OH (protected) (19)
General procedure 1 (1.0 g resin), followed by the mild cleavage procedure.
LCQ: m/z: 597.9 [M + H]+, 1194.8 [2M + H]+ (calculated [M + H]+ = 598.31)
LC-MS: m/z: 598.04 [M + H]+, 1195.20 [2M + H]+, Rt = 10.05 min
HPLC: Rt = 22.70 min
Synthesis of the peptide-polymer constructs
Boc-Gly-[Glu(OtBu)]7-Gly-star-PEG (protected) (20)
General procedure 2A was followed with star-PEG-NH2 HCl salt (200 mg, 20 µmol) and 
peptide Boc-Gly[Glu(OtBu)]7-Gly (1; 183 mg, 120 µmol). 
1H-NMR (400 MHz, CDCl3): δ = 1.38 – 1.51 (m, CH3), 1.95 – 2.62 (m), 3.59 – 3.68 (m, 
[CH2CH2O]n), 3.72 – 4.38 (m).
MALDI-TOF (dithranol): m/z: 15894, calculated m/z: 15911 for 217 ethylene glycol units.
H-Gly-[Glu]7-Gly-star-PEG (21)
Deprotection was performed via general procedure 2B, without the dialysis step.
1H-NMR (400 MHz, D2O): δ = 1.81 – 2.08 (m, Cα-CH2-CH2), 2.28 – 2.43 (m, Cα-CH2-CH2), 
3.43 – 3.82 (m, [CH2CH2O]n, CH2(Gly)), 4.17 – 4.31 (m, Cα).
MALDI-TOF (dithranol): m/z: 14071, calculated m/z: 14072 for 220 ethylene glycol units.
Calmodulin 2 – star-PEG (22)
General procedure 3 was followed using star-PEG-NH2 (75 mg, 7.5 µmol) and protected 
peptide GDADGNGTIDFPE (3; 87 mg, 45 µmol). After dialysis, SEC analysis resulted in peaks 
at Rt = 6.909 min (product), Rt = 9.705 min (peptide) and Rt = 17.506 min. The construct 
calmodulin 2 –star-PEG was not obtained in pure form.
Calmodulin 3 – star-PEG (23)
General procedure 3 was followed using star-PEG-NH2 (75 mg, 7.5 µmol) and protected 
peptide GDKDGNGYISAAEG (5; 93 mg, 45 µmol). After dialysis, SEC analysis resulted in peaks 
at Rt = 6.703 min (product), Rt = 8.997 min (peptide) and Rt = 17.264 min. The construct (20 
mg) was dissolved in 5 mL MeCN: H2O (45:55) for purification using preparative SEC (isocratic, 
MeCN: H2O 45:55). The purified product was analysed by MALDI-TOF mass spectrometry.
SEC: Rt = 6.748 min
MALDI-TOF (alpha-cyano): m/z: 12706, calculated m/z: 15341 for 220 ethylene glycol units.
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H-G[LEELLEE]2G-star-PEG (24)
General procedure 3 was followed using star-PEG-NH2 (75 mg, 7.5 µmol) and protected 
peptide Boc-Gly-[Leu-Glu(OtBu)-Glu(OtBu)-Leu-Leu-Glu(OtBu)-Glu(OtBu)]2-Gly-OH (7; 
108 mg, 45 µmol). After dialysis, SEC analysis resulted in peaks at Rt = 7.093 min (product), Rt 
= 10.74 min (peptide 8). The construct was hardly soluble in a mixture of MeCN: H2O (45:55), 
making purification using preparative SEC impossible. 
Boc-Gly-Glu(OtBu)-Gly-star-PEG (protected) (25)
General procedure 2A was followed using star-PEG-NH2 (75 mg, 7.5 µmol), PyBrOP (28 mg, 
8 eq, 60 µmol), peptide Boc-Gly-Glu(OtBu)-Gly (11; 25 mg, 8 eq, 60 µmol) and DiPEA (31 µL, 
24 eq, 180 µmol). 
1H-NMR (400 MHz, CDCl3): δ = 1.40 – 1.48 (m, CH3), 1.91 – 2.47 (m, Cα-CH2-CH2), 3.35 – 
3.99 (m, [CH2CH2O]n, CH2(Gly)), 4.34 – 4.56 (m, Cα).
MALDI-TOF (alpha cyano): m/z: 11575, calculated m/z: 11554 for 219 ethylene glycol units.
H-Gly-Glu-Gly-star-PEG (26)
Deprotection was performed according to general procedure 2B. 
1H-NMR (400 MHz, D2O): δ = 1.71 – 1.99 (m, Cα-CH2-CH2), 2.08 – 2.17 (m, Cα-CH2-CH2), 
3.21 – 3.78 (m, [CH2CH2O]n, CH2(Gly)), 4.21(m, Cα).
MALDI-TOF (alpha cyano): m/z: 11188, calculated m/z: 11193 for 225 ethylene glycol units.
Boc-Leu-Glu(OtBu)-Leu-star-PEG (protected) (27)
General procedure 2A was followed using star-PEG-NH2 (75 mg, 7.5 µmol), PyBrOP (28 mg, 8 
eq, 60 µmol), peptide Boc-Leu-Glu(OtBu)-Leu (13; 24 mg, 8 eq, 60 µmol) and DiPEA (31 µL, 
24 eq, 180 µmol). 
1H-NMR (400 MHz, CDCl3): δ = 0.82 – 1.00 (m, CH3 (Leu)), 1.41 – 1.52 (m, CH3 (Boc, OtBu)), 
1.60 – 2.18 (m), 3.38 – 3.87 (m, [CH2CH2O]n), 4.40 (m, Cα).
MALDI-TOF (alpha cyano): m/z: 11905, calculated m/z: 11914 for 217 ethylene glycol units.
H-Leu-Glu-Leu-star-PEG (28)
Deprotection was performed according to general procedure 2B. 
1H-NMR (400 MHz, D2O): δ = 0.82 – 1.04 (m, CH3 (Leu)), 1.23 – 1.85 (m, CH2, CH (Leu)) 
1.89 – 2.36 (m, Cα-CH2-CH2), 3.33 – 3.97 (m, [CH2CH2O]n), 4.34 (m, Cα).
MALDI-TOF (alpha cyano): m/z: 11556, calculated m/z: 11554 for 223 ethylene glycol units.
Boc-Ala-Glu(OtBu)-Ala-star-PEG (protected) (29)
General procedure 2A was followed using star-PEG-NH2 (75 mg, 7.5 µmol), PyBrOP (28 mg, 
8 eq, 60 µmol), peptide Boc-Ala-Glu(OtBu)-Ala (15; 27 mg, 8 eq, 60 µmol) and DiPEA (31 µL, 
24 eq, 180 µmol). 
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1H-NMR (400 MHz, CDCl3): δ = 1.24 – 1.50 (m, CH3 (Ala, Boc, OtBu)), 1.87 – 2.48 (m, Cα-
CH2-CH2), 3.37 – 3.73 (m, [CH2CH2O]n), 3.99 – 4.67 (m, Cα).
MALDI-TOF (alpha cyano): m/z: 11755, calculated m/z: 11754 for 221 ethylene glycol units.
H-Ala-Glu-Ala-star-PEG (30)
Deprotection was performed according to general procedure 2B. 
1H-NMR (400 MHz, D2O): δ = 1.26 – 1.38 (m, CH3 (Ala)), 1.81 – 2.30 (m, Cα-CH2-CH2), 3.27 
– 3.86 (m, [CH2CH2O]n), 4.23 (m, Cα).
MALDI-TOF (alpha cyano): m/z: 11321, calculated m/z: 11305 for 225 ethylene glycol units.
Boc-Phe-Phe-Glu(OtBu)-star-PEG (protected) (31)
General procedure 2A was followed using star-PEG-NH2 (250 mg, 25 µmol), PyBOP (78 mg, 6 
eq, 150 µmol), peptide Boc-Phe-Phe-Glu(OtBu) (17; 90 mg, 6 eq, 150 µmol) and DiPEA (104 
µL, 24 eq, 600 µmol).
1H-NMR (400 MHz, CDCl3): δ = 1.23 – 1.46 (m, CH3), 1.88 – 2.32 (m, Cα-CH2-CH2), 2.85 – 
3.12 (m, CH2 (Phe)), 3.38 – 3.85 (m, [CH2CH2O]n), 4.18 – 4.57 (m, Cα), 6.99 – 7.38 (m, Ar-CH)
MALDI-TOF (alpha cyano): m/z: 12286, calculated m/z: 12275 for 219 ethylene glycol units.
H-Phe-Phe-Glu-star-PEG (32)
Deprotection was performed according to general procedure 2B. 
1H-NMR (400 MHz, D2O): δ = 1.80 – 1.96 (m, Cα-CH2-CH2), 2.15 – 2.22 (m, Cα-CH2-CH2), 
2.96 – 3.13 (m, CH2 (Phe)), 3.29 – 3.90 (m, [CH2CH2O]n), 4.13 (m, Cα), 7.17 – 7.40 (m, Ar-CH)
MALDI-TOF (alpha cyano): m/z: 11740, calculated m/z: 11738 for 221 ethylene glycol units.
Boc-Phe-Glu(OtBu)-Phe-star-PEG (protected) (33)
General procedure 2A was followed using star-PEG-NH2 (250 mg, 25 µmol), PyBOP (78 mg, 6 
eq, 150 µmol), peptide Boc-Phe-Glu(OtBu)-Phe (18; 90 mg, 6 eq, 150 µmol) and DiPEA (104 
µL, 24 eq, 600 µmol).
1H-NMR (400 MHz, CDCl3): δ = 1.23 – 1.48 (m, CH3), 1.98 – 2.28 (m, Cα-CH2-CH2), 2.82 – 
3.10 (m, CH2 (Phe)), 3.38 – 3.87 (m, [CH2CH2O]n), 4.29 (m, Cα), 7.13 – 7.34 (m, Ar-CH).
MALDI-TOF (alpha cyano): m/z: 12228, calculated m/z: 12230 for 218 ethylene glycol units.
H-Phe-Glu-Phe-star-PEG (34)
Deprotection was performed according to general procedure 2B. 
1H-NMR (400 MHz, D2O): δ = 1.73 – 1.98 (m, Cα-CH2-CH2), 2.05- 2.18 (m, Cα-CH2-CH2), 
2.95 – 3.16 (m, CH2 (Phe)), 3.37 – 3.89 (m, [CH2CH2O]n), 4.32 (m, Cα), 7.11 – 7.40 (m, Ar-CH)
MALDI-TOF (alpha cyano): m/z: 11778, calculated m/z: 11782 for 222 ethylene glycol units.
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Boc-Glu(OtBu)-Phe-Phe-star-PEG (protected) (35)
General procedure 2A was followed using star-PEG-NH2 (250 mg, 25 µmol), PyBOP (78 mg, 6 
eq, 150 µmol), peptide Boc-Glu(OtBu)-Phe-Phe (19; 90 mg, 6 eq, 150 µmol) and DiPEA (104 
µL, 24 eq, 600 µmol).
1H-NMR (400 MHz, CDCl3): δ = 1.23 – 1.48 (m, CH3), 2.12 - 2.44 (m, Cα-CH2-CH2), 2.92 – 
3.08 (m, CH2 (Phe)), 3.15 – 3.98 (m, [CH2CH2O]n), 4.48 – 4.71 (m, Cα), 7.09 – 7.29 (m, Ar-CH);
MALDI-TOF (alpha cyano): m/z: 12107, calculated m/z: 12099 for 215 ethylene glycol units.
H-Glu-Phe-Phe-star-PEG (36)
Deprotection was performed according to general procedure 2B. 
1H-NMR (400 MHz, D2O): δ = 1.86 – 2.08 ((m, Cα-CH2-CH2), 2.85 – 3.03 (m, CH2 (Phe)), 
3.21 – 3.96 (m, [CH2CH2O]n), 4.47 (m, Cα), 7.17 – 7.36 (m, Ar-CH).
MALDI-TOF (alpha cyano): m/z: 11682, calculated m/z: 11694 for 220 ethylene glycol units.
Gelation studies
Gelation GE7G-star-PEG (21)
A 1 wt% solution of GE7G-star-PEG (21) was prepared by dissolving 5 mg in 50 µL 1 M 
NaOH, which was further diluted by addition of 450 µL HEPES buffer (20 mM, pH7.1). Aliquots 
of CaCl2 (2 µL = 1 eq) were added, resulting in final additions of 0.5 – 10 eq (1 eq CaCl2 
corresponds to 1 eq per peptide, hence 4 eq based on the total construct). Gelation was tested 
at r.t. via the inverted vial test. A 5 wt% solution of 21 was tested at r.t. and at 37°C by dissolving 
5 mg GE7G-star-PEG (21) in 50 µL 1 M NaOH and 50 µL HEPES buffer, and addition of CaCl2 
aliquots (0.5 – 20 eq). Gelation of 10 wt% solutions in NaOH (10 mg in 100 µL 1 M NaOH) 
and in ammonia (10 mg in 40 µL 25% ammonia and 55 µL H2O) was investigated by addition 
of CaCl2 aliquots (2 – 20 eq).
Gelation Calmodulin 3-star-PEG (23)
A 2 wt% solution of Calmodulin 3-star-PEG (23) was prepared by dissolving 2 mg in 100 µL 
MilliQ. Aliquots of CaCl2 (2 µL = 1 eq) were added, resulting in final additions of 0.5 – 10 eq (1 
eq CaCl2 corresponds to 1 eq per peptide, hence 4 eq based on the total construct). Gelation 
was tested at r.t. via the inverted vial test. 
Gelation GEG-star-PEG (26), LEL-star-PEG (28) and AEA-star-PEG (30)
Gel formation was studied with 15 wt% solution of GEG-star-PEG (26), LEL-star-PEG (28) and 
AEA-star-PEG (30) (15 mg in 100 µL MilliQ). Aliquots of CaCl2 (5 µL = 1 eq) were added, 
resulting in final additions of 1 – 4 eq (1 eq CaCl2 corresponds to 1 eq per peptide, hence 4 eq 
based on the total construct). Gelation was tested at r.t. via the inverted vial test. 
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Gelation FFE-star-PEG (32), FEF-star-PEG (34) and EFF-star-PEG (36)
Gel formation was studied with 15 wt% solution of FFE-star-PEG (32), FEF-star-PEG (34) and 
EFF-star-PEG (36) (15 mg in 100 µL MilliQ and 15 mg in 100 mM Tris buffer, pH 9.0). Aliquots of 
CaCl2 (5 µL = 1 eq) were added, resulting in final additions of 1 – 4 eq (1 eq CaCl2 corresponds 
to 1 eq per peptide, hence 4 eq based on the total construct). Gelation was tested at r.t. via 
the inverted vial test. 
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Chapter 3
Soft PEG-hydrogels with independently tunable
stiffness and RGDS-content for cell adhesion studies
This chapter has been published as:
Jonker, A.M.; Bode, S.A.; Kusters, A.H.; van Hest, J.C.M.; Löwik, D.W.P.M. 
Macromol. Biosci. 2015, 15, 1338-1347
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3.1. Introduction
Hydrogels are water-swollen cross-linked polymeric networks. Due to their high water 
content, biocompatibility and mechanical properties, hydrogels are promising biomaterials for 
mimicking the extracellular matrix (ECM).1-4 Poly(ethylene glycol) (PEG) is a common choice 
as the polymeric basis for synthetic hydrogels. PEG is hydrophilic, has excellent biocompatibility, 
low toxicity and is non-adhesive towards proteins and cells.5-7 PEG-based hydrogels can be 
formed by physical or chemical cross-links.8 Among the chemical cross-linking procedures, the 
copper-catalyzed “click” reaction between an azide and alkyne (CuAAC) is widely used as it 
is fast, high-yielding and modular, but most importantly orthogonal.9,10 In order to circumvent 
the necessity of applying cytotoxic copper ions, recently copper-free strain promoted azide-
alkyne cycloaddition (SPAAC)11-14, thiol-ene chemistry15-18, Diels-Alder cycloadditions19-22 
and the SPOCQ reaction (strain-promoted oxidation-controlled cyclooctyne–1,2-quinone 
cycloaddition) between a catechol and a ring-strained alkyne23,24 have emerged as efficient 
alternative cross-linking reactions.25,26 Among others, the SPAAC method has shown its validity 
in constructing hydrogels which promote cellular adhesion via the incorporation of synthetic 
adhesion peptides, such as the RGDS sequence.27-29 DeForest et al.30 demonstrated that 
star-shaped PEG functionalized with azide moieties can be clicked to cyclooctyne-containing 
peptides, leading to hydrogel formation. Also enzymatically cleavable peptide sequences were 
efficiently incorporated, making the hydrogels biodegradable.30 The bio-orthogonal character of 
these coupling chemistries ensures the functional integrity of the biological motifs in the final 
hydrogel structure. The broad applicability of these materials was demonstrated by successful 
cell culturing of a range of cells, such as fibroblasts, human mesenchymal stem cells and bone 
marrow derived stromal cells.30-33 
When culturing cells on hydrogels, it is important to understand how they interact with their 
surroundings. It has been stated that cells are able to feel the substrate they are attached to 
and that they will respond based on these external mechanical signals.34,35 For example it has 
been shown that the differentiation of mesenchymal stem cells is dependent on substrate 
stiffness. Culturing on soft gels (0.1 – 1 kPa) led to neurons, but myoblasts were formed on 
stiffer substrates (8 – 17 kPa) and cells differentiated into osteoblasts on rigid matrices (25 
– 40 kPa).36 Recent research indicates that these stem cells retain their phenotype on a non-
fouling zwitterionic hydrogel, independent of stiffness.37 In general, most cell lines seem to 
have a preference to adhere to and grow on stiffer substrates.35,38-45 However, there remains 
some debate about the influence of matrix stiffness on cell adhesion, differentiation and 
migration. Recently, Trappmann and co-workers46 demonstrated that human mesenchymal 
cells were able to spread and differentiate on collagen-coated polydimethylsiloxane (PDMS) 
hydrogel surfaces (0.1 kPa – 2.3 MPa) independent of their stiffness. Cells on collagen-coated 
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polyacrylamide (PAAm) gels (0.5 – 740 kPa) on the other hand could only spread on stiff 
surfaces and differentiated on soft surfaces due to their inability to form focal adhesions. This 
was confirmed by the fact that decreasing the number of anchoring points on stiff gels resulted 
in cellular behavior as if there were on soft gels. The authors therefore stated that cells apply a 
mechanical force on substrate-bound ECM and need the feedback to make cell-fate decisions. 
These results thus show that is it not the stiffness, but the mechanical feedback of the ECM 
that influences cell behavior.46 On the other hand, Missirlis and Spatz47 studied the effect of 
substrate elasticity on fibroblast adhesion using PEG hydrogels (5.5 – 65 kPa). They found that 
cells respond to differences in substrate elasticity and were unlikely to respond to differences in 
ligand tethering. Fibroblasts were found to spread increasingly better on stiffer substrates. These 
results thereby support the general idea that most cells prefer stiffer substrates.47 However, 
there are also studies that reported different cellular responses to hydrogel stiffness. The Caruso 
group revealed that HeLa cell adhesion on soft poly(methacrylic acid) PMASH hydrogels (2.5 
kPa) decreased with increasing film stiffness. They found negligible differences in the hydrogel 
film roughness, hydrophobicity and charge and stated that the differences in cell adhesion are 
caused by the mechanical properties of the gel.48 Robinson et al. found that proliferation of NIH 
3T3 cells and HUVECs was larger on gels with a lower strength. On the other hand, human 
vascular smooth muscle cells and adventitial fibroblasts showed enhanced growth on stiffer 
surfaces.49 All together, these examples highlight the need to further study the influence of the 
synthetic matrix on cellular adhesion, migration and differentiation.3
So far, most cellular adhesion studies have been performed with stiff substrates, usually exceeding 
the stiffness range of most mammalian organs, which have elastic moduli (G’) between 100 – 
10.000 Pa.43,44,46,47,50 In this study, we aim to investigate how different cell lines respond to various 
soft hydrogels. For this purpose, we fabricated soft hydrogels with PEG as the polymeric basis, 
using bicyclo[6.1.0]nonyne (BCN) based copper-free click chemistry.13 In order to promote 
cellular adhesion of our PEG hydrogels, an RGDS peptide motif was incorporated in the 
polymeric network (Figure 3.1). These clickable hydrogels constitute a platform that allows us 
to vary both the RGDS content and the polymer density independently of each other. In this 
way, we intend to get insight on the influence of the stiffness of soft hydrogels in combination 
with the amount of adhesion motifs on the cell viability of three different cell types. 
3.2. Hydrogel design
Hydrogels were fabricated using 4-armed poly(ethylene glycol) (Mn = 10 kDa, star-PEG) as 
the polymeric basis. As cross-linking methodology, we used copper-free strain-promoted 
click (SPAAC) chemistry, with a bicyclo[6.1.0]nonyne (BCN) derivative as the ring-strained 
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alkyne.13 Star-PEG-amine was functionalized with either an azide or BCN moiety, by coupling 
of azido acetic acid and BCN-OSu, respectively (Figure 3.1). Additionally, we also synthesized 
the corresponding di-functionalized PEG analogues. Hydrogels were formed by combining 
equimolar amounts of star-PEG-BCN and star-PEG-N3, or by replacing one of the star-polymer 
components by di-functionalized PEG. Upon mixing the components in water, the click reaction 
commenced, leading to the formation of a polymeric network. Cross-linking took place without 
the need of additional chemicals or further processing. Gel formation was qualitatively examined 
via the inverted vial test. We investigated the minimal polymer concentration required for 
gelation to occur, by varying the total polymer content from 5 up to 30 mg/mL. Very soft 
hydrogels were formed overnight for the combination of star-PEG-BCN with star-PEG-N3 
at a total polymer concentration of 10 mg/mL (1 wt%). This appeared to be the minimum 
gelation concentration, since only viscous solutions were obtained at 5 mg/mL. Increasing 
polymer concentration resulted in faster gelation times. Hydrogels could also be obtained when 
combining star-PEG polymers with di-functionalized PEG, but gelation times were significantly 
longer. When star-shaped polymers are used for gelation, more branching points are available, 
so a denser network is formed, leading to faster gelation. We therefore decided to continue 
with the star-shaped polymers for further studies.
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Figure 3.1. Hydrogel formation. A: Mixing of star-PEG-BCN with star-PEG-RGDS-N3 yields a stable 
hydrogel network (containing 100% RGDS). B: Cross-links are formed by copper-free click chemistry. C: 
The composition of the hydrogel network can be adjusted by mixing in certain amounts of star-PEG-N3, 
and thereby changing the total RGDS content. Furthermore, the RGDS-polymer can also be replaced by 
a RDGS-containing star-PEG (star-PEG-scrambled (structure not shown)). 
Next, IR-spectroscopy was performed on 30 mg/mL gels to confirm that gelation concurred 
via the click reaction. When equimolar amounts of azide and BCN were used, the typical azide-
signal around 2100 cm-1 could not be detected after hydrogel formation, while it was clearly 
present before cross-linking. When an excess of star-PEG-N3 was utilized, the azide-signal did 
not fully disappear after gelation had occurred (Figure 3.2).
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Figure 3.2. IR spectroscopy of 30 mg/mL PEG-hydrogels. A: ratio azide:alkyne 1:1, the azide-signal could 
not be detected after gelation had occurred. B: ratio azide: alkyne 2:1; when using an excess of azide in 
the hydrogels, the N3-signal was present (2103.79 cm-1).
Now that we confirmed that copper-free azide-BCN cycloaddition chemistry is suitable as a 
cross-linking method for soft hydrogel formation, we aimed to introduce peptide functionalities 
in the PEG polymer network (Figure 3.1). To be able to investigate the cellular adhesion 
properties of the hydrogels, we incorporated the well-known RGDS adhesion domain.27-29 First, 
this peptide was synthesized using standard Fmoc solid phase peptide synthesis, with coupling of 
azido-acetic acid as the final residue. The employed Barlos solid phase resin allowed mild resin 
cleavage to keep all acid-labile side-chain protecting groups in place. Coupling of the peptide 
to star-PEG-NH2 could therefore be performed selectively at the C-terminus. This method 
allowed us to easily obtain azidoGly-Arg-Gly-Asp-Ser-Gly functionalized star-PEG, which is 
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further referred to as star-PEG-RGDS-N3 (Figure 3.3, Chapter 2.3.1). We also synthesized 
the scrambled peptide (azidoGly-Arg-Asp-Gly-Ser-Gly) polymer construct star-PEG-scrambled, 
which was not expected to be able to induce cell adhesion. With these building blocks in hand, 
we were able to fabricate various soft hydrogels. Our modular approach allows us to vary 
both the polymer density and RGDS-content independently of each other. We could adjust 
the polymer density by varying the total polymer content. Hydrogels were prepared in the 
concentration range 10 – 30 mg/mL. Furthermore, we tuned the RGDS content by mixing in 
both star-PEG-RGDS-N3 and star-PEG-N3, for cross-linking to star-PEG-BCN. 
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Figure 3.3. Synthesis of star-PEG-RGDS-N3. 
3.3. Rheology
The mechanical properties of the PEG- and PEG-RGDS-hydrogels were determined using 
rheology. The storage (G’) and loss modulus (G’’) were measured using an oscillatory time 
sweep test. Hydrogels were prepared with varying total polymer concentration (10 – 30 mg/
mL) using a molar ratio of 1:1 between the azide and alkyne groups. The cross-over point at 
which G’ exceeds G’’ was determined as an estimate of the point of gelation. With increasing 
polymer concentration, the time to reach this point of gelation decreased. Gel formation started 
after 22 min for the 30 mg/mL PEG-only hydrogel, where the gelation time increased to 47 min 
for 20 mg/mL and 338 min for 10 mg/mL (Table 3.1). 
Table 3.1. Cross-over points (G’ exceeds G’’) in minutes for 10, 20 and 30 mg/mL hydrogels containing 
0, 50 and 100% RGDS. Gelation time increases with incorporation of the peptide moiety. * = Single 
measurement, the other 10 mg/mL gels were not constantly measured during the gelation process. 
RGDS Gelation point
10 mg/mL (min) 
Gelation point 20 mg/
mL (min)
Gelation point
30 mg/mL (min)
0% 338 ± 25 47 ± 2 22 ± 1
50% 423* 53 ± 1 25 ± 2
100% 478* 63 ± 2 29 ± 1
After reaching the cross-over point, G’ steadily increased for all hydrogels and reached a final 
value which was much larger than G’’ (Figure 3.4). Typically, G’’ values in the background range 
were obtained (0 ± 5 Pa). A significant increase in final G’ was found after set time points with 
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increasing polymer content. Hydrogels of 10 mg/mL showed a G’ of 25 Pa (16 h), while values 
for 20 mg/mL and 30 mg/mL were 1192 Pa (5.5 h) and 2298 Pa (2.5 h), respectively (Table 
3.2). Frequency sweep measurements were conducted on all cured hydrogels and G’ and 
G’’ were found to be independent of frequency. This corresponds to a predominantly elastic 
composition of the PEG gels (Figure 3.4). 
Figure 3.4. Rheology data of the PEG-hydrogels, G’ is represented by closed symbols, G’’ by open symbols. 
Top: time sweep measurement of the 20 mg/mL PEG-hydrogel. After reaching the gelation point (47 min), 
G’ steadily increases and reaches a final value (1192 Pa) which is much larger than G’’. Bottom: frequency 
sweep measurements of the 10, 20 and 30 mg/mL, showing that hydrogels have a predominantly elastic 
composition.
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Table 3.2. Hydrogel strength G’ (Pa) measured by rheology. Values were recorded after set time points 
of 16h, 5.5h and 2.5h for 10 mg/mL, 20 mg/mL and 30 mg/mL, respectively. All measurements performed 
with n = 3 or n = 4. Hydrogel strength increases with increasing polymer density. Incorporation of the 
RGDS-peptide results in lower moduli.
RGDS G’ 10 mg/mL G’ 20 mg/mL G’ 30 mg/mL
0% 25 ± 3 1192 ± 23 2298 ± 67
50% 18 ± 16 841 ± 21 2094 ± 64
100% 12 ± 1 611 ± 56 1496 ± 77
These results indicate that the PEG materials show typical hydrogel behaviour (G’ >> G’’); the 
obtained hydrogels are highly elastic and, as expected, stronger gels are obtained with increasing 
polymer content.51 Importantly, as intended, we obtained PEG hydrogels with relatively low 
stiffness. Our hydrogels have elastic moduli in the soft tissue range, comparable to that of most 
mammalian organs (G’ = 100 – 10.000 Pa) and are softer than most materials reported thus 
far.50 Swelling ratios of the 10, 20 and 30 mg/mL hydrogels were determined to be 1.032 ± 0.004, 
1.008 ± 0,004 and 1.013 ± 0.011, respectively (Table 3.5) Due to the low polymer content 
(1-3 wt%), these gels have a high water content, resulting in hardly any swelling. The polymer 
density of the hydrogels can thus only be varied effectively by appyling different concentrations 
of star-PEG polymers during hydrogel preparation. Next, we studied the mechanical properties 
of RGDS-containing hydrogels. We measured hydrogels containing 50 and 100% RGDS for all 
three polymer concentrations. Lower G’ values were obtained than for PEG-only hydrogels 
after set time points (Table 3.2). Since the cross-over point was observed at a later time-point 
(Table 3.1), we estimated that gelation was likely to occur more slowly in RGDS-containing 
hydrogels. To rule out the possibility that this pattern is sequence dependent, we also tested 
hydrogels containing the scrambled peptide sequence and found the same effect (G’ = 1355 
Pa ± 65, 100% Scrambled, 30 mg/mL) (Figure 3.5). To test our hypothesis that gelation occurs 
slower with peptide-containing hydrogels, we measured the 30 mg/mL hydrogels overnight 
(16h). We measured star-PEG, star-PEG-RGDS-N3 (100%) and star-PEG-scrambled (100%) and 
found G’ values of 3186 Pa, 2863 Pa and 3086 Pa, respectively (Table 3.4). Comparable G’ 
values were obtained with or without peptide for fully cured gels. We can therefore conclude 
that incorporation of peptide sequences does not hinder network formation, and thus, albeit 
slower, yields stable hydrogels. 
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Figure 3.5. Top: Representative time sweep measurement (2.5 h) of a 30 mg/mL 100% Scrambled 
hydrogel. G’ is represented by closed symbols, G’’ by open symbols. Final G’ value: 1355 ± 64 Pa 
(n = 3). Bottom: Strain sweep measurement of a 20 mg/mL PEG-only hydrogel to determine the linear 
viscoelastic region. Strain sweeps were measured for all other hydrogels compositions, giving the same 
results. Rheology measurements were conducted with 1% strain. 
3.4. Cell adhesion studies
3.4.1. Total cell count (WST-8 assay)
After synthesizing and studying the mechanical properties of our RGDS-containing PEG-
based gels, we set out to investigate the cell adhesion properties of these soft hydrogels. Since 
our hydrogel formation method easily allows us to vary the amount of RGDS present in 
the network, an RGDS concentration range was studied. We prepared hydrogels in the three 
polymer concentrations (10, 20 and 30 mg/mL) containing 1, 5, 10, 25, 50, 75 and 100% RGDS, 
in order to investigate how much RGDS is required to give cellular adhesion. This corresponds 
to a concentration range of RGDS clusters from 5 µM (1% RGDS, 10 mg/mL) up to 1500 
µM (100% RGDS, 30 mg/mL). If we assume that clusters of four peptides are homogeneously 
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distributed throughout the polymeric network, and that cells are able to interact with these 
peptides within 5 nm from the surface, we can calculate the amount of RGDS clusters in the 
top surface layer of the hydrogels.47,52 We calculated this range to be between 15 and 4500 
RGDS clusters/µm2. Massia and Hubbell demonstrated that a peptide spacing of 140 nm is 
sufficient for focal contact formation, which corresponds to 60 peptides/µm2.53 In the weakest 
hydrogel (10 mg/mL) with 1% RGDS (15 clusters/µm2), the adhesion points might thus be too 
far from each other for decent cellular adhesion, although each cluster already contains 4 RGDS 
moieties. Apart from the lowest RGDS concentrations, the range used here corresponds to 
previous studies on cell adhesion.47,54 
Figure 3.6. WST-8 assay with NIH 3T3 fibroblasts, the x-axis shows the different hydrogel compositions, 
the y-axis shows the cell viability calculated based on the positive gelatin control (set to 100%). Varying of 
the RGDS content does not have an influence on total cell count. The 10 and 20 mg/mL hydrogels have 
a high cell count, in contrast to the stiffest hydrogel of 30 mg/mL which shows a remarkable decrease in 
the total amount of living cells. 
To investigate the influence of RGDS-content on cell adhesion, gels with an RGDS concentration 
range (1, 5, 10, 25, 50, 75 and 100%) were tested in a WST-8 assay to measure the number 
of viable cells. Upon cellular reduction, the cell-permeable WST-8 is converted into the water 
soluble formazan, of which the absorbance can be measured.55 As a negative control, PEG-only 
hydrogels were tested. Since PEG is known to be non-adhesive, cellular adherence to these 
hydrogels is unlikely to occur.5-7 As a second negative control we also tested the star-PEG-
scrambled (RDGS) hydrogels. Based on the rheology studies, we left the gels overnight to allow 
them to cure fully. The next day, NIH 3T3 fibroblasts were seeded on each hydrogel. Gelatin-
coated wells were used as positive control; the total number of viable cells in these wells was 
set to 100%. The total cell count of the hydrogel samples was calculated as a percentage of 
the gelatin control. The WST-8 assay performed with the RGDS concentration range revealed 
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that changing the RGDS content did not have an influence on the total amount of viable cells 
(Figure 3.6). Within one hydrogel stiffness similar viability percentages were obtained for all 
different RGDS concentrations. Interestingly, clear differences in total cell count were observed 
between gels with varying stiffness (10, 20 and 30 mg/mL). The amount of viable cells on the 
10 and 20 mg/mL resembled the gelatin control, but their number clearly decreased on the 30 
mg/mL gels (Figure 3.6). Since the amount of RGDS did not show to have an influence on the 
total cell count, we decided to only study the influence of hydrogel stiffness on cell adhesion in 
further experiments. 
3.4.2. Confocal microscopy – Live/dead assay
Apart from the NIH 3T3 fibroblasts, we chose to study HeLa and human osteosarcoma (HOS) 
cells. We were interested in these cell lines, since they originate from different tissue. HOS cells 
originate from human bone tumor and might be more likely to adhere to stiffer surfaces. HeLa 
cells and NIH 3T3 fibroblasts are both derived from softer tissues, and are therefore interesting 
to compare to HOS cells. We studied the hydrogels with confocal laser scanning microscopy 
(CLSM) using a live/dead assay to assess viability. This assay consists of two dyes, one to color 
living cells (calcein-AM) and one for dead cells (ethidium homodimer-1, EthD-1). Calcein-AM 
is cell-permeable and is converted to the green fluorescent calcein by intracellular esterase 
activity of live cells. Ethidium homodimer-1 can only enter cells with a damaged membrane, and 
then binds to nucleic acids, leading to a bright red fluorescence. We first investigated whether 
cell adhesion is specific for the RGDS sequence by performing the live/dead assay with HeLa 
cells seeded on 20 mg/mL PEG-only, RGDS-containing and scrambled hydrogels (Figure 3.7). 
Since we found that varying the RGDS content does not have an influence, we decided to 
perform further studies with gels containing 50% RGDS. The live/dead assay showed red 
fluorescent cells for PEG-only and scrambled hydrogels, showing that cells do not remain viable. 
Furthermore, their transmission images revealed that these cells have a round morphology. As 
expected, gels lacking a cell adhesion motif are not suitable substrates for cellular adherence 
(Figure 3.19). Incorporation of the RGDS-motif turned the hydrogels into an appropriate 
substrate for cellular adhesion, as seen by the large number of green fluorescent cells and their 
spread morphology (Figure 3.7).
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Figure 3.7. Cell viability images for the live/dead assay on 20 mg/mL hydrogels. Images are composed 
from overlays of the calcein-AM (green) and ethidium homodimer-1 (EthD-1, red) channels. Dead cells 
(red) were observed on PEG-only (left) and scrambled hydrogels (right), live cells (green) were found on 
RGDS-containing hydrogels (center). Cell spreading is thus specific for the RGDS sequence. Upper picture: 
confocal fluorescence, lower picture: transmission image. Scale bar represents 50 µm for all micrographs.
Next, the live/dead assay was performed on the RGDS-containing hydrogels with the three 
cell types (HeLa, NIH 3T3 and HOS) (Figure 3.8, Figures 3.16-3.18). All hydrogel coatings 
were prepared in the same manner, containing 50% RGDS. Hydrogels only differed in the total 
polymer content (10, 20, 30 mg/mL) and thus in gel stiffness. Many live cells with a spread 
morphology were observed for HOS cells on all hydrogels, indicating that these bone marrow-
derived cells were able to spread on RGDS-hydrogels, independent of their stiffness (Figures 
3.8 and 3.9, Figure 3.18). The live/dead assay performed with HeLa cells and NIH 3T3 
fibroblasts revealed many live cells for the 10 and 20 mg/mL hydrogels, which nicely adhered in 
a spread morphology (Figure 3.8, Figures 3.16 and 3.17). Interestingly, cell adherence on the 
stiffest hydrogel (30 mg/mL) was clearly diminished for both HeLa cells and NIH 3T3 fibroblasts. 
The assay revealed a lower amount of adhered cells in both samples; however these cells were 
still viable as seen by the green fluorescent signals. NIH 3T3 fibroblasts on the 30 mg/mL gel 
showed a mixture of cells with a spread and round morphology, whereas HeLa cells mainly 
had a round morphology. Differences in cell adhesion between 10 or 20 mg/mL and 30 mg/
mL were significant, as determined by counting the total number of adhered cells (Figure 3.9, 
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Table 3.3). Both HeLa cells and NIH3T3 fibroblasts are derived from softer tissues than HOS 
cells and experience difficulties with adherence to the stiffest hydrogel (30 mg/mL) (Figures 
3.8 and 3.9; Figures 3.16 and 3.17)
Figure 3.8. Representative confocal fluorescence micrographs for HeLa, NIH 3T3 fibroblasts and HOS 
cells seeded on RGDS-containing hydrogels with different polymer densities. Cells are stained with calcein 
(green) and EthD-1 (red). Pictures are obtained from overlay images of the calcein and EthD-1 channels. 
From left to right: 10, 20 and 30 mg/mL hydrogels, all containing 50% RGDS. Scale bar corresponds to 50 
µm for all micrographs (for cell count, see Figure 3.9) (for transmission images, see Figures 3.16-3.18).
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Figure 3.9. Cell count, based on live-dead assay confocal images (n = 3, Figure 3.8). The amount of 
counted cells on 10 mg/mL hydrogels was set to 100%. HeLa and NIH 3T3 showed significant differences 
in the number of cells adhered to 10 or 20 mg/mL and the amount on 30 mg/mL gels. HOS cells did not 
show significant differences with varying hydrogel stiffness (for p-values, see Table 3.3, * means: p < 0.05; 
** means: p < 0.01, no star : not significant). 
Table 3.3. P-values for cell count based on live/dead confocal images (Figure 3.9). Values were obtained 
via an unpaired T-test based on a confidence interval of 95%.
p-values HeLa p-values NIH 3T3 p-values HOS
10 vs 20 mg/mL 0.0399 0.4307 0.4560
10 vs 30 mg/mL 0.0008 0.0076 0.9315
20 vs 30 mg/mL 0.0009 0.0056 0.4143
3.5. Discussion
The live/dead assay revealed that 10 and 20 mg/mL RGDS-containing hydrogels are suitable 
substrates for cell adhesion for all cell-types tested. Many live HOS cells with a spread 
morphology were also found for the stiffest hydrogel of 30 mg/mL, in contrast to the results for 
HeLa cells and NIH 3T3 fibroblasts for which the amount of spread cells was clearly decreased. 
Because we found that the RGDS concentration does not have an influence, the only difference 
with the 30 mg/mL hydrogels is the increased total polymer concentration, which affects the 
mechanical properties of the gel. Swelling of the gels was not taken into account, since none of 
the gels absorbed water due to their high water content. Based on literature results, we assume 
that the surface chemistry of the hydrogels is not affected by the increased polymer density.41,48 
Hence, the increased stiffness is likely to be the reason for the decreased cellular adhesion 
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properties of the 30 mg/mL hydrogels. These results are in contrast to the general consensus 
from literature that most cells seem to have a preference for stiffer substrates. There is, however, 
still debate on the influence of the mechanical properties on cellular adhesion. Several studies 
indicate that stiffness is an important factor to determine cell adhesion, whereas others state 
that it is the mechanical feedback of the ECM.35,38-47,50 Important to note in this discussion is 
that most hydrogels studied thus far have elastic moduli (G’) in the order of magnitude of kPa, 
or even MPa. The high stiffness of these gels might also influence the adhesion behavior of 
cells. The Caruso group investigated this effect by developing soft PMASH hydrogel films with a 
strength up to 2500 Pa, thus in the same range as our PEG-hydrogels.48 They found the same 
pattern as we did and thus opposite to what others have reported; decreasing cell adhesion 
was observed with increasing hydrogel stiffness. Negligible differences were seen in the surface 
chemistry of hydrogel films with various strengths, showing that cells respond to substrate 
elasticity. The authors postulated that this effect was due to the enhanced cell-film contact area 
for softer hydrogels. Additionally, the Heilshorn group studied spreading of fibroblasts on soft 
ELP-PEG gels. Many fibroblasts (~ 60%) spread on gels with a modulus of 1300 Pa, whereas 
only 3% of the cells showed a spread morphology on the stiffer hydrogel (2500 Pa).56 Moreover, 
the same effect was found by the Anseth group for human mesenschymal stem cells adhered 
to thiol-ene photopolymerized PEG-gels. Gels with a low G’ modulus (110 Pa) showed greater 
cell spreading than stiffer gels (1180 Pa).57 Results from the Caruso, Heilshorn and Anseth group 
are thus in good agreement with our data using SPAAC cross-linked PEG-hydrogels and were 
all performed on soft hydrogels (up to 2500 Pa).48,56,57 Taken together, this indicates that stiffness 
seems to have an influence on the cellular adhesion of soft hydrogels and results in decreased 
cellular adhesion with increasing hydrogel stiffness. 
3.6. Conclusion
We used bio-orthogonal copper-free azide-BCN cycloaddition chemistry (SPAAC) for the 
construction of soft PEG-based hydrogels. Hydrogels with different polymer densities were 
obtained by varying the total polymer content. From rheology studies to determine stiffness, 
storage moduli (G’) in the range of 25 Pa (10 mg/mL) till 2298 Pa (30 mg/mL) were obtained. 
The cellular adhesion motif RGDS could easily be incorporated in the hydrogel network. Gels 
containing the peptide moiety formed slower, but still yielded stable networks. The RGDS 
content and polymer density could be varied independently of each other. Live/dead assay 
studies revealed that HOS cells are viable and well-spread on all RGDS-containing hydrogels, 
independent of their stiffness. For both HeLa cells and NIH 3T3 fibroblasts many live cells were 
found on the 10 mg/mL (25 Pa) and 20 mg/mL (1192 Pa) gels. With increased hydrogel stiffness 
(30 mg/mL, 2298 Pa), cellular adhesion decreased. For hydrogels in the very soft regime we 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Soft PEG-hydrogels with independently tunable stiffness and RGDS-content for cell adhesion studies    105
3
studied, hydrogel stiffness seems to be a determining factor in cellular adhesion of HeLa cells 
and NIH 3T3 fibroblasts.
3.7. Acknowledgements
Saskia Bode is gratefully acknowledged for carrying out all the microscopy experiments, her 
expertise on the cell studies, all useful discussions and for co-authoring the manuscript. Addie 
Kusters is thanked for starting this research during his internship. Sander Leeuwenburgh is 
acknowlegded for fruitful discussions. The department of General Instruments of the Radboud 
University Nijmegen, especially Liesbeth Pierson, is thanked for providing light microscopy 
services. 
3.8. Materials and methods
The 2-chlorotrityl resin was purchased from Bachem (Bubendorf, Switzerland) and Fmoc-L-
amino acids were purchased from Novabiochem (EMD Chemicals, Gibbstown, USA) or Bachem. 
4-Armed poly(ethylene glycol)-NH2 (10 kDa) salt was obtained from JenKem Technology (USA). 
(1R,8S,9S)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate was purchased from 
Synaffix (Oss, The Netherlands). Fetal bovine serum (FBS) was from Integro (Zaandam, The 
Netherlands) and plain Dulbecco’s Modified Eagle Medium (DMEM) and trypsin/EDTA were 
both from PAA Laboratories (Pasching, Austria). The WST-8 dye was obtained from Dojindo 
Molecular Technologies (Rockville, USA). The Live/Dead® viability reagents were obtained from 
Life Technologies (Thermo Fisher Scientific Inc., Waltham, U.S.A.). All other chemicals were 
purchased from Sigma-Aldrich, Baker or Fluka and utilized as received. Human epithelial ovarian 
carcinoma (HeLa), human osteosarcoma (HOS) cells and NIH 3T3 fibroblasts were obtained 
from ATCC (Rockville, USA).
 
1H NMR spectra were recorded on a Varian Mercury (400 MHz). As a solvent shift reference, 
we used CDCl3 (δ = 7.26 ppm), and D2O (δ = 4.79 ppm). Mass spectra were recorded on a 
Thermo Finnigan LCQ-Advantage MAX or on a Bruker Biflex MALDI-TOF (Bruker Daltronik, 
Bremen, Germany). As matrix, α-cyano-4-hydroxycinnamic acid was used. IR-spectra were 
recorded on a Bruker Tensor 27 FTIR spectrometer. Column chromatography was performed 
with Silica gel 60 (particle size 0.040 – 0.063 mm Merck) or aluminum oxide (basic activated, 
pore size 58 Å, Sigma-Aldrich). Thin-layer chromatography (TLC) was performed on silica gel 
coated plates (Merck 60, F-254). Visualization was accomplished with UV-light and/or ninhydrin 
or permanganate staining. Lyophilization was achieved using an ilShin Freeze Dryer (ilShin, Ede, 
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The Netherlands). Analytic HPLC was performed on a Shimadzu LC-20A Prominence system 
(Shimadzu, ‘s Hertogenbosch, The Netherlands) equipped with a C18 ReproSil column, 150 x 
3 mm, particle size 3 µm (Dr. Maisch GmbH, Screening Devices, Amersfoort, The Netherlands). 
Elution of the peptides was achieved using an acetonitrile/water gradient containing 0.1% 
trifluoroacetic acid (5-100%, 1-31 min, flow 0.4 mL/min). LC-MS was performed on a Thermo 
Finnigan LCQ-Fleet ESI-ion trap (Thermo Fischer, Breda, The Netherlands) equipped with 
a Phenomenex C18 column, 50 x 2.0 mm, particle size 3 µm (Phenomenex, Utrecht, The 
Netherlands). An acetonitrile/water gradient containing 0.1% formic acid was used for elution (5-
100%, 1-10 min, flow 0.2 mL/min). Rheology measurements were performed on an AR2000ex 
rheometer (TA instruments, New Castle, USA). Absorbance was measured at 450 nm using a 
Tecan Infinite M200 Pro plate reader. Confocal laser scanning microscopy (CLSM) studies were 
performed on a Leica-microsystems (Mannheim, Germany) TCS SP2 AOBS system, installed on 
an inverted motorized DM IRE2 microscope and equipped with a 40 x water immersion HCX 
apo long distance lens. 
Star-PEG-BCN
To a dry reaction flask was added 10 kDa 4-armed poly(ethylene glycol)-NH2 HCl salt (600 mg, 
0.06 mmol), (1R,8S,9S)-bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate (BCN-OSu; 
87.4 mg, 0.30 mmol) and 100 µL triethylamine (100 µL, 0.72 mmol) in dry DCM (25 mL). The 
reaction mixture was stirred at r.t. overnight under N2 atmosphere. Extraction was performed 
with 2M NaOH (3 x 25 mL). The organic layer was dried over MgSO4 and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (MeOH:DCM 2:98, 
followed by 10:90). The product was afforded as a white powder after freeze-drying from 
dioxane (406 mg, 63%). 
Rf = 0.36 (MeOH:DCM, 10:90)
1H-NMR (400 MHz, CDCl3): δ = 0.86 – 1.01 (m, 4H), 1.25 – 1.43 (m, 8H), 1.52 – 1.66 (m, 8H), 
2.18 – 2.34 (m, 16H), 3.38 (m, 16H), 3.51 – 3.86 (m, [CH2CH2O]n), 4.15 (d, J = 8.0 Hz, 8H).
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 3.10
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Figure 3.10. MALDI –TOF spectrum star-PEG-BCN, calculated m/z: 10791 for 222 ethylene glycol units.
Azido-acetic acid58
Bromoacetic acid (13.9 g, 100 mmol) and sodium azide (13.0 g, 200 mmol) were dissolved in 
water (60 mL) and stirred for 48 h at r.t. Concentrated hydrochloric acid (50 mL) was added 
to the reaction mixture after which extraction was performed with diethylether (4 x 100 mL). 
The combined organic phases were dried over MgSO4 and evaporated in vacuo. The product 
was obtained as yellow oil and was dried under vacuum (9.86 g, 98%).
1H-NMR (400 MHz, CDCl3): δ = 3.98 (s, 2H)
LCQ: m/z: 138.7 [M + K]+ (calculated [M + K]+ = 139.15)
IR: 2115.73 cm-1 (N3)
Star-PEG-N3
To 4-armed poly(ethylene glycol)-NH2 HCl salt (800 mg, 80 µmol) in DCM (25 mL) was added 
subsequently benzotriazol-1-yl-oxy-tris dimethylaminophosphonium hexafluorophosphate 
(BOP; 283 mg, 0.64 mmol), azido acetic acid (65 mg, 0.64 mmol) and DiPEA (328 µL 1.92 
mmol). The reaction mixture was stirred overnight at r.t and extracted with 1 M KHSO4 (5 x 
50 mL) and brine (1 x 50 mL). The organic layer was dried over MgSO4 and concentrated in 
vacuo. The compound was purified by column chromatography on basic aluminum oxide, using 
MeOH:DCM (10:90) as eluent. Freeze-drying from dioxane afforded the product as a white 
powder (760 mg, 92%). 
Rf = 0.38 (MeOH:DCM, 10:90)
1H-NMR (400 MHz, CDCl3): δ = 3.41 (s, 8H), 3.45 – 3.55 (m, 16H), 3.57 – 3.70 (m, [CH2CH2O]
n), 3.96 (s, 8H).
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 3.11
IR = 2103.52 cm-1 (N3)
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Figure 3.11. MALDI-TOF spectrum star-PEG-N3, calculated m/z: 10463 for 223 ethylene glycol units.
Peptide synthesis
The peptides were synthesized from 2.0 g 2-chloro-trityl resin using Fmoc solid-phase peptide 
synthesis (SPPS). The resin was swollen in DCM for 20 min prior to use. Functionalization of 
the resin with the first amino acid was performed for 30 min with 2.0 eq of the required amino 
acid and 3.0 eq DiPEA. This procedure was repeated with a coupling time of 60 min, after 
which capping was performed with 2.0 eq DiPEA in methanol. Deprotection of the Fmoc-
groups was carried out with piperidine in DMF (20%, v/v) for 20 min. Subsequent couplings 
were performed with 3.0 eq of the required amino acid, 3.3 eq of N,N’-diisopropylcarbodiimide 
(DIPCDI) and 3.6 eq of N-hydroxybenzotriazole (HOBt) in DMF. After each coupling and 
deprotection step, a Kaiser test59 was done to ensure completion of the reaction. In the final 
step, azido acetic acid (3.0 eq) was coupled using DIPCDI (3.3 eq) and HOBt (3.6 eq). The 
peptides were cleaved from the resin with mild cleaving reagents, to ensure that the acid-labile 
protecting groups remained intact. Cleavage was performed by treatment of the resin with a 
mixture of dichloromethane (DCM), trifluoroethanol (TFE) and acetic acid (HOAc) (6:1:1) for 
3 h. The solvents were evaporated under reduced pressure and co-evaporation was performed 
with chloroform (3 x 40 mL). The peptides were afforded as white solids after freeze-drying 
from dioxane. 
Azidoacetyl-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Gly-OH (azidoGly-Arg-Gly-Asp-Ser-Gly-OH)
LCQ: m/z: 938.3 [M + H]+ (calculated [M + H]+ = 938.4)
LC-MS: m/z: 938.5 [M + H]+, Rt = 9.21 min
HPLC: Rt = 21.56 min
IR: 2107.08 cm-1 (N3)
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Azidoacetyl-Arg(Pbf)-Asp(OtBu)-Gly-Ser(tBu)-Gly-OH (azidoGly-Arg-Asp-Gly-Ser-Gly-OH 
(scrambled))
LCQ: m/z: 938.3 [M + H]+ (calculated [M + H]+ = 938.4)
LC-MS: m/z: 938.8 [M + H]+, Rt = 9.09 min
HPLC: Rt = 19.96 min
IR: 2102.76 cm-1 (N3)
Star-PEG-RGDS-N3 and star-PEG-scrambled 
To star-poly(ethylene glycol)-NH2 HCl salt (750 mg, 75 µmol) in DCM (20 mL) was added 
subsequently BOP (199 mg, 0.45 mmol), protected peptide (azidoGly-Arg-Gly-Asp-Ser-Gly-
OH or azidoGly-Arg-Asp-Gly-Ser-Gly-OH 422 mg, 0.45 mmol), and DiPEA (314 µL, 1.8 mmol). 
The reaction mixture was stirred overnight at r.t. Extraction was performed with 1 M KHSO4 (4 
x 60 mL) and brine (1 x 60 mL), after which the organic layer was dried over MgSO4. Column 
chromatography on basic aluminum oxide (MeOH: DCM; 10:90) afforded white powders after 
freeze-drying from dioxane (RGDS: 885 mg, 86%; Scrambled: 896 mg, 87%).
Star-PEG-RGDS-N3 (Azidoacetyl-Arg(Pbf)-Gly-Asp(OtBu)- Ser(tBu)-Gly-star-PEG)
Rf = 0.30 (MeOH:DCM 10:90)
1H-NMR (400 MHz, CDCl3): δ = 1.15 (s, 36H), 1.42 (s, 36H), 1.46 (s, 32H), 2.09 (s), 2.53 - 3.07 
(m), 3.48 – 3.70 (m, [CH2CH2O]n), 3.99 (m), 4.35 (m), 4.67 (m).
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 3.12
Figure 3.12. MALDI-TOF spectrum star-PEG-RGDS-N3 (Azidoacetyl-Arg(Pbf)-Gly-Asp(OtBu)- Ser(tBu)-
Gly-star-PEG), calculated m/z: 13239 for 210 polyethylene glycol units.
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Star-PEG-scrambled (Azidoacetyl-Arg(Pbf)-Asp(OtBu)-Gly-Ser(tBu)-Gly-star-PEG) 
Rf = 0.30 (MeOH:DCM 10:90) 
1H-NMR (400 MHz, CDCl3): δ = 1.18 (s, 36H), 1.42 (s, 36H), 1.46 (s, 32H), 2.09 (s), 2.52 - 3.00 
(m), 3.50 – 3.69 (m, [CH2CH2O]n), 3.95 (m), 4.49 (m), 4.75 (m).
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 3.13
Figure 3.13. MALDI-TOF spectrum star-PEG-scrambled (Azidoacetyl- Arg(Pbf)-Asp(OtBu)-Gly-
Ser(tBu)-Gly-star-PEG), calculated m/z: 13327 for 212 polyethylene glycol units.
Deprotection star-PEG-RGDS-N3 and star-PEG-scrambled
The protected peptide-star-PEG construct (350 mg; 25.6 µmol) was treated with TFA: TIS: H2O 
(95:2.5:2.5; 8 mL) for 4 h at r.t. The reaction mixture was concentrated and co-evaporated with 
toluene (4 x 30 mL). The product was dissolved in water and dialysed against 800 mL water 
using dialysis membranes with a MW cut-off of 3500 Da. Dialysis was performed for 5 days 
under regular exchange of the water (twice a day). After dialysis, the products were obtained as 
white solids by freeze-drying (RGDS: 289 mg, 92%; Scrambled: 298 mg, 95%). 
Star-PEG-RGDS-N3
1H-NMR (400 MHz, D2O): δ = 1.60 – 1.99 (m), 2.68 (m), 3.36 – 3.75 (m, [CH2CH2O]n), 3.84 
– 4.10 (m), 4.41 (m).
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 3.14
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Figure 3.14. MALDI-TOF spectrum star-PEG-RGDS-N3, calculated m/z: 12310 for 222 ethylene glycol 
units.
Star-PEG-scrambled
1H-NMR (400 MHz, D2O): δ = 1.57 – 1.98 (m), 2.69 (m), 3.35 – 3.74 (m, [CH2CH2O]n), 3.83 
– 4.10 (m), 4.38 (m).
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 3.15
Figure 3.15. MALDI-TOF spectrum star-PEG-scrambled, calculated m/z: 12353 for 223 ethylene glycol 
units.
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Hydrogel formation
Hydrogels were prepared by weighing off equal amounts of star-PEG-BCN and star-PEG-N3 
with a total polymer concentration of 10, 20 or 30 mg/mL. For example, a typical 30 mg/mL 
PEG hydrogel was obtained by dissolving 3.00 mg star-PEG-BCN in 100 µL MilliQ. To this 
solution was added 100 µL star-PEG-N3 (30 mg/mL, in MilliQ). The two hydrogel components 
were mixed by vortexing and left at room temperature to allow gel formation. For a peptide-
containing hydrogel, stock solutions of star-PEG-N3 and star-PEG-RGDS/star-PEG-RDGS were 
added to star-PEG-BCN. For example, a 50% RGDS-containing gel (20 mg/mL) was prepared 
by adding 50 µL star-PEG-N3 and 50 µL star-PEG-RGDS (each 20 mg/mL in MilliQ) to a star-
PEG-BCN solution (2 mg in 100 µL MilliQ). 
Rheology
The storage (G’) and loss modulus (G’’) of the hydrogels were measured using an AR2000ex 
rheometer (TA instruments). All measurements were performed using a flat steel plate geometry 
(20 mm, gap size 500 µm) and were performed at a temperature of 20°C. Hydrogel solutions 
were prepared at different polymer concentrations and RGDS-content. A molar ratio of 1:1 
between the alkyne and azide groups was used to ensure complete cross-linking. Hydrogel 
solutions were loaded on the rheometer as liquid (200 µL) and were measured during the 
gelation process. To minimize evaporation, a solvent trap was utilized which was filled with 
water. Initially, a strain sweep measurement was conducted on cured gels to determine the linear 
viscoelastic range, by measuring between 0.1 and 1000% strain at an angular frequency of 10 
rad/s. Within this range, a strain percentage (1%) was chosen to perform further measurements 
(Figure 3.5). Oscillatory time sweep measurements were measured at a constant strain of 1% 
and an angular frequency of 10 rad/s and were continued until stable values of G’ were obtained. 
Typically, time sweep tests were conducted for 2.5 h (30 mg/mL), 5.5 h (20 mg/mL) and 16 h 
(10 mg/mL). Additionally, overnight time sweep measurements (16 h) were performed for 30 
mg/mL hydrogels containing 0% peptide, 100% RGDS and 100% Scrambled peptide (Table 
3.4, n = 2). All other rheology measurements were performed with n = 3 or n = 4. 
Table 3.4. G’ values for overnight time sweep measurements (16 h) for 30 mg/mL gels (n = 2)
Peptide Overnight 
30 mg/mL (16h) 
0% 3186 ± 110
100 % RGDS 2863 ± 107
100% Scrambled 3086 ± 501
Swelling
Hydrogels (250 µL) were prepared from star-PEG-BCN and star-PEG-N3 following the general 
protocol using total polymer concentrations of 10, 20 and 30 mg/mL. Gels were allowed to 
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cross-link overnight, after which they were weighed to obtain the mass after gelation (Mg). After 
swelling for 24 h in MilliQ water, gels were weighed again, yielding the mass after swelling (Ms). 
The swelling ratio was given as Q = Ms/Mg. Samples were made with n = 5 for each polymer 
concentration (Table 3.5).
Table 3.5. Swelling ratios (Q) for star-PEG-BCN / star-PEG-N3 hydrogels as determined by dividing the 
mass after swelling (Ms) through the mass after gelation (Mg) (n = 5).
Hydrogel Swelling ratio Q 
10 mg/mL 1.032 ± 0.004
20 mg/mL 1.008 + 0.004
30 mg/mL 1.013 ± 0.011
Cell culture
NIH 3T3 fibroblasts and HeLa cells were maintained in sterile conditions in Dulbecco’s Modified 
Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS). 
For Human Osteosarcoma (HOS) cells, DF medium (DMEM: Ham’s F-12 nutrient mixture 1:1) 
containing 10% heat-inactivated FBS was used. Cells were maintained on tissue culture plastic 
and kept at 37°C in a humidified atmosphere of 7.5% CO2. Cells were passaged every 2-3 
days. Prior to cell studies, cells within a confluent layer were detached by trypsinisation (using 
trypsin/EDTA). Cells were resuspended in media and the number of cells was counted using an 
inverted microscope and a cell counting chamber (Fuchs-Rosenthal). 
WST-8 assay55
Hydrogels were formed in a 96-well plate; to each well 75 µL hydrogel solution (see hydrogel 
formation) was added. The plate was wrapped with parafilm and gels were allowed to form 
overnight (24 h). All samples were measured in triplo. As a positive control, a number of wells 
were coated with 1% gelatin to obtain 100% viable cells. NIH 3T3 fibroblasts were plated at a 
density of 18000 cells in 100 µL per hydrogel-containing well. Cells cultured on the hydrogels 
were incubated for 18 h (37°C, 7.5% CO2). Cells were examined under a standard inverted 
microscopy (Olympus CK2) prior to WST-8 addition, to evaluate the total cell count visually. 
Media were replaced by 100 µL WST-8 (1:10 in DMEM) and incubation was performed for 
4-6 h. The absorbance of the WST-8 solution was measured at 450 nm using a Tecan Infinite 
M200 Pro plate reader. For all samples and the gelatin control, the background absorbance was 
subtracted, which was the absorbance measured in wells that only contained the WST-8 dye in 
medium. Total cell count for all hydrogels was calculated as a percentage of the positive gelatin 
control, which was set to 100% viable cells. 
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Confocal microscopy
Hydrogel solutions were prepared, following the general protocol of hydrogel formation. All 
RGDS-hydrogels contained 50% of the cell adhesion domain. An 8-chambered coverslip (Nunc, 
Wiesbaden, Germany) was coated with gel by addition of a small layer of hydrogel solution. The 
coverslip was wrapped with parafilm and gels were allowed to cure for 24 h at r.t. In each well, 
40.000 cells in 250 µL medium were seeded. Wells coated with gelatin were used as positive 
control. Cells were incubated overnight (37°C, 7.5% CO2). After this incubation period, the 
cells were treated with the live/dead staining, which was prepared by diluting calcein-AM and 
ethidium homodimer-1 (EthD-1) in PBS to obtain a concentration of 4 mM calcein-AM and 8 
mM EthD-1 for HeLa and HOS cells, the concentration was lowered to 1.33 mM calcein-AM 
and 2.67 mM EthD-1 for NIH 3T3 fibroblasts. The samples were allowed to rest for 10 minutes, 
after which they were immediately analysed by confocal laser scanning microscopy. Calcein was 
excited with the 488 nm line of an argon ion laser, and emission was collected between 494 
and 515 nm. EthD-1 was excited with the 561 nm line of a yellow diode laser and emission was 
collected between 600 and 625 nm. Using the ImageJ software, overlay images of the calcein 
and EthD-1 signals were produced (Figures 3.7, 3.8 and 3.16-3.18). 
Figure 3.16. Live dead assay with HeLa cells, showing fluorescent overlay images of the calcein (green) 
and EthD-1 (red) channel and transmission images. HeLa cells were seeded on RGDS-containing hydrogels 
(50%) with varying stiffness (10, 20 and 30 mg/mL, left to right). Scale bar corresponds to 50 µm for all 
pictures.
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Figure 3.17. Live dead assay with NIH 3T3 fibroblasts, showing fluorescent overlay images of the calcein 
(green) and EthD-1 (red) channel and transmission images. Fibroblasts were seeded on RGDS-containing 
hydrogels (50%) with varying stiffness (10, 20 and 30 mg/mL, left to right). Scale bar corresponds to 50 
µm for all pictures.
Figure 3.18. Live dead assay with HOS cells, showing fluorescent overlay images of the calcein (green) 
and EthD-1 (red) channel and transmission images. HOS cells were seeded on RGDS-containing hydrogels 
(50%) with varying stiffness (10, 20 and 30 mg/mL, left to right). Scale bar corresponds to 50 µm for all 
pictures.
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Figure 3.19. Representative transmission images of both negative controls for all cell types. Hydrogels 
stiffness did not have an influence, no living cells were found for all PEG-only and scrambled hydrogels. 
Scale bar corresponds to 50 µm for all pictures.
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A fast and activatable cross-linking strategy 
for hydrogel formation
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4.1. Introduction
Hydrogels are water-swollen networks, formed by cross-links between the polymeric 
constituents. In the past years, they have received increasing attention as injectable drug 
deliverables, as scaffolds for the immobilization of biomolecules and as matrix materials in 
regenerative medicine. Poly(ethylene)glycol (PEG) is often applied as the polymeric basis, because 
it has excellent biocompatibility, is hydrophilic, shows low toxicity and is non-adhesive towards 
proteins and cells. Typically, the PEG-based polymers contain terminal mutually reactive groups 
that form a cross-linked network upon reaction.1-7 A variety of reactions have been successfully 
used to form gels via chemical cross-linking.8,9 The Cu(I)-catalysed azide-alkyne cycloaddition 
(CuAAC, commonly known as click chemistry), as introduced by Meldal and Sharpless10,11, has 
proven to be very promising to form PEG-based hydrogels as it is fast, high-yielding and modular, 
but most importantly orthogonal.12,13 However, the cytotoxicity associated with the Cu(I)-
catalyst limits the usage of CuAAC for the preparation of hydrogels for biomedical applications. 
Other conjugation strategies have also been reported for hydrogel formation such as thiol-
ene photoclick reactions14-16, Michael-type additions17,18, thiol-norbornene reactions19, oxime 
chemistry20, Diels-Alder cycloadditions21-23 and strain-promoted azide-alkyne cycloadditions 
(SPAAC).24-26 Especially, Diels-Alder reactions and SPAAC form viable alternatives to CuAAC 
as cross-linking method due to their bio-orthogonal character and spontaneous reactivity.27-30 
The Anseth group was the first to exploit SPAAC for hydrogel formation by using star-shaped 
PEG-azide and cyclooctyne-containing peptides. By incorporation of a photocleavable group, 
hydrogels could be post-modified with thiol-containing compounds using UV-light.24 However, an 
important aspect the abovementioned crosslinking methods are all lacking is a coupling strategy 
which is both fast and which can be activated. This is a highly desired property for injectable 
hydrogels and for other biomedical applications where spatiotemporal control of hydrogel 
formation is demanded. An interesting activatable and bio-inspired cross-linking method has 
been reported by Messersmith and co-workers. They functionalized four-armed PEG (Mn = 
10.000 Da) with the unnatural amino acid 3,4-dihydroxyphenylalanine (DOPA). Subsequent 
oxidation of the DOPA groups with sodium periodate resulted in hydrogel formation.31 In 
recent years, more groups have developed DOPA-inspired hydrogels with potential as adhesive 
materials in tissue engineering.32-34 Apart from covalent cross-linking methods, the catechol 
moiety is also capable of forming strong complexes with metal ions like Fe3+. This property was 
recently used as a non-covalent cross-linking method to rapidly form pH-induced reversible 
hydrogels.35,36 However, strategies to form covalently cross-linked hydrogels are still hampered 
by slow reaction kinetics.
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In this chapter, we report a fast and activatable cross-linking method for hydrogel formation using 
a strain-promoted oxidation-controlled cyclooctyne–1,2-quinone cycloaddition (SPOCQ).37 
We show that the formation of hydrogels out of four-armed star PEG functionalized with 
cyclooctyne derivative bicyclo[6.1.0]non-4-yne (BCN) and catechol DHPA (3,4 dihydroxy 
phenylacetic acid), proceeds extremely fast after oxidation of the catechol to the quinone, 
which can be triggered both chemically (Paragraph 4.2.1) and enzymatically (Paragraph 
4.2.2; Figure 4.1). Moreover, both BCN and DHPA are readily accessible, making this a user-
friendly cross-linking method for hydrogel formation. Furthermore, we demonstrate that the 
SPOCQ and SPAAC reactions can be used in concert, due to the large difference in reaction 
rates (Paragraph 4.3, Figure 4.1). The SPOCQ reaction thus offers a versatile, fast and 
activatable alternative to current hydrogel cross-linking strategies.
Oxidation
 N3
+
OH
OH
PEG
H H
PEG
Figure 4.1. Schematic overview of the SPOCQ reaction between catechol- and cyclooctyne-functionalized 
PEG, resulting in hydrogel formation upon oxidation. SPOCQ and SPAAC can be used as an orthogonal 
reaction pair, as demonstrated with an azide-functionalized fluorescent dye.
4.2. Hydrogel synthesis using SPOCQ
4.2.1. Sodium periodate as oxidizing agent
To form hydrogels with four-armed poly(ethylene) glycol (Mn = 10.000 Da, star-PEG), we 
first had to functionalize PEG with cyclooctyne derivative bicyclo[6.1.0]non-4-yne (BCN) 
and with DOPA derivative 3,4 dihydroxy phenylacetic acid (DHPA). This could simply be 
performed in one step by coupling of respectively BCN-succinimidyl ester (Chapter 3) or 3,4 
dihydroxy phenylacetic acid to star-PEG-amine. Hydrogel formation was studied at polymer 
concentrations of 10, 20 and 30 mg/mL (1-3 wt%). Sodium periodate was used to oxidize the 
catechol moieties. The oxidizing agent (1 eq) was added to an equimolar mixture of polymers 
star-PEG-BCN and star-PEG-DHPA. Hydrogels were formed almost instantaneously, due to the 
fast reaction kinetics of the SPOCQ reaction (Figure 4.2).37 
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Figure 4.2. Hydrogel formation using the SPOCQ reaction. A: A mixture of star-PEG-BCN and star-PEG-
DHPA is oxidized with sodium periodate or mushroom tyrosinase, to yield a stable hydrogel network. B. 
SPOCQ cross-linking between BCN and DHPA upon oxidization.
Varying the polymer concentration (10, 20 or 30 mg/mL) did not influence the gelation time. 
The mechanical properties of the hydrogels were measured using rheology. The storage (G’) 
and loss modulus (G’’) were determined with an oscillatory time sweep test. Due to fast gelation 
of our periodate-induced hydrogels, the gelation point (where G’ exceeds G’’) could not be 
determined. Stable G’ and G’’ values were already found from the start of the measurement and 
remained constant in an overnight time sweep study showing that gels very quickly obtained 
their final strength (Figure 4.3A).
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Figure 4.3. Rheological analysis of SPOCQ cross-linked hydrogels. a) Representative time sweep 
measurement (t = 5 min) of a NaIO4 oxidized hydrogel. Gels directly obtained their final G‘ (red line) 
and G‘‘ (blue line) values. b). Gelation time of mushroom tyrosinase cross-linked hydrogels as estimated 
via the inverted vial test. The gelation time was approximately 1 min with 2000 units/mL and increased 
with decreasing enzyme concentration. c). Representative time sweep measurement (t = 2 h) of enzyme 
cross-linked hydrogels (500 units/mL).
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Gels were found to be soft for all studied polymer concentrations (10, 20 and 30 mg/mL), as 
expected at these low weight percentages. Stronger gels were formed with increasing polymer 
content. G’ values of 65 Pa (10 mg/mL), 454 Pa (20 mg/mL) and 1375 Pa (30 mg/mL) were 
obtained for the periodate-induced gels. The PEG material displayed typical hydrogel behaviour, 
as G’ values were much larger than G’’ values. Frequency sweep measurements were conducted 
on all cured hydrogels and G’ and G’’ values were found to be independent of frequency 
(Figure 4.4). This corresponds to a predominantly elastic composition of the hydrogels. 
Figure 4.4. Rheological analysis of periodate-induced gels. G’ is represented by closed symbols, G’’ by 
open symbols. Top: Representative frequency sweeps of 10, 20 and 30 mg/mL hydrogels oxidized by 
sodium periodate. Bottom: Strain sweep measurement of a 20 mg/mL hydrogel to determine the linear 
viscoelastic region.
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Magic-angle spinning (MAS) 1H-NMR was performed on 30 mg/mL hydrogels with an equimolar 
polymer ratio in order to study cross-linking efficiency. We focused on the peak at δ = 2.2 ppm, 
from the protons next to the alkyne, which shifts upon reaction with the quinone. As expected, 
a small peak was still detectable in the gel, revealing the presence of dangling ends in the 
network (Figure 4.5). Next, we investigated the stability of star-PEG-BCN and star-PEG-DHPA 
upon storage. Solutions of both polymers were stored at room temperature and at 4°C for 1 
week. Hydrogels could still be formed in both cases; however, gels made with polymers stored 
at room temperature appeared to be less stiff. Time sweep measurements of hydrogels formed 
with polymers stored at 4°C for 1 week resulted in comparable moduli (G’ = 468 ± 26 Pa, n 
= 3) as obtained for freshly prepared gels (G’ = 454 ± 19 Pa, Table 4.2). Hydrogels prepared 
with polymers left at room temperature were less stiff, resulting in slightly lower G’ values (G’ 
= 361 ± 16 Pa, n = 2).
Figure 4.5. MAS 1H NMR spectrum showing the region where the alkyne signal resonates (δ = 2.2 ppm, 
protons next to the triple bond). Three different ratios of star-PEG-BCN: star-PEG-DHPA were measured. 
With an excess of star-PEG-BCN, more unreacted alkyne is present, with the most intense signal for the 
1:0.5 mixture.
4.2.2. Mushroom tyrosinase as oxidizing agent
Besides chemical activation of the catechol moiety, it can also be oxidized by enzymes such 
as mushroom tyrosinase.31 Also other gelation systems have been described in previous 
reports that utilize an enzymatic reaction for gel formation, like horseradish peroxidase31,38, 
phosphatase39 and transglutamidase40,41. Enzymatic cross-linking is advantageous due to the high 
substrate specificity of the enzyme. Furthermore, by tuning the enzyme concentration, the 
overall cross-linking rate can be controlled.42 We set out to investigate enzymatically induced 
gel formation with the SPOCQ reaction. To this end, we studied gelation of an equimolar 
mixture of star-PEG-DHPA and star-PEG-BCN with the enzyme mushroom tyrosinase. We 
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first investigated 20 mg/mL solutions at different enzyme concentrations (100 – 2000 units/
mL) (Figure 4.3B). Gelation times of the resulting enzymatically cross-linked hydrogels were 
estimated using the inverted vial test. Gelation was found to be fast and the time to gelation 
decreased, as expected, with increasing enzyme concentration. Samples of 20 mg/mL already 
gelled in approximately 1 min using an enzyme concentration of 2000 units/mL. Lowering the 
enzyme concentration to 100 units/mL still resulted in gel formation after approximately 20 min 
(Figure 4.3B, Table 4.1). 
Table 4.1. Gelation time of enzymatically (mushroom tyrosinase) cross-linked hydrogels, determined using 
the inverted vial test (n = 3).
MT (units/mL) Gelation time (s)
100 1147 ± 100
250 326 ± 21
500 143 ± 4
1000 92 ± 6
1500 71 ± 9
2000 65 ± 8
The gelation time of the hydrogels can thus easily be controlled by adjusting the enzyme 
concentration. In order to follow the gelation using rheology, we decided to perform these 
measurements with an enzyme concentration of 500 units/mL on hydrogel solutions with a 
total polymer content of 10, 20 and 30 mg/mL. Time sweep measurements were carried out 
for 2 h and showed that G’ began to increase rapidly after addition of the enzyme (Figure 
4.3C). The mechanical properties of enzymatically cross-linked hydrogels were comparable 
to periodate-induced gels. G’ values of 35 Pa (10 mg/mL), 476 Pa (20 mg/mL) and 921 Pa (30 
mg/mL) were acquired (Table 4.2). Hydrogels induced by tyrosinase also mainly had an elastic 
composition (Figure 4.6).
Table 4.2. Hydrogel strength G’ (Pa) measured by rheology. Values were recorded after 5 min for sodium 
periodate (n = 5) and after 2 h for mushroom tyrosinase (MT, n = 3). 
10 mg/mL 20 mg/mL 30 mg/mL
NaIO4 65 Pa ± 10 454 Pa ± 19 1375 Pa ± 21 
MT 35 ± 3 476 Pa ± 28 921 Pa ± 37
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Figure 4.6. Rheological analysis of enzymatically oxidized gels. G’ is represented by closed symbols, G’’ 
by open symbols. Top: Representative frequency sweeps of 10, 20 and 30 mg/mL hydrogels oxidized by 
mushroom tyrosinase (500 units/mL). Bottom: Strain sweep measurement of a 20 mg/mL hydrogel to 
determine the linear viscoelastic region.
These data show that the high reaction rate constant of the SPOCQ reaction also translates 
into fast hydrogel formation after enzymatic or chemical oxidation of the DHPA groups. A 
similar study that solely used four-armed PEG-DOPA constructs for gelation reported slower 
kinetics. Gelation of four-armed PEG-DOPA (130 mg/mL) occurred at a minimum of 18 min 
with NaIO4. Enzymatic cross-linking with 25.000 units/mL mushroom tyrosinase resulted in 
hydrogel formation after 2 days.31 Another study that used the SPAAC reaction for cross-linking 
obtained a gelation point (G’ > G’’) within 5 min, using a polymer concentration of 13.5 wt% 
(135 mg/mL).24 
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Figure 4.7. Rheology of SPAAC-cross-linked hydrogels; composed of star-PEG-BCN and star-PEG-N3. G’ 
is represented by closed symbols, G’’ by open symbols. Top: time sweep measurement (16 h) for a 10 mg/
mL, with the gelation point after approximately 6 h. Bottom: time sweep measurement (2.5 h) for a 30 mg/
mL hydrogel, with the gelation point after approximately 20 min (see Chapter 3.3).
To be able to make a direct comparison with SPOCQ, we also performed the SPAAC reaction 
with our low polymer concentrations. For this purpose, star-PEG-N3 was first synthesized by 
coupling of azido-acetic acid to star-PEG-amine. Cross-linking of star-PEG-BCN and star-PEG-N3 
with SPAAC resulted in gelation points of 20 min for 30 mg/mL up to 6 h for the 10 mg/mL 
hydrogel (Figure 4.7; Chapter 3.3). This clearly shows the high reaction rate of SPOCQ for 
hydrogel formation compared to the SPAAC reaction. Furthermore, the mechanical properties 
of SPOCQ formed PEG-hydrogels are also comparable to other previously reported PEG-
hydrogels. For instance, measured moduli of 10 wt % SPOCQ gels (G’ = 11.7 ± 0.6 kPa, 
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(Figure 4.8)) were similar to the reported moduli for 13.5 wt % SPAAC cross-linked gels 
(G’ = 12.0 ± 0.6 kPa)24 and to 13 wt% DOPA-DOPA cross-linked gels (G’ = 13 kPa).31 Moreover, 
Waite and co-workers recently introduced non-covalently cross-linked hydrogels with a more 
stable catechol analogue (3-hydroxy 4-pyridinone, HOPO). Gels formed via the coordination 
of Fe3+ to HOPO appeared to have similar mechanical properties (10 wt%, G’ = 12 kPa) as our 
SPOCQ formed hydrogels.43 
Figure 4.8. Rheological analysis of 100 mg/mL (10 wt%) SPOCQ cross-linked hydrogels, oxidized by 
periodate. G’ is represented by closed symbols, G’’ by open symbols. Gels obtained a G’ value of 11.7 ± 
0.6 kPa. Top: representative time sweep test (10 min). Bottom: frequency sweep measurement.
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4.3. SPOCQ and SPAAC as an orthogonal reaction pair
Now that we showed that the SPOCQ reaction can be applied as an efficient, activatable 
and fast cross-linking method for hydrogel formation, we wanted to further explore the 
possibilities to functionalize these hydrogels. In our previous research, we demonstrated that 
the 1,2-quinone and the azide moieties can be utilized as an orthogonal reaction pair due to 
their large difference in reactivity towards BCN.37 In this respect, we hypothesized that we could 
utilize this property to post-functionalize our SPOCQ-formed hydrogels using the SPAAC 
reaction. To this end, we first tested if gels could be formed with non-equimolar amounts of 
star-PEG-DHPA and star-PEG-BCN. We chose to study gels with a final polymer concentration 
of 20 mg/mL (2 wt%) containing star-PEG-DHPA and star-PEG-BCN in a ratio of 0.8: 1.0. 
Oxidation with sodium periodate still resulted in rapid gelation, corroborated by the inverted 
vial test. For subsequent functionalization, we utilized 3-azido-7-coumarin, a dye that shows a 
strong increase in fluorescence upon cycloaddition to an alkyne. We added azido-coumarin 
to already formed hydrogels containing an excess of BCN-groups. Illumination with UV-light 
showed fluorescence at the site of addition, proving that the BCN-groups are accessible for the 
SPAAC reaction with azido-coumarin (Figure 4.9).
Figure 4.9. Azido-coumarin added on pre-formed gels with an imbalanced polymer ratio, showing 
fluorescence at the side of addition. Gels were prepared by adding NaIO4 (1.0 eq per DHPA group) to a 
mixture of 8.89 mg star-PEG-DHPA (0.8 eq) and 11.11 mg star-PEG-BCN (1.0 eq). On top of the gel was 
added 0.5 eq N3-coumarin (based on the excess of BCN-groups), after which the sample was illuminated 
with UV-light.
Next, we evaluated whether the SPOCQ and SPAAC reactions can also be performed in one-
pot. For this experiment, hydrogels were prepared by adding a mixture of azido-coumarin and 
sodium periodate to a polymer mixture containing an imbalanced ratio of star-PEG-DHPA (0.8 
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eq) and star-PEG-BCN (1.0 eq). Immediate gelation was observed indicating that the presence 
of azido-coumarin did not interfere with the curing of the gel. Hydrogels containing a balanced 
ratio of star-PEG-DHPA (1.0 eq) and star-PEG-BCN (1.0 eq) were also prepared, which 
contained the same amount of azido-coumarin as for the imbalanced gel (0.8: 1.0). The gels 
were subsequently analyzed for coumarin fluorescence under UV-light and a marked difference 
in fluorescence was observed. As expected, the hydrogel with the imbalanced polymer ratio 
showed a much higher fluorescence than the hydrogel with the balanced polymer ratio (Figure 
4.10). In order to quantify the observed differences in fluorescence, we prepared hydrogels in 
microwell plates and measured the fluorescence using a microplate reader. As seen in Figure 
4.10, the fluorescence of the imbalanced gels (DHPA: BCN 0.8: 1.0) was significantly higher 
(40x) than the intensity of the balanced hydrogel (DHPA: BCN 1: 1). 
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Figure 4.10. Incorporation of a functional group (azido-coumarin, fluorescence increases after reaction 
with alkynes) in SPOCQ-formed gels using SPAAC. A. Schematic overview B. Gels with an imbalanced 
polymer ratio (excess star-PEG-BCN, 1) and a balanced ratio (2; top: picture under UV-light, bottom: 
regular picture). C. Fluorescence measurements showing that imbalanced hydrogels (1, red) display a 40x 
higher fluorescence intensity than balanced gels (2, blue). D. Emission at 468 nm of gels with an imbalanced 
(2.9· 104 ± 1.7·103)) and balanced ratio (7.4·102 ± 3.4·102)) and a background measurement of only 
azido-coumarin (46 ± 3).
Moreover, the same trend was seen in MAS NMR, where a larger fraction of unreacted alkyne 
was present in imbalanced gels compared to the balanced hydrogel, further exemplifying the 
possibility to use the unreacted BCN groups for functionalization with azido compounds 
(Figure 4.5). These findings show that the SPOCQ and SPAAC reaction can be used in one 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
132    Chapter 4
pot for the preparation of hydrogels (via SPOCQ) and the subsequent post-modification 
reaction (via SPAAC). 
Figure 4.11. Rheology of imbalanced hydrogels (20 mg/mL) containing star-PEG-BCN and star-PEG-
DHPA in a ratio of 1.0:0.8. G’ is represented by closed symbols, G’’ by open symbols. Top: time sweep 
measurement of non-functionalized imbalanced hydrogels (G’ = 285 ± 23 Pa, n = 5) Bottom: time sweep 
measurement of azido coumarin-functionalized hydrogels (G’ = 285 ± 48 Pa, n = 5). Incorporation of 
azido-coumarin does not change the mechanical properties of the hydrogel network. 
In addition, incorporation of azido-coumarin did not change the mechanical properties of the 
network, since non-functionalized imbalanced hydrogels showed the same moduli (Figure 
4.11). Using the same reactive group for cross-linking and functionalization can result in 
decreased hydrogel stiffness, as was shown for gels formed via the inverse electron demand 
Diels-Alder reaction.23 The advantage of using SPOCQ for hydrogel formation and SPAAC for 
simultaneous hydrogel functionalization was further exemplified when we prepared hydrogels 
with a lower polymer concentration of 10 mg/mL (1 wt%). We again used an imbalanced 
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polymer ratio (0.8: 1.0) and added azido-coumarin (1.5 eq, based on excess BCN) to the 
samples. SPOCQ cross-linked samples composed of star-PEG-DHPA (0.8 eq), star-PEG-BCN 
(1.0 eq) and azido-coumarin still formed hydrogels almost instantaneously after addition of 
sodium periodate. Similarly, we also prepared hydrogels cross-linked with SPAAC, to compare 
those to the SPOCQ formed gels. When an imbalanced polymer ratio of star-PEG-N3 (0.8 
eq) and star-PEG-BCN (1.0 eq) were reacted in the presence of azido-coumarin, hydrogel 
formation did not occur. However, when azido-coumarin was not added to the polymer 
mixture, SPAAC cross-linked hydrogels were formed (Figure 4.12, Table 4.3). These findings 
show that azido-coumarin interferes with the gel formation when SPAAC is used as chemical 
crosslinking method. Due to the high reaction rate of SPOCQ, one-pot functionalization is 
possible, even at low polymer concentrations.
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Figure 4.12. Competition experiment between SPOCQ and SPAAC, using a total polymer content of 
10 mg/mL. A. Sample containing 0.8 eq star-PEG-DHPA, 1.0 eq star-PEG-BCN and azido-coumarin, cross-
linked by SPOCQ. B. Sample containing 0.8 eq star-PEG-N3, 1.0 eq star-PEG-BCN and azido-coumarin, 
cross-linked by SPAAC. Azido-coumarin hampered the formation of a hydrogel. C. Sample containing 0.8 
eq star-PEG-N3 and 1.0 eq star-PEG-BCN, resulting in SPAAC cross-linked hydrogels. Left: reacted samples; 
middle: inverted vial test (sample B did not form a hydrogel); right: under UV-light irradiation to detect 
coumarin fluorescence (sample C does not contain azido-coumarin).
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4.4. Conclusion
In conclusion, we have shown that strain-promoted oxidation-controlled cyclooctyne-1,2-
quinone cycloaddition (SPOCQ) is a fast and efficient cross-linking method for hydrogel 
formation. Cross-linking is activable and was achieved by addition of either a chemical oxidizing 
agent (NaIO4) or an enzyme (mushroom tyrosinase) catalysing the oxidation of DHPA. We 
have also shown that the SPOCQ reaction can be regarded as an orthogonal reaction pair 
with SPAAC, which allows us to easily incorporate a second functionality during or after the 
curing process. We think that the combined usage of an imbalanced ratio of BCN and catechol 
groups for gel formation and the SPAAC reaction will provide a straightforward method to 
modify hydrogels with other functionalities or biomolecules, such as peptides for cell adhesion 
or biomineralization. Hydrogel modification can either be achieved directly in one-pot or 
sequentially on pre-formed gels. We expect these hydrogels to be ideal in those applications, 
where fast or spatiotemporally controlled gel formation is required.
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4.6. Materials and methods
Four-Armed poly(ethylene glycol)-NH2 (10 kDa) salt was obtained from JenKem Technology 
(USA). (1R,8S,9S)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate was purchased 
from SynAffix (Oss, The Netherlands). 3-Azido-7-hydroxycoumarin (N3-coumarin) was kindly 
donated by Jan Dommerholt. All other chemicals were purchased from Sigma-Aldrich, Baker or 
Fluka and utilized as received. 
1H NMR spectra were recorded on a Varian Mercury (400 MHz). Chemical shifts are given 
using TMS as reference (δ = 0 ppm). Mass spectra were recorded on a Bruker Biflex MALDI-
TOF (Bruker Daltronik, Bremen, Germany). As matrix, α-cyano-4-hydroxycinnamic acid was 
used. Column chromatography was performed with silica gel 60 (particle size 0.040 – 0.063 
mm Merck) or aluminum oxide (basic activated, pore size 58 Å, Sigma-Aldrich). Thin-layer 
chromatography (TLC) was performed on silica gel coated plates (Merck 60, F-254). Visualization 
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was accomplished with UV-light and/or ninhydrin or permanganate staining. Lyophilization was 
achieved using an ilShin Freeze Dryer (ilShin, Ede, The Netherlands). Rheology measurements 
were performed on an AR2000ex rheometer (TA instruments, New Castle, USA). UV 
irradiation was performed with a CAMAG UV-lamp (366 nm). Fluorescence measurements 
were performed on a Tecan Infinite M200 Pro plate reader. 
Star-PEG-BCN
To a dry reaction flask was added 4-armed poly(ethylene) glycol-NH2 HCl salt (600 mg, 
0.06 mmol), (1R,8S,9S)-bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate (BCN-
OSu; 87.4 mg, 0.30 mmol) and 100 µL triethylamine (100 µL, 0.72 mmol) in dry DCM 
(25 mL). The reaction mixture was stirred at r.t. overnight under N2 atmosphere and 
then washed with 2M NaOH (3 x 25 mL). The organic layer was dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(MeOH:DCM 2:98, followed by 10:90) to afford the product after freeze-drying from dioxane. 
The obtained white powder was stored at -20°C until further usage (406 mg, 63%).44 
Rf = 0.36 (MeOH:DCM, 10:90)  
1H-NMR (400 MHz, CDCl3, δ): 0.86 – 1.01 (m, 4H), 1.25 – 1.43 (m, 8H), 1.52 – 1.66 (m, 8H), 
2.18 – 2.34 (m, 16H), 3.38 (m, 16H), 3.51 – 3.86 (m, [CH2CH2O]n), 4.15 (d, J = 8.0 Hz, 8H) 
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 4.13.
Figure 4.13. MALDI –TOF spectrum star-PEG-BCN; calculated m/z: 10791 for 222 ethylene glycol units
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Star-PEG-DHPA
To star-poly(ethylene) glycol-NH2 HCl salt (500 mg, 50 µmol) in DMF (13 mL) was added 
subsequently benzotriazol-1-yl-oxy-tris dimethylaminophosphonium hexafluorophosphate 
(BOP; 133 mg, 0.30 mmol), 3,4 dihydroxy phenylacetic acid (51 mg, 0.30 mmol), and DiPEA 
(210 µL, 1.2 mmol). The reaction mixture was stirred overnight at r.t., after which the DMF was 
evaporated in vacuo. The residue was dissolved in DCM and washed with 1 M KHSO4 (3 x 40 
mL) and brine (1 x 40 mL). The organic layer was dried over Na2SO4. The product was purified 
with column chromatography on basic aluminum oxide (MeOH: DCM; 10:90). Lyophilization 
from dioxane afforded the product as a white powder, which was stored at 4°C. (445 mg, 84%)
Rf = 0.25 (MeOH:DCM, 10:90)
1H-NMR (400 MHz, CDCl3, δ): 3.36 – 3.86 (m, [CH2CH2O]n, CH2-Ar-CH), 6.61 – 7.03 (m, Ar-
CH)
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 4.14.
Figure 4.14. MALDI-TOF spectrum star-PEG-DHPA; calculated m/z: 10733 for 223 ethylene glycol units
Star-PEG-N3
To star poly(ethylene) glycol-NH2 HCl salt (800 mg, 80 µmol) in DCM (25 mL) was added 
subsequently BOP (283 mg, 0.64 mmol), azido acetic acid45 (65 mg, 0.64 mmol) and DiPEA 
(328 µL 1.92 mmol). The reaction mixture was stirred overnight at r.t and extracted with 
1 M KHSO4 (5 x 50 mL) and brine (1 x 50 mL). The organic layer was dried over MgSO4 
and concentrated in vacuo. The compound was purified by column chromatography on basic 
aluminum oxide, using MeOH:DCM (10:90) as eluent. Freeze-drying from dioxane afforded the 
product as a white powder (760 mg, 92%)
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Rf = 0.38 (MeOH:DCM, 10:90)
1H-NMR (400 MHz, CDCl3, δ): = 3.41 (s, 8H), 3.45 – 3.55 (m, 16H), 3.57 – 3.70 (m, [CH2CH2O]
n), 3.96 (s, 8H)
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure 4.15
IR = 2103.52 cm-1 (N3).
Figure 4.15. MALDI-TOF spectrum star-PEG-N3; calculated m/z: 10463 for 223 ethylene glycol units
Hydrogel formation
Hydrogels were formed by addition of NaIO4 or mushroom tyrosinase to an equimolar 
mixture of star-PEG-BCN and star-PEG-DHPA. Hydrogels were prepared in total polymer 
concentrations of 10, 20 and 30 mg/mL (1-3 wt%) in water (NaIO4) or in PBS (tyrosinase). For 
a typical hydrogel, equal volumes of the polymer mixture and the oxidizing agent were mixed 
to the final concentration. For the polymer mixture, stock solutions of 20, 40 and 60 mg/mL of 
star-PEG-BCN and star-PEG-DHPA were first freshly prepared and then mixed in a 1:1 fashion. 
For hydrogels formed by sodium periodate, a stock solution containing 1 eq NaIO4 (based on 
amount of DHPA groups, 4 eq NaIO4 per star-PEG-DHPA) was prepared in MilliQ. Hydrogels 
formed by mushroom tyrosinase were formed in 1 x PBS (pH 7.5), which was purged with O2 
for 15 min prior to use. A tyrosinase stock solution was prepared in PBS containing twice as 
many units/mL as needed in the final gel sample. 
Determination of gelation time
Gelation time was determined qualitatively using the inverted vial test. The test was not applied 
for hydrogels formed by sodium periodate, due to almost instant gel formation as soon as all 
components were mixed. For the enzymatically cross-linked hydrogels, the gelation times were 
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determined using a tyrosinase concentration series: 100 – 2000 units/mL. For this, a 4000 units/
mL stock solution in PBS was first prepared, of which a dilution series was made. Hydrogels (20 
mg/mL) were formed using the typical procedure. As soon as the enzyme solution was added to 
the polymer mixture, the time measurement was started. When the material stopped flowing, 
and the vial could thus be inverted, the measurement was ended. Gelation time measurements 
were performed in triplo (Table 4.1).
Rheology
The storage (G’) and loss modulus (G’’) of the hydrogels were measured using an AR2000ex 
rheometer (TA instruments). All measurements were performed using a flat steel plate 
geometry (20 mm, gap size 500 µM) and were performed at a temperature of 20°C. Hydrogels 
were prepared by loading 100 µL of a star-PEG-BCN/star-PEG-DHPA mixture directly on the 
testing platform. After addition of 100 µL NaIO4 or mushroom tyrosinase stock solution, the 
upper plate was immediately lowered and the measurement was started. Initially, a strain sweep 
measurement was conducted to determine the linear viscoelastic range of the hydrogels, by 
measuring between 0.1 and 1000% strain at an angular frequency of 10 rad/s. Within this range, 
a strain percentage (1%) was chosen to perform further measurements. The values of G’ and 
G’’ for periodate-induced gels (10, 20 and 30 mg/mL) were determined using an oscillatory 
time sweep test for 5 min at a constant strain of 1% and an angular frequency of 10 rad/s. Time 
sweep measurements for enzyme-induced gels were performed for 2 h, using a final enzyme 
concentration of 500 units/mL. To minimize evaporation, a solvent trap was utilized which was 
filled with water. For frequency sweep measurements, the angular frequency was measured 
between 0.1 and 100 rad/s and a constant strain of 1%. All measurements were performed 
at least in triplicate. SPAAC cross-linked hydrogels were measured by loading an equimolar 
mixture of star-PEG-BCN and star-PEG-N3 on the rheometer. Time sweep measurements were 
conducted for 16 h for 10 mg/mL hydrogels and for 2.5 h for 30 mg/mL gels, using the same 
settings as above.
Stability measurements
Star-PEG-DHPA and star-PEG-BCN solutions of 40 mg/mL were prepared in MilliQ and stored 
at 4°C and at room temperature for 1 week. In order to determine the stability of the polymers 
in solution, hydrogels of 20 mg/mL were prepared with the aged solutions using sodium 
periodate as oxidizing agent. Hydrogels prepared with polymers left at room temperature 
were less stiff, resulting in slightly lower G’ values. For long term storage it is therefore advisable 
to store the polymers as solids at lower temperatures. 
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Magic-angle spinning (MAS) 1H NMR
Hydrogels were prepared in final polymer concentrations of 30 mg/mL using the standard 
procedure with sodium periodate as oxidizing agent. Gels were prepared with three different 
ratios of star-PEG-BCN: star-PEG-DHPA of 1:1 (balanced), 1:0.8 and 1:0.5. The total sample 
volume used was 200 µL. NMR experiments were performed on a Varian 300 MHz solid 
state NMR spectrometer. Single pulse 1H NMR experiments were performed using a 9.5 mm 
Chemagnetics probe, with magic-angle spinning at a frequency of 1605 Hz. The gels were 
prepared in a Teflon sample insert that fit snugly into the 9.5mm rotor. T1 measurements were 
performed to ensure that the repetition delay of 10s was sufficiently long so that measurements 
were quantitative. For each preparation 256 scans were accumulated (Figure 4.5).
Fluorescence measurements
For post-functionalization: see Figure 4.9. Imbalanced hydrogels contained a polymer ratio of 
0.8: 1.0 of star-PEG-DHPA and star-PEG-BCN. For example, a 200 µL hydrogel (20 mg/mL) 
contained 1.78 mg star-PEG-DHPA (0.8 eq) and 2.22 mg star-PEG-BCN (1.0 eq). Hydrogels 
were oxidized by sodium periodate, using 1 equivalent of NaIO4 per DHPA group. Gels 
contained 1.5 equivalents 3-azido-7-hydroxycoumarin (N3-coumarin) per BCN-group, based 
on the excess of star-PEG-BCN (in the example: 0.44 mg). Balanced hydrogels contained an 
equimolar polymer ratio (1:1, for example 2.0 mg star-PEG-DHPA and 2.0 mg star-PEG-BCN). 
The amount of N3-coumarin remained equal for balanced hydrogels. For a typical hydrogel, 
a star-PEG-DHPA/star-PEG-BCN mixture (100 µL) was prepared, to which a N3-coumarin/
NaIO4 mix (100 µL) was added. This N3-coumarin/NaIO4 mixture was prepared using a stock 
solution of N3-coumarin in DMSO, in such a way that the maximum DMSO concentration 
in the mixture was 5%. Hydrogels were irradiated under UV-light (366 nm) using a UV-lamp 
(CAMAG). The fluorescence of N3-coumarin containing hydrogels was measured using a Tecan 
Infinite M200 Pro plate reader. Hydrogels were prepared in a 96-wells plate, with a sample 
volume of 80 µL. Hydrogels were left for 15 min before the measurement was started. An 
emission scan was performed between 400 and 600 nm, using an excitation wavelength of 360 
nm. To determine the background fluorescence, a mixture of star-PEG-DHPA, N3-coumarin and 
NaIO4 was measured. All fluorescence measurements were performed with n = 9. 
Competition reaction SPOCQ and SPAAC.
Hydrogels with a total polymer content of 10 mg/mL were prepared with three different 
polymer compositions (Table 4.3). The first sample contained 0.8 eq star-PEG-DHPA, 1.0 eq 
star-PEG-BCN, 1.5 eq N3-coumarin (based on the excess of BCN) and 1 eq NaIO4 (per DHPA 
group), and was prepared in a similar manner as before. The second sample contained 0.8 eq 
star-PEG-N3, 1.0 eq star-PEG-BCN and an equal amount of N3-coumarin (1.5 eq), and was 
prepared by making a polymer mixture in MilliQ, to which a stock solution of N3-coumarin in 
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DMSO (2.5%) was added. The third sample only contained the star-PEG-N3 (0.8 eq) – star-
PEG-BCN (1.0 eq) polymer mixture in MilliQ. Sample 2 and 3 were left overnight to allow gel 
formation to occur. The inverted vial test was utilized to check gel formation of the samples. 
The gels or solutions were examined under UV-light (366 nm) using a UV-lamp. Samples were 
prepared in triplicate.
Table 4.3. Overview sample composition for the SPOCQ/SPAAC competition experiment. Total sample 
volume: 400 µL. Total polymer concentration: 10 mg/mL. N3-coumarin: from stock solution: 24.6 mM (in 
DMSO, 1.5 eq based on excess of BCN groups). NaIO4: from stock solution: 3.54 mM (1 eq based on 
amount of DHPA groups). * = added together to a solution of star-PEG-DHPA and star-PEG-BCN.
Sample 1 Sample 2 Sample 3
Star-PEG-BCN 2.22 mg 2.22 mg 2.22 mg
Star-PEG-DHPA 1.78 mg - -
Star-PEG-N3 - 1.78 mg 1.78 mg
N3-coumarin 10 µL* 10 µL -
NaIO4 190 µL* - -
MilliQ 200 µL 390 µL 400 µL
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Chapter 5
SPAAC and SPOCQ cross-linked hydrogels as matrices 
for encapsulation of aligned peptide amphiphile fibres
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5.1. Introduction
5.1.1. Peptide amphiphile fibres
In nature, higher order structures, such as spheres, rods, disks, channels, sheets and fibres are 
commonly obtained via the self-assembly of amphiphilic molecules.1,2 Amphiphiles have the 
ability to self-assemble in aqueous solution, in such a way that the hydrophilic domains are 
exposed to water, while the hydrophobic regions are hidden from the aqueous environment. A 
versatile class of amphiphiles is constituted by peptide amphiphiles, which are composed of a 
hydrophobic aliphatic tail and a hydrophilic peptide sequence, linked to each other via an amide 
bond. Potential applications of peptide amphiphiles lie in those areas where the formation 
of higher order structures is required, such as mimicking the extracellular matrix (ECM) (see 
also Chapter 1.4.3.). The ECM is the biological material that surrounds cells in tissue and 
is composed of proteoglycan filaments, collagen fibres and elastin. Peptide amphiphiles form 
β-sheet structures that resemble the architecture of natural fibres of the ECM. They can easily 
be synthesized using solid phase peptide synthesis (SPPS).Webber et al. for example used 
SPPS for peptide amphiphile synthesis by coupling of palmitic acid to the N-terminus of an 
RGDS-containing peptide. These constructs self-assembled in cylindrical micelles, forming 
nanometre wide fibres, micrometres in length. The potential of these amphiphiles in biological 
applications was proven by in vitro and in vivo studies with bone marrow derived cells.3 The 
Tirrell group synthesized peptide amphiphiles via coupling of two palmitic acid tails to a peptide. 
The peptide component was derived from a T-cell epitope from the tumour antigen ovalbumin. 
The assembled cylindrical micelles were used for in vivo studies and showed protection from 
tumours by stimulation of ovalbumin-specific T-cells.4 
5.1.2. Diacetylene-containing peptide amphiphile fibres
The mechanical integrity of nanofibres formed from peptide amphiphiles is, like many self-
assembled structures held together by secondary interactions, usually limited, making the 
structures prone to disassemble.5 A facile method to cross-link the individual components was 
presented by Hartgerink et al. The peptide amphiphiles contained four cysteine residues in 
the peptide sequence, which were used to form intermolecular disulfide bridges. This method 
to introduce stability is reversible; addition of mild reducing agents disconnects the disulfide 
bridges.6 Another interesting method to prevent fibre disassembly is the incorporation of 
diacetylene moieties in the alkyl tails. Diacetylenes can be polymerised using UV irradiation, 
yielding highly conjugated backbones.7 The topochemical polymerisation proceeds when the 
spacing between the monomers is 4.9 Å and when they are in an angle of 45°.8,9 This conjugated 
π-system is highly ordered, accompanied by an intense blue colour of the polydiacetylenes. 
Upon environmental influences such as changes in temperature, pH and mechanical stress, the 
π-system becomes less ordered leading to a colour change from blue to pink (Figure 5.1).10-13 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
146    Chapter 5
R1
R2
R3
R4
R
R1
R2
R3
R4
R
R
R1
R2
R3
R4
R
UV
Temperature
Mechanical stress
Figure 5.1. Diacetylenes can be polymerised using UV irradiation resulting in a characteristic blue colour. 
The colour change to pink occurs upon external environmental changes.
Diacetylene-containing peptide amphiphiles have been widely studied (Figure 5.2). The Stupp 
group for example showed that these compounds have a high degree of internal order and 
a characteristic ß-sheet structure. The replacement of linear by branched peptides led to 
a decrease in polymerisation efficiency.14 Biesalski et al. showed the high degree of stability 
of peptide amphiphiles containing the cell binding motif RGDS as the peptide component. 
Polymerised fibres could be transferred to solid substrates and be removed without losing 
surface functionality. Fibroblasts were able to adhere to the fibres and showed a spread 
morphology.15 
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Figure 5.2. General structure of a diacetylene-containing peptide amphiphile.
Also in our group, a lot of research has been carried out on diacetylene-containing peptide 
amphiphiles. For example, a systematic study on the length of the alkyl tail was performed. 
Van den Heuvel clearly showed that a longer alkyl tail improves the stability of the formed 
nanofibres.16 Furthermore, peptide amphiphiles were used as macro-initiator for atom 
transfer radical polymerisation (ATRP), by incorporation of α-bromo esters as initiator in the 
peptide component. Steric crowding introduced by performing the ATRP reaction led to the 
characteristic colour change from blue to pink.13 Recently, our group showed that RGDS-
containing fibres mixed with spacer fibres can be used to sense cell adhesion. Upon cellular 
adherence, the characteristic colour change from blue to pink was observed. In fact, this could 
be tuned by varying the C-terminal amino acid of the spacer amphiphile. The colour change was 
most prominent for lysine as the C-terminal residue.17
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Hydrogels as matrices for encapsulation of aligned peptide amphiphile fibres    147
5
An interesting additional feature of certain peptide amphiphile fibres is the possibility to align 
them. Apart from the order obtained from spontaneous assembly, the fibres can thus be further 
organized at a macroscopic level. Our group showed the assembly of diacetylene-containing 
peptide amphiphiles with a peptide component derived from the CS protein of a malaria 
parasite (GANPNAAG). Upon applying a strong magnetic field (20 T), the fibres showed a 
high degree of alignment parallel to the magnetic field yielding materials with highly anisotropic 
optical properties.18,19 The Stupp group reported the alignment of peptide amphiphile nanofibres 
containing cell-adhesion motif IKVAV using shear.20 The IKVAV motif is present in the C-terminal 
coiled-coil domain of laminin-1 and is known to promote neurite outgrowth of several neuronal 
cell types.21 The aim of the research was to control the directional growth of neuronal cells. For 
this purpose, neuronal cells were mixed with the peptide amphiphiles, resulting in nanofibre gels 
with encapsulated cells. Due to the presence of the IKVAV motif, neurite growth was promoted. 
These neurites grew along the direction of the aligned nanofibres, showing the ability to control 
the orientation of neuronal cells.22,23
In the abovementioned method, fibre alignment is achieved by pipetting of a peptide amphiphile 
solution into a CaCl2 solution. The shear forces caused by pipetting led to alignment, whereas 
gel formation is triggered by the calcium ions that screen the charged amino acid residues. The 
drawback of this method is that the obtained gel is held together by physical interactions, which 
are often weak. When the gel disassembles, fibre alignment will also be disrupted. This could be 
circumvented if the peptide amphiphile fibres are captured in a covalently cross-linked matrix. We 
therefore set out to develop a novel system in which we can align and fixate peptide amphiphile 
fibres in a more permanent polymeric network structure based on our previously described 
hydrogels (Figure 5.3, Chapters 3 and 4). In order to obtain materials which are of potential 
interest to study directional neuronal cell growth IKVAV-containing fibres will be incorporated 
in a hydrogel. Contrary to the procedure described by Stupp, neuronal cells will be added after 
the preparation of the matrix material. As cellular ingrowth in the polymer network is thus 
required, a polymeric building block will be used containing a matrix metalloproteinase (MMP) 
sensitive peptide motif. MMPs are naturally occurring in the ECM where they are responsible 
for remodelling. This chapter first describes our investigations regarding the encapsulation of 
peptide amphiphile fibres in SPAAC cross-linked hydrogel matrices. It was tested whether fibres 
still displayed their characteristic topochemical polymerisation and whether network formation 
was still possible (Paragraph 5.2.1; 5.2.2). Our next step focussed on the alignment of the 
fibres in a strong magnetic field and the subsequent formation of a hydrogel network around 
these aligned fibres (Paragraph 5.2.3). Furthermore, we also investigated the possibilities 
of using the newly developed SPOCQ cross-linking method to create the matrix structure 
(Paragraph 5.2.4). Moreover, this chapter will provide an outlook what will be required to 
apply these gels for directing neuronal cell growth (Paragraph 5.2.5).
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Figure 5.3. Schematic representation of the peptide amphiphile fibres aligned in a magnetic field and 
encapsulated in the hydrogel matrix. Aligned peptide amphiphile fibres are represented in purple, star-PEG 
polymers in blue and the cross-links between the polymeric constituents are represented in green. Both 
SPAAC and SPOCQ are examined as cross-linking method. The white arrow indicates the direction of 
the magnetic field.
5.2. Results and Discussion
5.2.1. Gel and fibre formation
We first investigated whether we could encapsulate fibres in a SPAAC cross-linked hydrogel 
network. Peptide amphiphiles were synthesized by solid phase peptide syntheses as described in 
earlier chapters. The peptide component was composed of a Gly-Ala-Gly-Ala-Glu pentapeptide. 
The GAGAE sequence was chosen since it is known to be most susceptible to environmental 
changes.13 This peptide sequence was therefore used in the first gelation tests, and was later 
on lengthened to introduce the IKVAV motif (GAGAEIKVAV). Alkyl tail 10,12-pentacosadiynoic 
acid, containing the diacetylene moiety, was N-terminally coupled to the peptides to obtain the 
desired amphiphiles (Figure 5.4).24 
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Figure 5.4. Structures of peptide amphiphiles with GAGAE and GAGAEIKVAV.
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GAGAE fibres were prepared by heating a solution of the peptide amphiphiles in water to 
90°C, which was allowed to cool slowly to room temperature. Polymerisation of the fibres was 
carried out next by illumination with UV-light for 15 minutes. Fibres prepared in this manner 
thus obtained their characteristic blue colour, indicative of the highly ordered packing of the 
alkyl tails within the fibres.24 These polymerised fibres were mixed with polymers star-PEG-
BCN and star-PEG-N3, to test whether this could lead to fibre-containing hydrogels. Fibre 
solutions of 0.5 mg/mL and 1.0 mg/mL were added to a polymer mixture of 20 mg/mL and 
were left to allow gel formation. After approximately 75 minutes gelation occurred, which was 
similar to previous gelation times for SPAAC cross-linked hydrogels (see Chapter 3). The blue 
fibre-loaded gels were heated to test whether the fibres were still sensitive to environmental 
changes. Upon heating, the fibre-loaded gels showed indeed their characteristic colour change 
from blue to pink (Figure 5.5). 
Figure 5.5. GAGAE fibre containing hydrogels. Left: unpolymerised peptide amphiphiles, resulting in a 
colourless hydrogel. Middle: polymerised GAGAE fibres, giving a blue gel. Right: upon heating a colour 
change to pink occurred. 
We next tested whether polymerisation was also possible within the hydrogel network. A 
peptide amphiphile solution was mixed with the polymers to form a hydrogel. This colourless 
gel was polymerised under UV-light, which resulted in blue fibre-containing gels. Upon heating, 
pink gels were also obtained (Figure 5.5). These gelation tests show that the peptide amphiphile 
fibres still display their characteristic polymerisation behaviour when encapsulated in a hydrogel 
network. 
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5.2.2. Rheology
To test whether SPAAC cross-linking occurred efficiently, the mechanical properties of the 
fibre-loaded gels were measured by means of rheology. These tests were performed with 
samples containing 10, 20 and 30 mg/mL hydrogels and polymerised GAGAE fibres (0.5 and 
1.0 mg/mL) (Figure 5.6, Table 5.1). Time sweep measurements resulted in comparable G’ 
values as previously measured for non-fibre containing gels (see Chapter 3). The values for the 
loss modulus (G’’ ± 13 Pa) were somewhat higher than before, indicating that the fibre-loaded 
hydrogel is more viscous (Figure 5.6).
Figure 5.6. Time sweep measurement by rheology (5.5 h) on a 20 mg/mL hydrogel containing 1.0 mg/
mL GAGAE fibres.
Moduli for the 20 mg/mL gels were somewhat lower than expected, but still in the same 
order of magnitude as before. There were no differences in the mechanical properties of gels 
containing 0.5 mg/mL or 1.0 mg/mL fibres. These data show that the mechanical properties 
of the SPAAC cross-linked gels are not affected when fibres are encapsulated in the polymer 
network (Table 5.1). An interesting observation was that due to a strain sweep measurement 
conducted on the blue fibre gels, the applied mechanical stress resulted in less ordered fibres 
as indicated by the occurrence of the typical pink colour. In summary, when combined, both the 
hydrogel and the peptide amphiphile fibres showed their characteristic behaviour. We can thus 
efficiently encapsulate fibres in our SPAAC cross-linked hydrogel network. 
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Table 5.1. Hydrogel strength G’ (Pa) of fibre-containing SPAAC hydrogels measured by rheology. Values 
were recorded after set time points of 16h, 5.5h and 2.5h for 10 mg/mL, 20 mg/mL and 30 mg/mL, 
respectively, for gels containing 0.5 and 1.0 mg/mL GAGAE fibres. Rheology data for gels without fibres: 
see Chapter 3.
GAGAE Fibres G’ 10 mg/mL G’ 20 mg/mL G’ 30 mg/mL
0.5 mg/mL 16 Pa 876 Pa 2489 Pa
1.0 mg/mL 13 Pa 878 Pa 2379 Pa
No fibres 25 Pa 1192 Pa 2298 Pa
5.2.3. Magnetic alignment of GAGAE and GAGAEIKVAV fibres in SPAAC cross-linked 
hydrogels
After establishing the possibility to prepare hydrogels containing peptide amphiphile fibres, we 
proceeded with fibre alignment. Previous research by our group showed the possibility to align 
GANPNAAG-containing fibres using strong magnetic fields.18 Since our peptide component 
(GAGAE / IKVAV) was different than the one reported in literature, we decided to first 
examine which magnetic field strength was required to obtain proper alignment of the fibres 
without the gel matrix. The level of alignment was determined by measuring the birefringence, 
which is the property that the refractive index of a material depends on the direction of light. 
In our experiments, we used a 32 T magnet equipped with a temperature controller and a set-
up to measure birefringence in situ. The peptide amphiphile samples were loaded in a quartz 
optical cell, which was placed in the magnet. In order to get proper alignment, the fibres were 
first disassembled by heating the peptide amphiphiles to 80°C. After that, the magnetic field 
was switched on and the assembly was allowed to take place upon cooling to 20°C, while 
recording the birefringence to measure alignment. Birefringence was measured as retardation 
(in degrees); these terms are directly proportional when the path length is constant between 
measurements.
The experiments were first performed with GAGAE fibres at magnetic field strengths of 0, 5, 
10, 15 and 20 T (Figure 5.7). As expected, we did not measure birefringence at 0 T, as the curve 
resembled the control sample with only water. With increasing field strength, increasing values 
of retardation were recorded, with the highest value being -8.9° (delta retardation) for the 20 
T sample. Fibres are thus more aligned when a higher magnetic field is applied. The retardation 
is negative in value, meaning that the alkyl chains are orientated perpendicular to the magnetic 
field (Figure 5.8).18,25 
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Figure 5.7. Birefringence values of GAGAE fibres when exposed to a magnetic field of 0, 5, 10, 15 and 
20 T during cooling from 80°C to 20°C. Fibres were more aligned at higher magnetic fields, as larger 
negative retardation values were measured. Fibre alignment was not obtained at 0 T. Laser : λ = 632.8 nm; 
path length 0.001 m. Top: graphical representation. Bottom: graph with maximum delta retardation values 
(values at 20°C).
Peptide Alkyl tail
Figure 5.8. Schematic representation of aligned peptide amphiphile fibres (purple). The alkyl tails are 
orientated perpendicular to the applied magnetic field (black arrow). 
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After magnetic alignment, the fibres were polymerised by illumination with UV light for 15 
minutes. Polymerised fibres showed their typical blue colour. The alignment of the fibres could 
easily be visualised by placing a polariser film on top of the sample. When the polariser was 
placed parallel to the direction of the applied magnetic field, the light was strongly absorbed in 
contrast to a perpendicular orientation of the polariser (Figure 5.9).
Figure 5.9. Polymerised peptide amphiphile fibre samples after magnetic alignment, analysed with a 
polariser film. Left: polariser film placed parallel to the direction of the magnetic field, leading to a strong 
absorbance of the light. Right: polariser film placed perpendicular to the applied field. 
This effect could also be measured quantitatively when the polariser film was placed in a 
UV spectrometer. A large difference in absorbance was measured between the parallel and 
perpendicular orientation (Figure 5.10 A). Linear dichroism analysis of the UV-Vis spectra 
showed the same trend as the birefringence as alignment was largest for an applied magnetic 
field of 20 T. This was confirmed by the calculated dichroic ratio, obtained by dividing the 
absorbance in the parallel direction by the absorbance in the perpendicular direction for the 
absorbance maximum at 640 nm. (Figure 5.10 B).
The experiment was repeated with peptide amphiphile fibres which were composed of a 
mixture of GAGAEIKVAV and GAGAE peptide amphiphiles in a ratio of 1:6 (Figure 5.4).17 
The fibre mixture was placed in a magnetic field of 20 T, because this gave the best alignment 
for only GAGAE fibres. Comparable retardation values (delta retardation = -8.4°) were found, 
showing that GAGAEIKVAV containing fibres can also be aligned. 
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Figure 5.10. UV spectra of aligned GAGAE fibres. A) Differences in UV absorbance parallel and 
perpendicular to the applied magnetic field for the 20 T sample, showing fibre alignment. B) Dichroic 
ratios at the different magnetic field strengths, showing that differences in absorbance are largest at 20T, 
confirming that alignment is largest at 20 T.
 
After demonstrating the alignment of peptide amphiphile fibres, we proceeded with the 
encapsulation of the aligned fibres in our hydrogel network. For this purpose, we synthesized 
a new polymeric building block for hydrogel formation, containing an MMP-sensitive peptide 
motif. MMP stands for matrix metalloproteinases, which is a family of proteinases able to 
degrade a variety of extracellular matrix components. From literature it is known that generating 
space within the hydrogel network is important for cellular growth. By incorporating an MMP-
sensitive peptide motif, a cellular cleavage site is present, leading to a more dynamic 3D cellular 
environment.26-29 We chose to synthesize peptide N3-GGPQGIAGQG, which contains the 
MMP-sensitive motif GPQG↓IAGQ. This 8-residue containing peptide is a known substrate 
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for several MMP family members.30 Peptide N3-GGPQGIAGQG (N3-MMP) was coupled to 
star-PEG using the previously exploited coupling strategy with BOP and DiPEA (Chapter 2). 
Gelation of star-PEG-BCN and star-PEG-MMP-N3 occurred as expected, which was simply 
examined using the inverted vial test (Figure 5.12). Next, we aimed for encapsulating aligned 
fibres in our SPAAC cross-linked hydrogels. For this purpose both star-PEG building blocks were 
mixed together in a 1:1 ratio with a total concentration of 20 mg/mL, with the GAGAE peptide 
amphiphiles (1.0 mg/mL). The sample was placed in the magnet, which was already heated 
to 80°C, after which the reaction mixture was cooled down to 20°C within approximately 
45 minutes. We envisaged that fibre alignment could still occur before gel formation was 
complete, as it was previously shown that gelation of PEG gels occurred after 75 minutes at 
room temperature (see Chapter 3). During the cooling down process, retardation became 
initially indeed more negative in value, indicating the beginning of fibre alignment. Only a short 
time later however, the retardation values levelled off (Figure 5.11). Probably, cross-linking of 
the polymers proceeded too quickly and the alignment process was stopped as the solution 
became increasingly viscous. In order to slow down gelation, a lower hydrogel concentration, 15 
mg/mL, was applied. Fibres indeed had more time to align, leading to higher retardation values 
than for the 20 mg/mL sample. However, also in this case alignment levelled off as soon as the 
hydrogel cross-linking occurred and remained low when compared to the alignment of fibres 
at 20 T without the presence of a hydrogel (Figure 5.11). 
Figure 5.11. Birefringence values of GAGAE fibres entrapped in a hydrogel network, which was formed 
in situ during magnetic alignment. Hydrogel formation disrupts fibre alignment; especially in the 20 mg/
mL sample hardly any birefringence was measured. For comparison, GAGAE fibres without any hydrogel 
components at 0 T and 20 T are displayed. 
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To prevent disturbance of the fibre alignment by concurrent hydrogel formation, we tested if 
it was possible to perform hydrogel cross-linking after fibre alignment. In this new approach, 
we mixed star-PEG-MMP-N3 with GAGAE-fibres and performed alignment with a magnetic 
field strength of 20 T. After polymerisation of the fibres, a small volume of star-PEG-BCN was 
added on top of the sample in the optical cell. The sample was left overnight, to allow gelation 
to occur fully. The next day, a darker blue colour was observed in the upper part of the sample 
cell, which appeared to be the only part were gelation occurred. Star-PEG-BCN was thus not 
able to diffuse through the whole cell, resulting in local gelation at the site of addition. When 
the polariser film was placed on the dark blue upper part, the polariser effect was much smaller 
than in the non-gelled lower part of the sample cell. This again shows that gelation disrupted the 
alignment of the fibres. SPAAC-mediated hydrogel formation either in situ during the alignment 
process or after alignment leads thus in both cases to a disrupted alignment (process) of the 
peptide amphiphile fibres. 
5.2.4. Magnetic alignment of GAGAE fibres and star-PEG-polymers in SPOCQ cross-
linked hydrogels
As an alternative to the SPAAC chemistry, SPOCQ cross-linking was envisioned (see Chapter 
4). A great advantage of this new cross-linking method is that it is activatable. Gelation only 
occurs after addition of an oxidizing agent, which can be either sodium periodate or the 
enzyme mushroom tyrosinase. Oxidizer NaIO4 is a small molecule, which is therefore expected 
to diffuse easily through the sample. In this respect, we hypothesized that diffusion problems 
as previously seen for star-PEG-BCN were less likely to occur. It was tested whether SPOCQ 
can be used to cross-link fibre-containing hydrogels after magnetic alignment. A mixture of star-
PEG-BCN, star-PEG-DHPA (Figure 5.12) and GAGAE fibres was loaded in the optical cell and 
placed in the magnet. After reaching a temperature of 80°C, the magnetic field strength was 
increased to 20 T. Fibres nicely aligned parallel to the applied field, as seen from the negative 
birefringence values. 
Results were comparable to the values previously obtained for only GAGAE fibres (Figure 
5.7), indicating that the presence of the two polymers did not hinder fibre alignment (Figure 
5.13 A). After polymerisation with UV light, the polariser film indicated proper alignment of the 
peptide amphiphile fibres. The alignment was also measured with UV spectroscopy, showing 
a clear difference in absorbance between light in the parallel and the perpendicular direction 
(Figure 5.13 B). 
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Figure 5.12. Structures of the polymers used for SPAAC cross-linking (star-PEG-BCN and star-PEG-
MMP-N3) and SPOCQ cross-linking (star-PEG-BCN and star-PEG-DHPA).
The magnetic alignment of the star-PEG-BCN, star-PEG-DHPA and GAGAE fibres mixture 
was performed twice, to obtain two identical samples. One of these samples was used to 
test gelation with sodium periodate as oxidizing agent, the other was used to test the enzyme 
mushroom tyrosinase. In both cases, a small volume of the oxidizing agent was added on top of 
the sample in the optical cell. Since oxidation of the DHPA groups results in a yellow colour, we 
expected to see the diffusion of the oxidizing agent throughout the optical cell. After addition 
of both NaIO4 and the enzyme, the samples were left for 16 h. We observed a colour change 
in the upper part of both optical cells, especially for the enzyme sample, which turned orange. 
However, because of the blue colour of the aligned fibres, it was hard to visualize whether the 
oxidizing agent diffused throughout the whole cuvette. UV spectroscopy was used to measure 
the alignment. Absorbance values were slightly higher than before addition of the oxidizing 
agent (Figures 5.13 B and 5.14), probably caused by the fact that oxidation results in a yellow 
colour. Importantly, a large difference in absorbance was still measured, indicating that alignment 
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was not affected. Samples were also examined after 2 and 14 days. The colour did not change 
significantly, making it hard to determine whether gelation occurred. UV measurements still 
showed a large difference between the two directions of light (Figure 5.14). However, this 
could also mean that gelation had not occurred, or as reported in previous research, the fibres 
remained aligned because they were closely packed between the two glass plates of the optical 
cell.18,31 
Figure 5.13. Magnetic alignment of a star-PEG-BCN / star-PEG-DHPA / GAGAE fibre mixture. A) 
Birefringence measurement, showing that the fibres are properly aligned. B) UV spectrum of aligned fibres, 
showing the expected large difference in absorbance between the parallel and perpendicular directions. 
The spectrum was recorded before addition of an oxidizing agent. 
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Figure 5.14. UV spectra for the NaIO4 oxidized star-PEG-BCN / star-PEG-DHPA/ GAGAE fibre mixture, 
followed over time. The large differences in UV absorbance parallel (solid line) and perpendicular (dashed 
line) to the applied magnetic field remained, indicating that fibres are still aligned after 2 weeks. 
In order to unambiguously determine whether gelation had taken place throughout the entire 
sample, we opened the optical cells containing the 2 week old samples. The enzyme-oxidized 
reaction mixture showed only gel formation in the upper part of the sample, revealing that 
once the enzyme starts with the formation of the polymeric network diffusion is strongly 
hampered. A large part of the sample was still a fibrous liquid (Figure 5.15). As expected, 
fibre alignment was completely lost, as was demonstrated with the polariser film experiment. 
Gratifyingly, opening of the periodate-oxidized reaction mixture showed a hydrogel throughout 
the whole sample. NaIO4 is thus able to diffuse through the whole optical cell, leading to 
oxidation of the DHPA-groups and thus to gel formation (Figure 5.15). The polariser film 
showed that the fibres were still aligned. We thus managed to encapsulate magnetically aligned 
fibres in a SPOCQ cross-linked hydrogel network. 
NaIO4 Enzyme
Figure 5.15. Magnet samples after opening of the optical cell. Left: NaIO4 as oxidizing agent leads to 
hydrogel formation throughout the whole cell. Right: enzyme mushroom tyrosinase leads to a hydrogel 
network in the upper part (orange coloured), the remaining of the optical cell was a fibrous liquid. 
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As an extra proof to show alignment, transmission electron microscopy (TEM) was performed. 
As expected, TEM analysis of the enzyme-oxidized sample showed non-aligned fibres. For the 
periodate-oxidized sample, it was difficult to obtain good contrast, but aligned fibres were 
indeed observed (Figure 5.16). Scanning electron microscopy (SEM) on both samples was 
not successful, as this only showed porous structures, probably caused by the hydrogel surface. 
Thus, alignment of GAGAE fibres could easily be performed in presence of polymers star-PEG-
BCN and star-PEG-DHPA using a magnetic field of 20 T. Oxidizing agent sodium periodate was 
added on top of the sample and was able to diffuse throughout the whole sample in a time 
period of 2 weeks. The fibres were encapsulated in the SPOCQ cross-linked hydrogel, and 
remained aligned as visualized with UV spectroscopy and TEM.
NaIO4 Enzyme
Figure 5.16. Transmission electron microscopy (TEM) pictures of magnetically aligned peptide amphiphiles. 
Left: with sodium periodate as oxidizing agent, a SPOCQ cross-linked hydrogel is formed with aligned 
fibres entrapped in the gel network (scale bar : 200 nm). Right: with enzyme mushroom tyrosinase, cross-
linking does not lead to proper gel formation, peptide amphiphile fibres do not retain their alignment 
(scale bar : 2 µm).
5.2.5. Future research
After establishing a successful protocol to construct a hydrogel with aligned peptide amphiphile 
fibres, the main challenge that remains is to show biological activity of this material in cell 
culturing applications directed to neuronal outgrowth. Two biological motifs that were installed, 
the MMP cleavage domain and IKVAV should be tested whether they have retained their 
activity. Literature supports the hypothesis that incorporation of MMP cleavage domains in 
hydrogels has potential to enable successful cell culturing by allowing controlled degradation 
of the network.27,32-37 An example is the research by Fonseca et al. who modified alginate with 
an MMP cleavable peptide. Human mesenchymal cells showed an elongated morphology with 
MMP peptide and RGD-containing alginate gels, but when this was repeated without the MMP 
motif only round cells were found.27,32 Lutolf et al. reported Michael-type cross-linked PEG 
hydrogels with MMP-cleavable peptides. The MMP motif was required to make the hydrogel 
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network degradable, which was shown by the ability of fibroblasts to enter the network.36 MMP 
motif containing PEG hydrogels were also used to study the proliferation and differentiation 
of human mesenchymal cells. The morphology of the cells depended on the degradability of 
the hydrogels, as cells able to remodel their environment express higher levels of specific 
differentiation markers.37 All of these examples highlight the importance of MMP cleavable 
sequences in creating a dynamic cellular environment within the hydrogel network.27,32-37 
A good starting point for future research would be to add HeLa cells or NIH3T3 fibroblasts to 
a SPAAC cross-linked MMP-hydrogel containing (unaligned) RGDS fibres. We hypothesize that 
this 3-D system results in proper cell adhesion to the RGDS fibres, as the MMP motifs create 
a cleavable hydrogel network and thus allow cells to find the adhesion motifs. This experiment 
should then be repeated with IKVAV-containing fibres and neuronal cells, to confirm that the 
IKVAV motif is a proper motif for cellular adhesion of this cell type. Due to our experience with 
SPAAC cross-linked hydrogels as suitable matrices in cell studies, this is suggested as a good 
starting point for cell culturing studies. However, we have also demonstrated that SPAAC cross-
linking is not compatible with the magnetic alignment procedure. We therefore should gain more 
knowledge about using SPOCQ cross-linking in cell studies (see Chapter 6). Both suggested 
experiments with the RGDS and IKVAV containing fibres should thus also be performed with 
SPOCQ cross-linked MMP hydrogels. The final step would then be to magnetically align the 
IKVAV-containing fibres using a 20 T magnetic field. After hydrogel cross-linking, neuronal cells 
can be added, which are able to grow into the MMP-containing network. Finally, cell studies 
need to be performed with the neuronal cells, to investigate whether cells show directional 
growth along the IKVAV motifs of the aligned fibres. 
5.3. Conclusion 
Peptide amphiphiles fibres were successfully encapsulated in a SPAAC cross-linked hydrogel 
network, as both the fibres and the gel retained their characteristic behaviour. Fibres containing 
the GAGAE and GAGAEIKVAV peptide components were aligned in a magnetic field, up to 
a field strength of 20 T. UV analysis confirmed fibre alignment, as polarized light parallel to the 
direction of the applied field was strongly absorbed. Magnetic alignment was however disrupted 
both by in situ SPAAC cross-linking and by SPAAC based gel formation after alignment. The 
activatable SPOCQ cross-linking method provided a way to encapsulate aligned fibres in a 
hydrogel network. Fibre alignment was performed in presence of star-PEG-DHPA and star-
PEG-BCN, after which oxidation with sodium periodate resulted in a hydrogel network. Future 
research should focus on 3-D cell culturing with degradable hydrogel networks, created by 
incorporation of a matrix metalloprotease (MMP) motif. By incorporation of adhesion motif 
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IKVAV on the aligned fibres, it should be possible to make a hydrogel network to direct neuronal 
cell growth. 
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5.5. Materials and methods
General notes experimental section
Materials and methods and standard solid phase peptide synthesis (SPPS) can be found in 
Chapter 2. The preparation of polymers star-PEG-BCN and star-PEG-N3 are described in 
Chapter 3. The synthesis of star-PEG-DHPA is outlined in Chapter 4.
Peptide N3-GGPQGIAGQG (protected)
N3-Gly-Gly-Pro-Gln(Trt)-Gly-Ile-Ala-Gly-Gln(Trt)-Gly-OH
MMP sensitive peptide N3-GGPQGIAGQG was synthesized via standard SPPS using a 
2-chlorotrityl resin. Azido-glycine was coupled as the N-terminal residue. A mild cleavage 
protocol was used by treatment of the resin with a mixture of dichloromethane (DCM), 
trifluoroethanol (TFE) and acetic acid (HOAc) (6:1:1) for 3 h. The solvents were evaporated 
under reduced pressure and co-evaporation was performed with chloroform (3 x 40 mL). The 
peptide was purified by preparative HPLC. 
LCQ: m/z: 1351.1 [M + H]+, 1373.5 [M + Na]+ (calculated [M + H]+ = 1351.62)
LC-MS: m/z: 1352.0 [M + H]+, Rt = 10.76 min
HPLC: Rt = 28.02 min
Synthesis of star-PEG-MMP-N3 (star-PEG-GQGAIGQPGG-N3) (protected)
To star-poly(ethylene glycol)-NH2 HCl salt (250 mg, 25 µmol) in DCM (20 mL) was added 
subsequently BOP (66 mg, 6 eq, 150 µmol), protected peptide N3-GGPQGIAGQG (203 mg, 
6 eq, 150 µmol), and DiPEA (102 µL, 24 eq, 0.60 mmol). The reaction mixture was stirred 
overnight at r.t. Extraction was performed with 1 M KHSO4 (3 x 40 mL) and brine (1 x 40 
mL), after which the organic layer was dried over Na2SO4. Column chromatography on basic 
aluminium oxide (MeOH: DCM; 10:90) afforded the protected peptide-polymer construct as a 
white powder after freeze-drying from dioxane (348 mg; 91%).
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1H-NMR (400 MHz, CDCl3): δ = 0.70 – 0.98 (m), 1.22 – 1.58 (m), 1.82 – 2.61 (m), 3.45 – 3.75 
(m, [CH2CH2O]n,), 4.34 (m, Cα), 7.10 – 7.25 (m, Trt).
MALDI-TOF (DHB): m/z: 15477, calculated m/z: 15466 for 222 ethylene glycol units.
Deprotection of star-PEG-MMP-N3 (star-PEG-GQGAIGQPGG-N3)
Deprotection of the protected star-PEG-MMP-N3 construct (320 mg) was performed by 
treatment with TFA: TIS: H2O (95: 2.5: 2.5; 12 mL) for 4 h at r.t. The reaction mixture was 
partially concentrated and precipitated in Et2O. Freeze drying from water afforded the product 
as a white solid (200 mg; 72%).
1H-NMR (400 MHz, D2O): δ = 0.66 – 0.79 (m), 0.95 – 1.09 (m), 1.21 – 1.35 (m), 1.69 (m), 
1.75 – 1.92 (m), 2.00 (m), 2.09 – 2.28 (m) 3.38 – 3.71 (m, [CH2CH2O]n,), 4.12 – 4.29 (m, Cα).
MALDI-TOF (alpha-cyano): m/z: 13404, calculated m/z: 13396 for 220 ethylene glycol units.
Synthesis peptide amphiphiles
Peptide amphiphiles containing GAGAE and GAGAEIKVAV as peptide component were 
prepared via standard solid phase peptide synthesis (SPPS) using a 2-chlorotrityl resin. In the 
final step, 10,12-pentacosadiyonic acid (3 eq) was coupled, using DIPCDI (3.3 eq) and HOBt 
(3.6 eq). Cleavage from the resin was performed by treatment of the resin with TFA: TIS: H2O 
(95: 2.5: 2.5) for 3 h at r.t. The peptide amphiphile was afforded by precipitation in ether, followed 
by freeze-drying from acetic acid. Purification was performed using preparative HPLC. 
10,12C25-Gly-Ala-Gly-Ala-Glu (
10,12C25-GAGAE)
LC-MS: m/z: 760.12 [M + H]+ (calculated [M + H]+ = 760.48)
HPLC: Rt = 34.54 min
10,12C25-Gly-Ala-Gly-Ala-Glu-Ile-Lys-Val-Ala-Val (
10,12C25-GAGAEIKVAV)
LC-MS: m/z: 1271.6 [M + H]+ (calculated [M + H]+ = 1270.83), Rt = 12.13 min.
HPLC: Rt = 30.45 min
Fibre formation
The peptide amphiphiles were dissolved in MilliQ, at a concentration of 1.0 mg/mL. Sonication 
of the samples was performed for 15 min at 25°C. Samples were heated to 90°C using a water 
bath and were allowed to cool to room temperature overnight in the water bath. 
Fibre polymerisation
After fibre formation, samples were illuminated with UV-light for 15 minutes. Fibres were 
illuminated from above, with a distance of 3 cm between the lamp and the sample, using a 
Bluepoint 2 UV lamp. After UV treatment, fibres showed their characteristic blue colour.
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Gelation and fibre formation studies
Star-PEG-BCN (4.0 mg) and star-PEG-N3 (4.0 mg) were dissolved in 400 µL polymerised 
GAGAE fibre solution (1.0 mg/mL; blue). The mixture was left at room temperature to allow 
gelation (20 mg/mL). Similarly, gels with a polymer content of 10 and 30 mg/mL and a fibre 
content of 0.5 or 1.0 mg/mL were prepared. Hydrogels were heated to 90°C, showing their 
characteristic colour change from blue to pink. Rheology studies were conducted by measuring 
time sweeps of 16 h, 5.5 h and 2.5.h for gels with a polymer content of 10, 20 and 30 mg/
mL, respectively and a fibre content of 0.5 or 1.0 mg/mL. Rheometer settings were equal as 
described before (see Chapter 3 or 4). Frequency and strain sweeps were also performed on 
the fibre-containing hydrogels. 
Star-PEG-BCN (4.0 mg) and star-PEG-N3 (4.0 mg) were dissolved in 400 µL GAGAE solution 
(1.0 mg/mL; not polymerised; colourless). The sample was kept in the dark. After gelation had 
occurred (20 mg/mL; 75 min), it was heated to 90°C and allowed to cool to room temperature 
to enable fibre formation. The sample was polymerised with UV light (15 min; resulting in the 
expected blue gel) and after that heated to 90°C (giving a pink gel).
Magnetic alignment of peptide amphiphile fibres
Prior to measuring the peptide amphiphile fibre samples, several temperature sweeps (20 → 
80°C and 80 → 20 °C) were conducted on a water sample to check the temperature effect on 
the retardation values. Only small variations in retardation values were recorded, showing that 
temperature changes do not have an influence on the birefringence measurements. Peptide 
amphiphile fibres were formed as described above, in concentrations of 1.0 mg/mL. For the 
IKVAV-containing amphiphiles, a mixture of GAGAEIKVAV and GAGAE fibres in a ratio of 1:6 
was prepared. Fibres (± 350 µL) were loaded in a quartz optical cell with a pathlength of 1 
mm. Samples were measured on a 32 T Bitter magnet from the High Field Magnet Laboratory 
(HFML).This magnet has a power of 18 MW, a bore size of 50 mm and is equipped with a 
temperature controller and a birefringence set-up. In this set-up, the sample was placed between 
two crossed polarizers. Monochromatic light was produced by a HeNe laser (λ = 632.8 nm; 
pathlength 0.001 m). The birefringence set-up was furthermore equipped with a photo-elastic 
modulator (PEM) and a photodetector.38 Samples were placed in the magnet, which was 
already heated to a temperature of 80°C. When the temperature was stable at 80°C, the 
magnet was switched on to the desired strength (5 T, 10 T, 15 T or 20 T) using a sweep rate of 
80 mT/s. The temperature was lowered to 20°C in approximately 45 minutes, under constant 
measuring of the birefringence. The magnet was switched off when a temperature of 20°C 
was reached. As a control experiment, this procedure was repeated without magnetic field (0 
T). For all experiments, the pathlength was kept constant (1 mm), meaning that birefringence 
and retardation are equal. The measured birefringence values were graphically represented 
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as delta retardation (°). The birefringence value recorded at 80°C was taken as the constant 
starting point; delta retardation was calculated by subtracting this constant value. After magnetic 
alignment, samples were polymerised with UV light for 15 minutes. All samples were examined 
using a polariser film.
Magnet samples for SPAAC cross-linking
Samples for in situ hydrogel formation were prepared by dissolving star-PEG-BCN in a GAGAE 
fibre solution (1.0 mg/mL) and by dissolving star-PEG-MMP-N3 in a GAGAE fibre solution (1.0 
mg/mL). Amounts of the polymers were chosen to yield a ratio of 1:1 between the BCN and 
N3 groups and a final polymer concentration of 15 mg/mL or 20 mg/mL. Directly after mixing 
the two polymer-fibre solutions, the mixture (± 350 µL) was loaded in the optical cell and 
placed in the magnet (already at 80°C). Measurements were performed at 20 T as described 
above. The fibres in the resulting hydrogels were polymerised with UV light. The sample for 
hydrogel formation after magnetic alignment was prepared by dissolving star-PEG-MMP-N3 in a 
GAGAE fibre solution (1.0 mg/mL). This solution (± 320 µL) was loaded in the optical cell and 
aligned using a magnetic field of 20 T. After polymerisation of the fibres, star-PEG-BCN (20 µL) 
was loaded on top of the sample. The total polymer concentration of the resulting hydrogel 
was 20 mg/mL (ratio BCN: N3 1:1). As a control experiment, a birefringence measurement was 
performed on a mixture of polymers of star-PEG-BCN and star-PEG-MMP-N3. The formed 
hydrogel was measured at 20 T. All samples were examined using a polariser film.
Magnet samples for SPOCQ cross-linking
Two equal samples were prepared by dissolving star-PEG-BCN in a GAGAE fibre solution (1.0 
mg/mL) and by dissolving star-PEG-DHPA in a GAGAE fibre solution (1.0 mg/mL). A ratio of 
1:1 between the BCN and catechol groups was taken with a final polymer concentration of 
20 mg/mL. After mixing the two polymer-fibre solutions, the mixture (± 300 µL) was loaded 
in the optical cell and placed in the magnet (already at 80°C). Measurements were performed 
at 20 T as described above. The fibres in the resulting hydrogels were polymerised with UV 
light. Samples were examined with a polarizer film and measured in a UV spectrometer. To 
one of the samples, 50 µL sodium periodate (1 eq, based on amount of DHPA groups) was 
added on top of the material in the optical cell. To the other sample, 50 µL enzyme mushroom 
tyrosinase (500 units/mL) was added. Both samples were analysed using the polarizer film and 
UV spectroscopy 16 h, 2 days and 2 weeks after addition of the oxidizing agent. After 2 weeks, 
both optical cells were opened to check gel formation. 
UV spectroscopy
UV spectra were recorded on a Jasco-v630 spectrometer at a wavelength range of 400 – 800 
nm. Samples used for magnetic alignment (in a 1 mm quartz optical cell) were measured. A 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
166    Chapter 5
polarizer film was placed in front of the light beam, to be able to measure parallel (0°) and 
perpendicular (90°) to the applied magnetic field. UV spectra were corrected by subtracting the 
background spectrum recorded for water. UV spectra were baseline corrected using the Origin 
software. To determine the dichroic ratio, maximum absorbance values for the peak around 640 
nm were taken. The absorbance in the parallel direction divided through the absorbance in the 
perpendicular direction yields the ratio. 
Transmission electron microscopy (TEM)
TEM samples were prepared for the two SPOCQ cross-linked samples (periodate and enzyme). 
A carbon-coated copper grid was placed on the samples for 1 min, followed by staining with 
a 1% uranyl acetate solution in MilliQ for 30 seconds. The grid was floated on MilliQ water for 
1 min, after which the excess of water was removed by blotting with filter paper. A JEOL 1010 
transmission electron microscope set was used for imaging, with an accelerating voltage of 60 
kV. 
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Chapter 6
Dual cross-linked hydrogels by combining chemical 
and physical cross-linking
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6.1. Introduction
As outlined in the introductory chapter, hydrogels can show distinctly different properties if 
they are cross-linked via either chemical or physical methods (Chapter 1). Chemical cross-
linking often leads to stronger hydrogels of which the mechanical properties can easily be 
tuned by varying the cross-linking density. Physically cross-linked hydrogels, on the other hand, 
can be made stimuli responsive. These materials undergo a solution-to-gel state transition in 
response to external stimuli, such as temperature,1,2 pH,3 light and ionic strength.4,5 A great 
advantage of physical cross-linking is that it does not depend on organic solvents or the addition 
of cross-linking reagents. Furthermore, the specific sub-set of in situ forming hydrogels holds 
great promise as drug delivery system, as these gels undergo the sol-to-gel transition upon 
administration in the body, which often is mediated by ionic crosslinking.1,2,4,6,7 In particular 
carbohydrates have been used for this type of physically cross-linked hydrogels. Chitosan is 
a polysaccharide composed of the monomers β-2-acetamido-2-deoxy-D-glucopyranose and 
2-amino-2-deoxy-D-glucopyranose. Chitosan is obtained by the deacetylation of chitin, which 
is the main component of the skeleton of crustaceans such as shrimps and crabs. Due to 
its biocompatibility and biodegradability, chitosan has already been used in several medical 
applications, for example as bioadhesive and mucoadhesive material.8,9 In order to perform 
physical cross-linking, chitosan needs to be dissolved, which is enabled by protonation of the 
amine groups.10 A straightforward way of gel formation was attained by the addition of various 
metal ions, such as Pt(II), which formed coordinate covalent bonds with these protonated 
amine groups by complexation.11 Chitosan hydrogels were also obtained by addition of polyol 
phosphate salts (e.g. glycerol) to an aqueous chitosan solution. This transferred the gelation 
process from being purely pH-dependent to a combined pH and temperature-dependent 
system. The chitosan/polyol mixture remained a liquid at physiological pH and below room 
temperature, but formed a gel when the temperature was increased to 37°C.10 
The most pronounced example of a physically cross-linked carbohydrate-based hydrogel is 
alginate. As also outlined in Chapter 2, alginate is a polysaccharide composed of the two 
monomers α-L-guluronic acid (G) and β-D-mannuronic acid (M). In the polymer, blocks of one 
of the monomers are present, as well as regions with alternating units. An important feature 
of alginate is its ability to form gels with divalent cations such as Ca2+, Ba2+ and Sr2+. Gelation 
is not induced by monovalent cations and by Mg2+.12-14 Alginate-based hydrogels have been 
used in several biomedical applications, including wound healing,15,16 cell encapsulation,17 drug 
delivery18,19 and in tissue engineering.20-22 An example is the work by Zhao et al. who developed 
an injectable calcium phosphate-alginate hydrogel. Human umbilical cord mesenchymal stem cells 
were encapsulated in the hydrogels and remained viable. Cells also showed osteodifferentiation 
and synthesized bone minerals, showing the potential of alginate-based hydrogels for bone 
tissue engineering.20 
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A class of synthetic polymers that can both be chemically and physically cross-linked are 
the polyphosphazenes. These organometallic polymers contain a backbone with alternating 
nitrogen and phosphorus atoms, whereby two side groups are attached to each phosphorus 
atom.23 Polyphosphazenes with carboxylatophenoxy side groups were synthesized and their 
gelation behaviour was studied. These polymers were insoluble in neutral or acidic water, but 
dissolved in basic solutions. Upon addition of calcium ions rapid gelation occurred, via the 
formation of salt bridges between carboxylic acid groups of neighbouring polymers. These gels 
dissolved when calcium was replaced by monovalent ions.24 Polyphosphazenes hydrogels are 
also temperature sensitive and therefore studied to be applied as responsive membranes.23 
As already mentioned, purely physically cross-linked hydrogels have a few disadvantages, as they 
are usually weak and can lose their mechanical integrity over time.25 Furthermore, studies on 
alginate showed that calcium cross-linking can give rise to non-uniform hydrogel structures.26 
Therefore, chemical cross-linking procedures have also been applied to the abovementioned 
carbohydrates. In case of chitosan, cross-linking agents such as glutaraldehyde and genipin were 
added to make bridges between the polymeric chains. Chemical cross-linking of chitosan using 
genipin occurred via a heterocyclic linkage and the formation of amide bonds.8,27 In case of 
alginate, the polymers were modified to be able to use a chemical cross-linking procedure for 
hydrogel formation and to gain control over the mechanical properties. Alginate polymers were 
functionalized with tetrazine or norbornene groups, which can react together in a Diels-Alder 
cycloaddition reaction. The covalently cross-linked hydrogels were used for the encapsulation 
of NIH 3T3 cells, which could easily be performed with high cell viability. Furthermore, RGDS 
functionalized thiol-containing peptides were linked to the norbornene groups. This made 
the alginate gels cell-adhesive, as was shown by 2D and 3D cell culture studies.28 For the 
polyphosphazenes, cross-linking was improved by making use of polymers with carboxylate 
functional substituents. These polymers were chemically cross-linked by 60Co gamma radiation, 
to generate stable, pH sensitive hydrogels. In basic solutions, a higher swelling ratio was reported 
than in acidic solutions, which also led to faster release of an encapsulated fluorescent dye.29 In 
a later study, it was found that the cross-linking between metal ions and the carboxylic acid side 
chains can be controlled by redox reactions.30
In most cases, only purely physical or purely chemical cross-linking methods have been applied 
to the carbohydrates. However, an interesting alternative is to combine the properties of both 
physically and chemically cross-linked hydrogels by making use of a dual cross-linking system. A 
recent study by the Alsberg group demonstrated this by using both ionic and photo cross-linking. 
Methacrylated alginate was first ionically cross-linked using calcium. The remaining carboxylic 
acid groups were then used for photo cross-linking using UV light. Hydrogels prepared via this 
dual cross-linking method showed increased stiffness and decreased swelling compared to single 
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cross-linking using one of the methods.31 In another study, a two-step cross-linking protocol was 
performed with hyaluronic acid hydrogels. In the first step, a Michael-type reaction between 
a part of the acrylate groups and proteolytically degradable peptides was carried out. In the 
second step, the remaining acrylate groups were used for a free radical polymerisation using UV 
light. Rheology studies showed increased mechanical properties for hydrogels that were dually 
cross-linked. These gels were used for 3-D cell culturing, in which protease-mediated cellular 
remodelling was prevented when gels were also cross-linked by UV-light.32 
In this chapter, we aim for developing a novel dual cross-linking procedure, by combining very 
efficient physical and chemical cross-linking methods. By making use of two complementary 
techniques for network formation, advanced hydrogels can be prepared, with improved 
mechanical properties. As chemical cross-linking method the SPOCQ conjugation reaction, 
as reported in Chapter 4, was employed.33 This method was first optimized with respect to 
hydrogel formation capacity (Paragraph 6.2.1 and 6.2.2). Importantly, the biocompatibility 
of SPOCQ cross-linking was studied by employing cell adhesion studies, in order to test the 
potential of these gels for biomedical applications (Paragraph 6.2.3). As physical cross-linking 
method, we aimed for using ionic interactions with calcium ions. In Chapter 2 of this thesis, 
these interactions were already studied by making use of polymers functionalized with Ca2+-
binding peptides, however, with limited success. Therefore, we first studied physical cross-linked 
hydrogels, by using the strong interaction between bisphosphonate alendronic acid and Ca2+ 
(Paragraph 6.3) After studying both cross-linking methods separately, we combined them 
and studied dual cross-linked hydrogels (Paragraph 6.4). Finally, we investigated the possibility 
to make stimuli responsive hydrogels, by addition of thermally triggerable calcium-containing 
liposomes to alendronic acid functionalized polymers (Paragraph 6.5).
6.2. Further research on SPOCQ cross-linked hydrogels
6.2.1. 8-armed SPOCQ cross-linked hydrogels
As described in Chapter 4, we developed the strain-promoted-oxidation-controlled 
cyclooctyne-1,2-quinone cycloaddition (SPOCQ) reaction as a fast and activatable cross-linking 
method for hydrogel formation. We showed that reaction of cycloctyne-functionalized PEG 
(star-PEG-BCN) and catechol-functionalized PEG (star-PEG-DHPA) yields hydrogels after 
oxidation by either sodium periodate or enzyme mushroom tyrosinase.33 These studies were 
all carried out with 4-armed PEG (star-PEG), whereby each polymer thus contains 4 functional 
groups. We now extended this research by studying the gelation of 8-armed PEG constructs. 
In this way, we can obtain more insight in the mechanical properties of the hydrogels, by 
investigating the influence of the type of polymer on gel strength. This 8-armed poly(ethylene)
glycol contains a tripentaerythritol core, as depicted in Figure 6.1. 
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Figure 6.1. Structures of 8-armed-PEG-BCN and 8-armed-PEG-DHPA, with the tripentaerylthritol core 
(right).
Polymer 8-armed-PEG-NH2 (Mn = 20000 Da) was first functionalized with cyclooctyne 
derivative bicyclo[6.1.0]non-4-yne (BCN) and with catechol 3,4-dihydroxyphenylacetic acid 
(DHPA) to obtain 8-armed-PEG-BCN and 8-armed-PEG-DHPA, respectively (Figure 6.1). 
We performed gelation studies at the same polymer concentrations (10, 20 and 30 mg/mL) 
as previously performed for the star-PEG (4-armed) constructs (Chapter 4). Oxidation of a 
mixture of 8-armed-PEG-BCN and 8-armed-PEG-DHPA with sodium periodate immediately 
resulted in hydrogel formation (Figure 6.2). Rheological analysis showed higher moduli than 
for the 4-armed-PEG-constructs, at the same polymer concentrations. In fact, the values for the 
elastic modulus G’ were almost a factor 2 higher for 8-armed PEG, compared to 4-armed-PEG 
based hydrogels. By doubling the number of functional groups per polymer, the number of 
branching points is also twice as high. This gives rise to a denser polymeric network, which nicely 
corresponds with the rheological analysis (Figure 6.2 and Table 6.1). This data shows that 
the strength of SPOCQ cross-linked gels can, apart from changing the polymer concentration, 
also be tuned using 8-armed PEG polymers. In view of time, we did not continue with these 
8-armed gels, but use of these branched polymers can be valuable in further studies where 
control over the mechanical properties of hydrogels is demanded. 
Table 6.1. Comparison of G’ (Pa) values for 4-armed and 8-armed PEG hydrogels, oxidized by sodium 
periodate. Values were recorded on the rheometer during 5 min (4-armed: n = 5; 8-armed: n = 3)
10 mg/mL 20 mg/mL 30 mg/mL
4-armed PEG 65 Pa ± 10 454 Pa ± 19 1375 Pa ± 21 
8-armed PEG 104 Pa ± 3 834 Pa ± 30 2197 Pa ± 133 
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Figure 6.2. Rheological analysis of 8-armed SPOCQ cross-linked hydrogels oxidized by NaIO4. Top: 
representative time sweep measurement of a 20 mg/mL hydrogel showing G’ (closed symbols) and G’’ 
values (open symbols). Bottom: G’ values compared with 4-armed SPOCQ cross-linked hydrogels for 10, 
20 and 30 mg/mL.
6.2.2. Vitamin B2 oxidation of the SPOCQ reaction
In order to be able to use SPOCQ cross-linked hydrogels in biomedical applications, it is 
important to investigate the biocompatibility of these gels. We therefore envision performing 
cell adhesion studies. As outlined before, the SPOCQ reaction was performed with oxidizing 
agents sodium periodate and mushroom tyrosinase. The toxicity of these reagents towards 
cells will be investigated, but before commencing these studies, we first focused on another 
possibility to perform oxidation. A biocompatible photo-oxidation of dopamine was reported 
using vitamin B2 (Riboflavin). Vitamin B2 photo-decomposes upon visible light or UV light, 
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leading to the formation of reactive oxygen species. The interaction of dopamine with vitamin 
B2 and the formed oxygen species cause oxidation of the catechol to the quinone.34 The 
potential of vitamin B2 as biocompatible oxidizing agent for the SPOCQ reaction was studied. 
First, a solution of star-PEG-BCN, star-PEG-DHPA (4-armed) and vitamin B2 was illuminated 
with UV-light using a lamp with a wavelength range of 320 – 450 nm. The viscosity of the 
polymer solution increased after illumination for 45 minutes. Eventually, the formation of a 
soft hydrogel was observed. However, due to the long illumination time required and the heat 
generated by the lamp, a large part of the water was evaporated. In order to improve the 
photo-oxidation process, a high power UV-lamp was utilized. In this way, only a short exposure 
of the sample was required. Nevertheless, due to the small sample volume and the power of 
the lamp, still most of the water was evaporated, resulting in a polymer film. To use a more 
benign irradiation source, we used visible light by simply placing a vial containing star-PEG-BCN, 
star-PEG-DHPA and vitamin B2 in the windowsill. After 3 hours, the complete sample volume 
was converted to a hydrogel, with no evaporation taking place. In order to determine the 
mechanical properties of these photo-oxidized gels, gels were made in a mold and allowed 
to cross-link with visible light for one day. Rheological analysis confirmed the formation of 
a hydrogel as G’ values exceeded G’’ values. The photo-oxidized gels were very soft, as G’ 
values of 96 Pa were obtained (Figure 6.3). These first gelation tests were performed with a 
polymer concentration of 50 mg/mL and with 0.5 eq vitamin B2 per DHPA group. Since the 
oxidation reaction depends on the interaction with vitamin B2, as well as on the generation 
of reactive oxygen species, the optimal amount of vitamin B2 was not exactly known. We 
therefore prepared samples with 0.25 eq, 0.5 eq and 1 eq vitamin B2 per DHPA group. We also 
changed the total polymer content to the previously used amount of 20 mg/mL in order to 
determine if the applied conditions still resulted in hydrogel formation. Rheology studies with 
these vitamin B2 ratios and polymers star-PEG-BCN and star-PEG-DHPA (20 mg/mL) showed 
only small differences in the moduli of the gels (Figure 6.3). As the ratio of vitamin B2 does 
not seem to influence the mechanical properties, we decided to continue with 0.5 eq vitamin 
B2, as this amount was also readily soluble. Since we aimed to investigate the biocompatibility 
of the SPOCQ reaction, we will use the established gelation procedure with vitamin B2 in cell 
adhesion studies (see Paragraph 6.2.3). In conclusion, vitamin B2 can be used as an oxidizing 
agent in the SPOCQ reaction by making use of illumination with visible light. The resulting 
hydrogels had poor mechanical properties. Based on this, and based on the lengthy illumination 
time, we conclude that the vitamin B2 oxidization process is not ideal. Optimization of this 
method can be achieved by using a UV-lamp with a more suitable wavelength, for example 
a blue LED lamp of 467 nm. Moreover, the addition of superoxide dismutase to the reaction 
mixture is recommended. This compound increases the production of reactive oxygen species 
and thereby enhances the reaction rate of the photo-oxidation. 34
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Figure 6.3. Rheological analysis of vitamin B2 oxidized hydrogels after exposure to visible light (24h). 
Top: representative time sweep measurement of a 50 mg/mL gel with 0.5 eq vitamin B2. Weak gels were 
obtained, as seen for the G’ value of 96 Pa ± 22 (n = 3). Bottom: Comparison of 20 mg/mL hydrogels with 
0.25, 0.5 and 1 eq vitamin B2 (per DHPA group) showing minimal differences in moduli. 
6.2.3. Cell adhesion studies with SPOCQ cross-linked hydrogels
The biocompatibility of SPOCQ cross-linked hydrogels was investigated, by performing cell 
adhesion studies. Gels were prepared with all three oxidizers, in order to determine the toxicity 
of these reagents. In accordance with the cell adhesion studies performed for the SPAAC 
cross-linked gels (Chapter 3), cell adhesion motif RGDS was incorporated in the SPOCQ 
polymers. Peptide RGDS was synthesized using solid phase peptide synthesis and N-terminally 
functionalized with 3,4-dihydroxyphenylacetic acid (DHPA). The previously developed coupling 
strategy using BOP and DiPEA was applied, to afford polymer star-PEG-RGDS-DHPA. As 
expected, rapid gelation also occurred when this peptide-containing polymer was used in the 
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SPOCQ reaction with star-PEG-BCN. Three different oxidizing agents were now available to 
test in cell adhesion studies. A cell adhesion test was performed with RGDS-containing SPOCQ 
gels, oxidized via mushroom tyrosinase. This test showed that the use of the enzyme induced 
toxicity, as only cell parts or cells with a round morphology were found (data not shown). 
This behaviour was known from literature studies which indicated that mushroom tyrosinase 
triggers apoptosis.35,36 We therefore decided to focus on sodium periodate and vitamin B2 
as oxidizing agents for cell adhesion studies. Based on the research in Chapter 3, we started 
with an RGDS content of 50%. Hydrogels were prepared in a total polymer content of 20 mg/
mL with 1 eq sodium periodate or 0.5 eq vitamin B2 (per DHPA group) for oxidation. All gels 
were left for one day to allow sufficient exposure of the vitamin cross-linked ones to visible 
light. After gel formation had been confirmed, the hydrogels were washed for 4 hours with PBS. 
Cell adhesion studies were carried out with NIH 3T3 fibroblasts, which were seeded onto the 
hydrogels and then incubated overnight. Cell viability was assessed by performing a live/dead 
assay. As expected, cells seeded on gels without adhesion motif RGDS gave red (or orange) 
fluorescent signals and showed a round morphology in their transmission images (Figure 6.4). 
Vitamin B2
PEG-only
NaIO4
PEG-only
Figure 6.4. Cell viability images for the live/dead assay on 20 mg/mL SPOCQ cross-linked hydrogels. 
Images are composed from overlays of the calcein-AM (green, live cells) and ethidium homodimer-1 
(EthD-1, red cells) channels. Gels without cell adhesion motif RGDS yielded red (or orange) fluorescent 
cells with a round morphology. Upper picture: confocal fluorescence, lower picture: transmission image. 
Scale bar represents 50 µm for all micrographs.
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Incorporation of RGDS turned the SPOCQ cross-linked hydrogels into a good substrate for 
cellular adhesion. For both NaIO4 and vitamin B2, a large number of green fluorescent cells 
were found which nicely showed their elongated morphology. For vitamin B2, the live/dead 
assay was also performed with gels containing 100% RGDS, also revealing nicely elongated 
fibroblasts (Figure 6.5). These cell studies confirmed that SPOCQ cross-linking can be used 
for the preparation of cell adherent hydrogels, and that both NaIO4 and vitamin B2 are suitable 
oxidizing agents to provide biocompatible gels.
Vitamin B2
50 % RGDS
Vitamin B2
100 % RGDS
NaIO4
50% RGDS
Figure 6.5. Cell viability images for the live/dead assay on 20 mg/mL SPOCQ cross-linked and RGDS-
containing hydrogels, showing nicely elongated viable fibroblasts (green fluorescent). Images are composed 
from overlays of the calcein-AM and EthD-1 channels. Upper picture: confocal fluorescence, lower picture: 
transmission image. Left and middle: vitamin B2 as oxidizing agent, gels containing 50 and 100% RGDS, 
respectively. Right: sodium periodate as oxidizing agent, gel containing 50% RGDS. Scale bar represents 50 
µm for all micrographs.
6.3. Physical cross-linking using Ca2+
Now that we further studied the mechanical properties of SPOCQ cross-linked hydrogels and 
showed their biocompatibility, we investigated the second, physical, cross-linking technique that 
we want to apply in our dual cross-linked hydrogel, based on ionic interactions with calcium ions. 
In Chapter 2, the hydrogel formation of peptide-polymer constructs containing calcium-binding 
peptides was already studied. It was shown that addition of calcium did not result in gelation, 
probably because Ca2+-binding to the peptides was too weak to make physical cross-links 
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between the polymers. In this chapter, we set out to further investigate physically cross-linked 
hydrogels with calcium. Bisphosphonates were identified as a particularly interesting class of Ca2+ 
binding small molecules. They contain two phosphate groups connected to the same carbon 
which induces the ability to coordinate divalent ions. Calcium binding occurs by coordination 
of the ion with one oxygen from each phosphate group. An important bisphosphonate is 
alendronic acid, in which the central carbon contains, apart from the two phosphates, also 
a hydroxyl group. This increases the calcium binding efficiency by formation of a tridentate 
conformation. Bisphosphonates are successfully used in the treatment of bone disorders such 
as osteoporosis, due to their high affinity towards bone mineral hydroxyapatite.37-39 
It was shown that alendronic acid can be built in in a polymeric hydrogel network. Alendronic acid 
was functionalized with a vinyl group, which was used for reaction with 2-hydroxy methacrylate 
(HEMA). Upon gamma irradiation, a hydrogel was formed, containing alendronic acid as 
functional group.40 Recently, a hydrogel system was prepared in which acrylated alendronic acid 
was reacted with poly(ethylene)glycol diacrylate. Upon addition of initiators, cross-linking was 
induced which resulted in hydrogel formation. In this research, swelling studies were conducted 
in which the monovalent NaCl was compared to the divalent CaCl2. Upon soaking in the salt 
solutions, all gels shrank, but only the samples with NaCl were able to retain their initial size 
upon rinsing with MilliQ water. Furthermore, it was demonstrated that hydrogels containing 
calcium as reversible cross-linkers could be secured in a certain shape, which showed the 
relatively strong coordination between alendronic acid and calcium.41 
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Figure 6.6. Structure of star-PEG-alendronic acid
The strong binding properties of alendronic acid towards calcium inspired us to use this 
bisphosphonate as a replacement for the calcium-binding peptides described in Chapter 
2. We therefore synthesized polymer star-PEG-alendronic acid (Figures 6.6 and 6.7). For 
the preparation of this compound, a star-PEG construct was used in which each arm was 
functionalized with N-hydroxy succinimidyl ester (NHS). Coupling of alendronic acid to star-
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PEG-NHS needed to be carried out under basic conditions, since this allows alendronic acid 
to dissolve. Attempts to perform the synthesis in basic water (by addition of NaOH, pH 10) 
or in normal PBS buffer (pH 7.4) were not successful. In both cases, the obtained products 
appeared to be insoluble in water, which is unlike what was expected for star-PEG-alendronic 
acid. Moreover, NMR and MALDI-TOF analysis did not confirm conversion to the product. As 
the reaction is likely to be pH sensitive due to the ionic character, we decided to use a stronger 
buffer and prepared PBS containing 100 mM phosphate. Alendronic acid was dissolved in this 
buffer, the pH was brought to 7.4 and star-PEG-NHS was added. After purification, the product 
could easily be dissolved in water. NMR and MALDI-TOF analysis confirmed the successful 
synthesis of star-PEG-alendronic acid.
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Figure 6.7. Physical cross-linking upon calcium addition using star-PEG polymers functionalized with 
bisphosphonate alendronic acid. 
We next investigated the gelation of star-PEG-alendronic acid upon addition of calcium (Figure 
6.7). A polymer concentration of 50 mg/mL (5 wt%) was first tested with 100 mM CaCl2 
which nicely and rapidly formed a hydrogel. A polymer content of 30 mg/mL (3 wt%) appeared 
to be the minimum concentration for gelation, as only viscous solutions were obtained at 
lower polymer concentrations. Rheology studies were carried out on a range of hydrogels 
formed from star-PEG-alendronic acid (30 – 100 mg/mL) and CaCl2 (100 mM) (Figure 6.8). 
As expected, G’ values increased with increasing polymer content. Moduli up to 8000 Pa were 
obtained for 100 mg/mL (10 wt%) star-PEG-alendronic acid gels. 
A well-known advantage of physically cross-linked gels is their self-healing behaviour. We 
demonstrated this by cutting a hydrogel into two pieces. After only 5 min, these pieces fused 
together in such a way that the crack could not be detected anymore. This simple test showed 
the self-healing behaviour of the star-PEG-alendronic acid gels. Moreover, we could easily 
demonstrate the reversibility of the cross-linking method by addition of the strong calcium 
binder EDTA. This caused disassembly of the hydrogel network, as calcium binding to EDTA 
disrupts the ionic bridges between adjacent polymer chains.
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Figure 6.8. Rheology data of calcium cross-linked gels using star-PEG-alendronic acid in concentrations 
of 30,40, 50, 75 and 100 mg/mL. Moduli up to 8000 Pa were obtained for 100 mg/mL physically cross-
linked gels. 
6.4. Dual cross-linking: SPOCQ and Ca2+
We next set out to combine both chemical and physical cross-linking techniques, in order to 
overcome the disadvantages of each of the separate methods. Especially the weak mechanical 
properties often encountered with purely physically cross-linked gels can be improved when a 
second (chemical) cross-linking procedure is incorporated. 
Ca2+
Ca2+
Ca2+
+ BCN
BCN
BCN
BCNDHPA
DHPA
DHPA
DHPA Ca2+
Star-PEG-alendronic acid
NaIO4
Ca2+
50%
50%
Figure 6.9. Schematic overview of dual cross-linked hydrogels. Star-PEG-BCN and star-PEG-DHPA 
are chemically cross-linked upon oxidation by NaIO4 (represented by stars). Star-PEG-alendronic acid 
polymers are physically cross-linked by Ca2+. Star-PEG-alendronic acid makes up 50% of the total polymer 
content, the other half is a mixture of star-PEG-BCN/star-PEG-DHPA (1:1). 
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In order to combine the chemical cross-linking method SPOCQ with the physical cross-linking 
procedure using calcium (Figure 6.9), we mixed polymers star-PEG-BCN and star-PEG-DHPA 
with star-PEG-alendronic acid. The first two can be chemically cross-linked using SPOCQ, while 
star-PEG-alendronic acid is able to make physical cross-links with calcium. Mixed gels were 
prepared with a total concentration of 60 mg/mL (6 wt%), in which half of the total polymer 
content was star-PEG-alendronic acid (30 mg/mL) and the other half was composed of a 1:1 
mixture of star-PEG-BCN and star-PEG-DHPA (30 mg/mL). Oxidizing agent sodium periodate 
(NaIO4) was added to the aqueous solution of these three polymers, to allow chemical cross-
linking using SPOCQ. As expected, a hydrogel was rapidly formed. G’ values of these single cross-
linked hydrogels were lower than values reported before for 30 mg/mL SPOCQ cross-linked 
gels (Chapter 4, Table 6.1). This is probably caused by steric hindrance due to the presence of 
star-PEG alendronic acid polymers. This hypothesis was tested by addition of non-functionalized 
star-PEG to a mixture of star-PEG-BCN and star-PEG-DHPA. This gave comparable G’ values 
as when star-PEG-alendronic acid was used, showing that steric hindrance indeed is a limiting 
factor. In order to allow dual cross-linking, a mixture of NaIO4 and CaCl2 was added to the 
solution of the three polymers. Also in this case, rapid gel formation occurred. Gels were 
prepared on the rheometer plate, to enable direct analysis of the mechanical properties. Gels 
directly obtained their final moduli. G’ values of the dual cross-linked hydrogel were much higher 
than for gels only cross-linked by NaIO4 (Figure 6.10). These results clearly showed that the 
chemically cross-linked network was strengthened by the calcium-induced ionic bridges. Single 
and dual cross-linking was also performed on hydrogels with a total polymer content of 80 and 
100 mg/mL (8 and 10 wt%). Also in this case, dual cross-linked hydrogels were much stiffer than 
gels only cross-linked by sodium periodate (Figure 6.10; Table 6.2). As expected, moduli were 
higher than for the 60 mg/mL gels, due to the higher polymer concentration in these gels. These 
experiments show that a mixture of star-PEG-BCN, star-PEG-DHPA and star-PEG-alendronic 
acid can be chemically cross-linked using SPOCQ and at the same time physically using calcium 
binding. Hydrogels prepared via this dual cross-linking method showed improved mechanical 
properties, compared to gels that were only chemically cross-linked. 
Table 6.2. G’ values of single (NaIO4) and dual cross-linked (NaIO4 and Ca2+) hydrogels. Values were 
recorded on the rheometer during 5 min (n = 3).
Hydrogel 60 mg/mL 80 mg/mL 100 mg/mL
NaIO4 72 ± 13 126 ± 18 256 ± 17
NaIO4 + Ca2+ 688 ± 58 1138 ± 107 1969 ± 302
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Figure 6.10. Rheology data of mixed hydrogels containing star-PEG-BCN, star-PEG-DHPA and star-PEG-
alendronic acid. For single (chemical) cross-linking NaIO4 was added, for dual (chemical and physical) 
cross-linking a mixture of NaIO4 and Ca2+ was added. Top: representative time sweep of an 80 mg/mL 
hydrogel. Bottom: overview of G’ values. Dual cross-linking gave much stiffer hydrogels than single cross-
linking. 
6.5. Stimuli responsive hydrogels using calcium-releasing liposomes
In order to control the physical gelation of star-PEG-alendronic acid, we investigated the 
possibilities to time the release of calcium. The Messersmith group studied calcium-containing 
thermally triggerable liposomes, which released the entrapped calcium upon an increase in 
temperature to 37°C.42,43 We decided to adopt the procedure to prepare calcium-releasing 
liposomes and use them for gelation of star-PEG-alendronic acid. Liposomes were composed 
of phospholipids dipalmitoylphosphatidylcholine (DPPC) and dimyristoylphosphatidylcholine 
(DMPC) in a molar ratio of 90:10. A lipid cake of these phospholipids was first prepared, to 
which an aqueous solution of CaCl2 was added. Encapsulation of the calcium was achieved by 
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sonication at 55°C. After removal of unencapsulated calcium via some centrifugation steps, 
calcium-containing liposomes were obtained.42,43 The liposomes were added to a solution of 
star-PEG-alendronic acid (60 mg/mL). The sample was kept at room temperature (20°C) and 
remained liquid. Next, the liposome/star-PEG-alendronic acid mixture was heated to 37°C, 
which resulted in rapid gelation. The elevated temperature thus provided release of the 
entrapped calcium, leading to physical cross-linking of star-PEG-alendronic acid. The release 
profile of the calcium-loaded liposomes was determined with UV spectroscopy, using calcium-
sensitive dye Arsenazo III. This clearly showed that the entrapped calcium is released around 
body temperature, as absorbance values rapidly increased upon reaching temperatures of 35°C 
and higher (Figure 6.11). The use of triggerable liposomes provided an on demand release of 
calcium and resulted in the preparation of stimuli-responsive hydrogels. 
 
Figure 6.11. Release profile of calcium-loaded liposomes, determined via UV spectroscopy. Top: 
absorbance values of calcium-sensitive dye Arsenazo III. Bottom: absorbance values at 650 nm plotted 
against temperature, showing that release of calcium starts at 35°C and is close to its maximum value at 
37°C. 
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6.6. Conclusion
In this chapter, dual cross-linked hydrogels were studied by combining chemical and physical 
cross-linking. First, the hydrogel forming capacity of chemical cross-linking method SPOCQ 
was further studied. We showed that 8-armed PEG constructs can also be cross-linked, leading 
to elastic moduli (G’) which were almost a factor 2 higher than 4-armed hydrogels. Apart 
from sodium periodate and enzyme mushroom tyrosinase, we showed that vitamin B2 can 
be used as an oxidizing agent in the SPOCQ reaction. The biocompatibility of SPOCQ cross-
linked hydrogels was shown by performing cell adhesion studies. RGDS-containing gels oxidized 
with NaIO4 or with vitamin B2 were found to be good substrates for cell adhesion, giving 
viable and nicely elongated NIH 3T3 fibroblasts. Secondly, physical cross-linking was studied, 
by using the ionic interaction of calcium ions. Gelation of bisphosphonate containing polymer 
star-PEG-alendronic acid occurred rapidly upon addition of calcium, resulting in moduli up to 
8000 Pa for 100 mg/mL (10 wt%) gels. Dual cross-linking was achieved by combining physical 
cross-linking (calcium) with chemical cross-linking (SPOCQ), leading to enhanced mechanical 
properties than for only chemically cross-linked gels. Finally, the physical cross-linked hydrogels 
were made stimuli responsive, by addition of thermally triggerable Ca2+-containing liposomes. 
This is promising for biomedical applications such as bone tissue engineering where a controlled 
release of calcium is demanded.
As an outlook on further research concerning the research performed in this chapter, a good 
starting point will be to first optimize the SPOCQ oxidation protocol using vitamin B2. Next, 
the mechanical properties of the dual cross-linked gels can be further studied, for example by 
constructing a hybrid polymer, containing two different functional groups (DHPA/BCN and 
alendronic acid). In this way, one polymer can participate both in chemical cross-linking as well 
as in physical cross-linking. Thereby a more intricate network will be created, which likely will 
result in hydrogels with improved mechanical properties. Cell studies are interesting with the 
dual cross-linked gels, whereby the optimized vitamin B2 oxidization procedure can also be 
examined. These in vitro studies are also interesting for the physically cross-linked gels with star-
PEG-alendronic acid, especially when using bone-marrow cells (see Chapter 7). Moreover, after 
studying the mechanical properties of the stimuli-responsive hydrogels, use of the triggerable 
liposomes will be a valuable addition for further in vitro studies with star-PEG alendronic acid 
hydrogels.
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6.8. Materials and methods
General notes experimental section
Materials and methods and standard solid phase peptide synthesis (SPPS) can be found in 
Chapter 2. The preparation of polymers star-PEG-BCN and star-PEG-DHPA is described in 
Chapter 4. General information on rheology can be found in Chapter 3. 
Materials and methods
8-Armed poly(ethylene glycol)-NH2 (20 kDa) HCl salt, with a tripentaerythritol core, was 
obtained from JenKem Technology (USA). 4-armed PEG-NHS (N-hydroxy succinimidyl ester ; 
10 kDa) was purchased from NOF America Corporation (Sunbright; USA). Phospholipids 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) were obtained from Avanti Polar Lipids, Inc. (USA). Arsenazo III was 
purchased from Sigma-Aldrich. For UV illumination, a Dr Hönle, Bluepoint 2 UV-lamp was used 
with a wavelength range of 320 – 450 nm (maximum 365 nm). Unless mentioned otherwise, 
a 1x PBS buffer (pH 7.4) was utilized containing 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 
and 1.8 mM KH2PO4. 
8-armed-PEG-BCN
To a dry reaction flask was added 8-armed poly(ethylene glycol)-NH2 HCl salt (M = 20000 Da, 400 
mg, 20 µmol), (1R,8S,9S)-bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate (BCN-OSu; 
58.3 mg, 0.2 mmol) and 67 µL triethylamine (0.48 mmol) in dry DCM (10 mL). The reaction mixture 
was stirred at r.t. overnight under N2 atmosphere. Extraction was performed with 2M NaOH 
(3 x 15 mL). The organic layer was dried over Na2SO4 and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (MeOH:DCM 2:98, followed by 10:90). 
The product was afforded as a white powder after freeze-drying from dioxane (113 mg, 26%). 
1H-NMR (400 MHz, CDCl3): δ = 0.86 – 1.01 (m, 8H), 1.29 – 1.45 (m, 16H), 1.52 – 1.65 (m, 
16H), 2.15 – 2.34 (m, 32H), 3.37 (m, 32H), 3.45 – 3.91 (m, [CH2CH2O]n), 4.14 (d, J = 8.0 Hz, 
16H).
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8-armed-PEG-DHPA
To 8-armed-poly(ethylene glycol)-NH2 HCl salt (M = 20000 Da, 400 mg, 20 µmol) in DMF 
(10 mL) was added subsequently benzotriazol-1-yl-oxy-tris dimethylaminophosphonium 
hexafluorophosphate (BOP; 89 mg, 0.2 mmol); 3,4 dihydroxy phenylacetic acid (34 mg, 0.2 
mmol), and DiPEA (279 µL, 1.6 mmol). The reaction mixture was stirred overnight at r.t., after 
which the DMF was evaporated in vacuo. The residue was dissolved in DCM and washed with 
1 M KHSO4 (3 x 15 mL) and brine (1 x 15 mL). The organic layer was dried over Na2SO4. The 
product was purified with column chromatography on basic aluminum oxide (MeOH: DCM; 
10:90). Lyophilization from dioxane afforded the product as a white powder (292 mg, 69%). 
1H-NMR (400 MHz, CDCl3, δ): 3.34 – 3.85 (m, [CH2CH2O]n, CH2-Ar-CH), 6.62 – 6.87 (m, Ar-
CH) MALDI-TOF (α-cyano-4-hydroxycinnamic acid): 21465, calculated m/z: 21465 for 446 
ethylene glycol units.
DHPA-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Gly-OH
The peptide was synthesized using solid phase peptide synthesis, following the general protocol 
as described in Chapter 2. The synthesis was carried out with 1.0 g 2-chlorotrityl resin. In the 
final step, 3,4 dihydroxy phenylacetic acid (DHPA) was coupled, by addition of a solution of 
DHPA (2.0 eq), HOBt (3.5 eq) and triethylamine (3.5 eq) in DMF. After shaking for 3 minutes, 
a solution of HBTU (2.0 eq) in DMF was added and the coupling was left for 1 h. Cleavage 
from the resin was performed mildly, by treatment with a mixture of dichloromethane (DCM), 
trifluoroethanol (TFE) and acetic acid (HOAc) (6:1:1) for 3 h. The solvents were evaporated 
under reduced pressure and co-evaporation was performed with chloroform (3 x 40 mL). 
Freeze-drying from dioxane afforded the peptide as a white powder. 
LCQ: m/z: 1062.3 [M + H]+ (calculated [M + H]+ = 1062.5)
HPLC: Rt = 22.24 min
DHPA-GRGDSG-Star-PEG (protected)
To star-poly(ethylene glycol)-NH2 HCl salt (190 mg, 19 µmol) in DMF (10 mL) was added 
subsequently BOP (51 mg, 114 µmol), peptide DHPA-GRGDSG-OH (101 mg, 95 µmol), and 
DiPEA (79 µL, 0.46 mmol). The reaction mixture was stirred overnight at r.t. Evaporation of 
the DMF was performed and the residue was dissolved in DCM (30 mL). Extraction was 
performed with 1 M KHSO4 (3 x 20 mL) and brine (1 x 20 mL), after which the organic layer 
was dried over Na2SO4. Column chromatography on basic aluminum oxide (MeOH: DCM; 
10:90) afforded the product as a white powder after freeze-drying from dioxane (177 mg; 66%). 
1H-NMR (400 MHz, CDCl3, δ): 1H-NMR (400 MHz, CDCl3): δ = 1.16 (s, 36H), 1.42 (s, 36H), 
1.46 (s, 32H), 2.09 (s), 2.46 - 3.00 (m), 3.50 – 3.71 (m, [CH2CH2O]n), 4.17 (m), 4.41 (m), 4.65 
(m), 6.66 – 6.94 (m, Ar-CH).
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DHPA-GRGDSG-Star-PEG
Deprotection of DHPA-GRGDSG-star-PEG (145 mg) was performed by treatment with 
TFA: TIS: H2O (95:2.5:2.5; 8 mL) for 3 h at r.t. The reaction mixture was precipitated from 
diethyl ether. After overnight stirring in 1 M HCl, the product was dialysed against water using 
a membrane with a MW cut-off of 3500 Da. Freeze drying afforded the product as a white 
solid (93 mg; 71%)
1H-NMR (400 MHz, D2O): δ = 1.30 – 1.77 (m), 2.55 – 3.00 (m), 3.39 – 3.63 (m, [CH2CH2O]n), 
4.13 (m), 4.28 (m), 6.59; 6.69 (2m; Ar-CH).
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): 12401 (calculated m/z: 12411 for 213 ethylene 
glycol units. 
Star-PEG-alendronic acid
Prior to the synthesis a PBS solution containing 100 mM phosphate was freshly prepared by 
dissolving 9.95 mg KCl (2.67 mM), 403 mg NaCl (137.93 mM), 102 mg KH2PO4 (15 mM) and 
Na2HPO4 (85 mm) in 50 mL MilliQ water. The buffer was sonicated for 5 min. Alendronic acid 
(39.9 mg, 160 µmol) was dissolved in 10 mL PBS (100 mM phosphate) and the solution was 
brought to a pH of 7.4 with NaOH. Star-PEG-NHS (4-armed, M = 10000 Da; 200 mg, 20 µmol) 
was added and the reaction mixture was stirred overnight at r.t. The solution was transferred 
to a dialysis bag and dialyzed overnight against 600 mL water using membranes with a MW 
cut-off of 3500 Da. The product was afforded after freeze-drying as a white paper-like solid 
(188 mg; 86%). 
1H-NMR (400 MHz, CDCl3, δ): 1.45 – 1.71 (m, NH-CH2CH2CH2-C), 2.40; 2.53 (2t, C(O)
CH2CH2C(O)), 2.96 – 3.06 (m, NH-CH2CH2CH2-C), 3.44 – 3.65 (m, [CH2CH2O]n).
31P-NMR δ: 35 ppm
MALDI-TOF (α-cyano-4-hydroxycinnamic acid): 11218, calculated m/z: 11210 for 221 ethylene 
glycol units. 
Hydrogel formation – sodium periodate and vitamin B2
Hydrogels were formed by addition of NaIO4 or vitamin B2 to an equimolar mixture of star-
PEG-BCN and star-PEG-DHPA. Hydrogels were prepared in total polymer concentrations of 
10, 20 and 30 mg/mL (1-3 wt%) in MilliQ. For a typical hydrogel, equal volumes of the polymer 
mixture and the oxidizing agent were mixed to the final concentration. For the polymer mixture, 
stock solutions of 20, 40 and 60 mg/mL of star-PEG-BCN and star-PEG-DHPA were first freshly 
prepared and then mixed in a 1:1 fashion. For NaIO4, a stock solution of 1 eq sodium periodate 
in MilliQ (based on amount of DHPA groups, 4 eq NaIO4 per star-PEG-DHPA) was prepared. 
For vitamin B2, a stock solution of 0.5 eq per DHPA group in MilliQ was prepared. Mixtures of 
the polymers with vitamin B2 were illuminated with visible light by placing them in front of the 
window for 24 h. The same procedures were used for hydrogel formation with 8-armed-PEG-
BCN and 8-armed-PEG-DHPA.
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Mixed gels: star-PEG-BCN, star-PEG-DHPA and star-PEG-alendronic acid
Hydrogels were prepared with a total polymer content of 60 mg/mL, 80 mg/mL and 100 mg/
mL. For 60 mg/mL gels, a polymer mixture containing 6 mg star-PEG-BCN, 6 mg star-PEG-
DHPA and 12 mg star-PEG-alendronic acid in 200 µL PBS was prepared. In the same way, 
polymer mixtures for 80 mg/mL and 100 mg/mL gels were prepared. A solution of the oxidizing 
agent was prepared in PBS, containing 1 eq NaIO4 (based on amount of DHPA groups, 4 eq 
NaIO4 per star-PEG-DHPA). For dual cross-linking, a mixture containing NaIO4 (1 eq per DHPA 
group) and CaCl2 (200 mM) in PBS was prepared. Hydrogels were prepared directly on the 
rheometer plate by mixing equal amounts of the polymer mixture (100 µL) and the oxidizing 
agent solution (100 µL; NaIO4 or NaIO4/CaCl2) to obtain the final concentration (60, 80 or 100 
mg/mL; CaCl2: 100 mM). Oscillatory time sweep measurements were measured for 5 min at a 
constant strain of 1% and an angular frequency of 10 rad/s. 
Hydrogel formation: star-PEG-alendronic acid with Ca2+
Hydrogels were prepared with total star-PEG-alendronic acid concentrations of 30, 40, 50, 
75 and 100 mg/mL (3, 4, 5, 7.5, 10 wt%). Twice as concentrated stock solutions were used, by 
dissolving star-PEG-alendronic acid in PBS (containing 100 mM phosphate), for example 6 mg in 
100 µL for the 30 mg/mL gel. A 200 mM CaCl2 stock solution was prepared in MilliQ. For each 
hydrogel, the star-PEG-alendronic acid and calcium stock solutions were mixed in a 1:1 fashion, 
to obtain the final concentrations (Ca2+ for every gel: 100 mM). Gels were prepared directly on 
the rheometer plate, to measure oscillatory time sweeps for 15 min at a constant strain of 1% 
and an angular frequency of 10 rad/s. 
Live/dead assay
Hydrogel solutions were prepared in a total polymer content of 20 mg/mL, following the general 
protocol of hydrogel formation. Hydrogels containing 50% RGDS were prepared by mixing 
star-PEG-RGDS-DHPA and star-PEG-DHPA (1:1), for cross-linking to star-PEG-BCN. Gels were 
also prepared with 100% star-PEG-RGDS-DHPA. Hydrogels were oxidized by vitamin B2 or 
by NaIO4 and were prepared in an 8-chambered coverslip (Nunc, Wiesbaden, Germany) in 
sample volumes of 150 µL for vitamin B2 and 50 µL for periodate. The coverslip containing 
the mixture with the vitamin B2 oxidizing agent was placed in the windowsill for exposure to 
visible light for one day. Hydrogels were washed with PBS for 4 hours. In each well, 40.000 cells 
in 250 µL medium were seeded. Wells coated with gelatin were used as positive control. NIH 
3T3 fibroblasts were incubated overnight (37°C, 7.5% CO2). After this incubation period, the 
cells were treated with the live/dead staining, which was prepared by diluting calcein-AM and 
ethidium homodimer-1 (EthD-1) in PBS to obtain a concentration of 1.33 mM calcein-AM 
and 2.67 mM EthD-1. The samples were allowed to rest for 10 minutes, after which they were 
immediately analyzed by confocal laser scanning microscopy. Calcein was excited with the 488 
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nm line of an argon ion laser, and emission was collected between 494 and 515 nm. EthD-1 
was excited with the 561 nm line of a yellow diode laser and emission was collected between 
600 and 625 nm. Using the ImageJ software, overlay images of the calcein and EthD-1 signals 
were produced.
Preparation of calcium-releasing liposomes
Liposomes were prepared from phospholipids 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC) and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). A thin film of DPPC: 
DMPC (90:10 mol%) was prepared by drying a mixture of 9 mg DPPC and 0.92 mg DMPC 
in dichloromethane. To the lipid cake was added 2 mL CaCl2 (0.2 M). The mixture was then 
stirred at 55°C for 30 min. Sonication was performed at 55°C, until an optically clear solution 
was obtained (2 hours). Ethanol was added to a final concentration of 4 M. The solution was 
left at r.t. for 15 min, after which it was heated to 50°C and bubbled with dry argon to remove 
the ethanol. To remove unencapsulated calcium, the liposomes were washed with 800 µL iso-
osmotic buffered saline (0.2 M NaCl, 10 mM HEPES, 1 mM EDTA, pH 7.4) and centrifuged 
at 4°C (13000 rpm) for 10 minutes. This washing procedure was performed five times. For 
each washing step, 125 µL calcium sensitive dye Arsenazo III (500 µM) was added to 125 
µL supernatant and the absorbance was determined at 650 nm using a plate reader. The low 
absorbance values for washing steps 4 and 5 confirmed removal of unencapsulated calcium. 
Hydrogel formation star-PEG-alendronic acid and liposomes
To a solution of star-PEG-alendronic acid in PBS (60 mg/mL; PBS containing 100 mM phosphate) 
was added NaCl, to increase the osmolality to 525 mmol/kg. Three parts of the star-PEG-
alendronic acid solution were mixed with one part of liposome material. The temperature was 
increased to 37°C, using a waterbath.
UV measurements on liposomes
UV spectra were recorded on a Jasco-v630 spectrometer at a wavelength range of 400 – 
700 nm. A 0.04 mM Arsenazo III solution was prepared in 0.258 M NaCl. A mixture of 10 µL 
liposome material in 4 mL Arsenazo III solution was prepared, from which 2.5 mL was loaded in 
a cuvette. UV spectra were recorded at a temperature gradient of 1 °C/min, with a delay time 
of 20 seconds before measuring. A temperature range from 25°C to 40°C was utilized. Spectra 
were corrected by subtracting the background spectrum recorded for the liposome/Arsenazo 
III mixture at 25°C and were measured in triplo.
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7.1. Brief summary
In this thesis, several bio-inspired cross-linking methods for hydrogel formation have been 
studied, aiming for biomedical applications. The first goal was to investigate hydrogels as 
bone tissue engineering scaffolds, by adopting the calcium-binding features found in bio-
macromolecules such as bone sialoproteins and alginate. Physically cross-linked hydrogels were 
developed based on calcium-binding peptides (Chapter 2). These were linked to 4-armed 
polymer poly(ethylene)glycol (star-PEG), to obtain peptide-polymer constructs. The physical 
cross-linking of these constructs was studied by addition of calcium ions. The calcium binding 
ability of the peptides appeared to be insufficient to result in a cross-linked hydrogel network. 
We therefore switched our focus to chemically cross-linked hydrogels by making use of strain-
promoted click (SPAAC) chemistry. In Chapter 3, the SPAAC reaction between ring-strained 
alkyne BCN and an azide was used to ensure cross-linking between star-PEG-BCN and star-
PEG-N3. This resulted in soft hydrogels with tunable mechanical properties. Incorporation of 
cell-binding peptide RGDS turned these hydrogels into good substrates for cell adhesion. 
Studies performed with NIH 3T3 fibroblasts and HeLa cells showed decreased cell adhesion 
to stiffer hydrogels. In contrast, the bone marrow derived HOS cells were able to adhere 
and spread independently of the mechanical properties of the hydrogels. In Chapter 4, we 
developed a novel chemical cross-linking method, called strain-promoted oxidation-controlled 
cyclooctyne–1,2-quinone cycloaddition (SPOCQ). Hydrogel formation between catechol 
functionalized star-PEG-DHPA and star-PEG-BCN occurred rapidly upon oxidation. This was 
achieved both chemically using sodium periodate and enzymatically with mushroom tyrosinase. 
We also showed that SPAAC and SPOCQ can function as an orthogonal reaction pair, by 
allowing gels to form rapidly using SPOCQ and to be functionalized subsequently using SPAAC. 
Both chemical cross-linking methods were used in Chapter 5, in which we constructed a 
hydrogel peptide amphiphile fibre composite material. These fibres, containing a diacetylene 
moiety in the alkyl tail, could easily be encapsulated in the hydrogel network, without losing 
their characteristic topochemical polymerisation. We furthermore showed that the fibres were 
aligned when assembled in a strong magnetic field. In order to stabilize the fibre alignment, 
SPAAC cross-linking was tested. However, formation of the polymeric network interfered 
with the fibre alignment process. Fortunately, the SPOCQ cross-linking method proved to be 
highly suited, as it could be activated after alignment was completed. In Chapter 6, we aimed 
for developing dual cross-linked hydrogels by combining physical and chemical cross-linking 
methods, in order to obtain advanced hydrogels with improved mechanical properties. Firstly, 
the hydrogel forming capacity of SPOCQ was further employed by using vitamin B2 as oxidizing 
agent and by cell adhesion studies demonstrating the biocompatibility of the chemically cross-
linked gels. Secondly, we turned our attention to the ionic interactions of alendronic acid to 
develop physically cross-linked gels. The high affinity of this bisphosphonate towards calcium 
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resulted in the rapid physical gelation of star-PEG-alendronic acid. Finally, we combined SPOCQ 
cross-linking with Ca2+ binding, resulting in a dual cross-linked gel with enhanced mechanical 
properties compared to a single cross-linked system. Moreover, the physically cross-linked 
star-PEG-alendronic acid gels were made stimuli responsive, by incorporation of thermally 
triggerable calcium-releasing liposomes.
7.2. Future perspectives 
7.2.1. Challenges for using hydrogels in biomedical applications
Hydrogels have great potential to be used in biomedical applications, such as tissue engineering 
and for the controlled delivery of drugs. However, in order to boost the clinical use of hydrogels, 
advanced gels should be developed which mimic the in vivo environment and which can easily 
be administered. Hence, the main challenges to focus on are injectability, degradability and 
mimicking the extracellular matrix. In this respect, the way in which cross-linking occurs is 
essential, as this determines the mechanical properties, the biocompatibility and influences 
hydrogel administration. This thesis focussed on several cross-linking methods, of which the 
potential for biomedical applications will now be discussed. This will be done based on the main 
challenges we need to overcome before hydrogels are routinely used in a clinical setting.
7.2.2. Chemical and/or physical cross-linking
An important factor that determines the biocompatibility of hydrogels is the way in which 
cross-linking occurs. Physical cross-linking methods are preferred, as chemical cross-linking often 
requires the use of organic solvents and/or reagents. The cytotoxicity caused by residual chemical 
reactants hampers the use of chemically cross-linked gels for biomedical applications. A valuable 
improvement for the chemical cross-linking procedures came from the rapid evolution of click 
chemistry in the past few years. These water-based chemistries are fast, modular, high-yielding 
and, importantly, bio-compatible. As described in literature and in this thesis, click chemistry 
has shown its value in the preparation of chemically cross-linked hydrogels. Click reactions 
such as SPAAC and SPOCQ allow precise control over the mechanical properties of the 
hydrogels (Chapter 3 and 4).1 Physical cross-links, on the other hand, are advantageous due 
the fact that gelation can be designed to occur upon application of an external trigger (pH, 
temperature, stress, ionic). A drawback of this type of cross-linking is that these hydrogels often 
display weak mechanical properties. In this respect, a system in which chemical and physical 
cross-linking methods are combined is desired. We described such a system in Chapter 6, 
by making a network containing both physical and chemical cross-links, via Ca2+ binding to 
alendronic acid and the SPOCQ reaction, respectively. These mixed systems showed enhanced 
mechanical properties. This is an example of the emerging activities in the hydrogel field on 
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interpenetrating polymer networks. These hydrogels are formed when a second polymeric 
network is polymerised within a pre-polymerised gel. In most cases, natural polymers such as 
chitosan or alginate are combined with synthetic polymers. In this way, a dense network is easily 
generated, giving hydrogels with strong mechanical properties.2,3 An example is the synthesis 
of hydrogel beads composed of alginate and pre-polymerised poly(N-isopropylacrylamide) 
(PNIPAAM). Drug indomethacin was directly mixed with the two polymers to ensure efficient 
loading. Cross-linking occurred upon injection into a Ca2+ solution. These hydrogel beads 
are temperature and pH-sensitive and give release rates up to 95% for indomethacin, which 
shows their potential for drug release.4,5 The fact that interpenetrating polymer networks are 
based on natural polymers, also has some disadvantages for use as biomaterials. It is often 
difficult to obtain identical compositions when samples from natural sources are used, and 
their purification might be problematic. With this in mind, replacement of alginate with the 
synthetic star-PEG-alendronic acid can be beneficial. Apart from the combination with SPOCQ, 
star-PEG-alendronic acid can also be studied in combination with PNIPAAM. This will increase 
control over the physical properties of the gel, and by combination with polymer PNIPAAM, 
temperature and pH sensitivity can be introduced. In this way, a new class of stimuli-responsive 
interpenetrating hydrogels can be developed, with high potential as drug delivery vehicles.2,3
7.2.3. Injectability
As mentioned before, hydrogels are promising materials for the controlled delivery of drugs. 
Their high water content and porous morphology allows diffusion of molecules in and out of 
the polymeric network, making them suitable as drug delivery material. Ideal about hydrogels 
is the fact that they can be made injectable, by making use of their transition from solution 
to gel state. This in situ gelation allows the administration of hydrogels in a minimally invasive 
manner. Physically cross-linked hydrogels are often studied in this regard, as they show shear-
thinning behaviour. This means that the material flows like a low viscosity solution when applying 
shear stress, but recovers into the gel state when the stress is removed. Additionally, the sol-
to-gel transition can be achieved via the stimuli-responsiveness of physically cross-linked gels, 
as the encountered environmental changes upon administration to the body lead to gelation. 
For chemically cross-linked hydrogels, the covalent bonds are formed in vivo, meaning that 
biocompatibility is an essential criterion. Moreover, the reaction needs to be efficient and selective, 
as it must not interfere with the encapsulated pharmaceuticals. The emergence of the bio-
orthogonal click reactions as well as the successful cell studies performed with these hydrogels, 
show that chemically cross-linked hydrogels are also promising as injectables. However, there 
are some points that need to be taken into account when studying the injectability of hydrogels. 
The first point is the gelation time, which is crucial for proper administration. If gelation occurs 
too slowly, the low viscous polymer solution can leak to surrounding tissues. On the other hand, 
with a too fast gelation rate, clogging in the syringe during injection is likely to occur. Apart 
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from the gelation time, the delivery time of the encapsulated drugs needs to be taken into 
account. A problem with the delivery of drugs is the initial burst release upon administration, as 
the drug can diffuse out of the system before gel formation. One way to improve this and to 
better control the delivery is by investigating the introduction of specific interactions between 
the polymer and the drug.6-8 Further research on the hydrogel systems described in this thesis 
can focus on the injectability. For the SPAAC cross-linked gels, the slow reaction kinetics might 
be troublesome, as it might give rise to leakage before gelation. Increasing the polymer content 
could solve this issue, but this then also gives rise to stiffer gels. As outlined in Chapter 3, the 
stiffness range of most mammalian organs is between 100 and 10.000 Pa (G’). It is important 
to develop a hydrogel with a stiffness that matches the target tissue. A SPOCQ cross-linked gel 
could encounter clogging issues as gelation occurs rapidly. For this system, a double-barreled 
syringe can be studied, in which the oxidation agent and the polymeric building blocks are kept 
apart during injection. Upon reaching the target tissue, mixing of the two components leads to 
rapid in situ gelation, thereby minimizing leakage.
7.2.4. Degradability
Apart from the injectability studies, the degradability is another important aspect when 
investigating hydrogels for biomedical applications. When hydrogels are used in tissue engineering 
or for delivery of drugs or cells, long term stability is required. In this case, slow degrading 
polymers should be used. This also prevents the initial burst release issues, as discussed before. 
Furthermore, when studying the degradation profile of the hydrogels, one should also take 
into account what the degradation products are. It is for example known that the degradation 
products of polymers such as PLGA cause a decrease in pH, which might cause damage to 
proteins or lead to inflammation at the site of injection. However, in the design of our hydrogels, 
we chose to only use PEG, since the medical use of this polymer has already been approved 
by the FDA. In the design of hydrogels it is important to study the degradation rate, since 
this directly corresponds with the release rate of encapsulated drugs, proteins or cells. Ideally, 
the mechanical properties and the degradation profile should be balanced, to ensure proper 
functionality of the hydrogel.8,9 
7.2.5. 3-D Cells studies & Mimicking the ECM
An important goal in the hydrogel field is mimicking of the extracellular matrix (ECM). The 
ECM is the biological material that surrounds cells in tissue. Important criteria to reach this 
goal are cell adhesion, cell migration and proteolytic degradation of hydrogels. This illustrates 
the importance of our cell adhesion studies. Both SPAAC and SPOCQ cross-linked hydrogels 
were found to be good substrates for cellular adhesion. In this thesis, only 2-D cell adhesion 
studies were performed. However, mimicking the ECM requires a 3-D cellular environment. 
An important way to achieve this is the incorporation of matrix metalloproteinase (MMP) 
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cleavable sequences, as this allows cells to actively remodel their surroundings. These MMPs are 
naturally occurring in the ECM, where they are responsible for remodelling. By incorporation 
of an MMP cleavable motif, a dynamic cellular environment is created within the hydrogel 
network. Further studies on our hydrogels should therefore concentrate on cellular adherence 
in three dimensions. As outlined in Chapter 5, an interesting system to start with is the MMP-
motif containing hydrogels combined with IKVAV-containing peptide amphiphiles. The hydrogels 
contain both a cellular adhesion motif (IKVAV or RGDS) and an enzyme-cleavable MMP 
sequence, which allows cells to adhere in a 3-D fashion. Moreover, when magnetically aligned 
IKVAV-containing peptide amphiphile fibres are incorporated, these hydrogels can be studied as 
potential scaffolds for the directional growth of neuronal cells. Eventually, this could allow us to 
regenerate neural tissues in a controlled environment and manner. We consider the 3-D studies 
with the peptide amphiphiles containing hydrogels as a good starting point for achieving the 
goal to use our hydrogels for tissue engineering applications. Adjusting the peptide components 
in the hydrogel makes it easy to incorporate multiple functionalities in the network, which is an 
important step in mimicking the ECM.7,10 
7.2.6. Bone tissue engineering
In Chapter 6, we introduced calcium-induced gelation of star-PEG-alendronic acid polymers. 
Further studies on this physically cross-linked hydrogel should aim for regeneration of bone 
tissue. Important in this aspect is that the material needs to have a high affinity for bone mineral 
hydroxy apatite. Our hydrogel contains bisphosphonate alendronic acid, which is known to be 
responsible for targeting and binding to bone via binding to calcium. Star-PEG-alendronic acid 
hydrogels are therefore promising as scaffold for bone tissue regeneration. In future research, 
cell studies with human bone marrow mesenchymal stem cells (hBMSC) are recommended. 
These cells can differentiate into the bone synthesizing osteoblasts. After harvesting from a 
patient, hBMSC can be cultured and combined with a scaffold to repair bone defects. hBMSC 
can be loaded in star-PEG-alendronic acid hydrogels, after which it is important to study their 
ability to differentiation into osteoblasts. The next step would then be to study them in vivo on 
their ability to repair cancellous bone defects. Moreover, we want to study the injectability of 
the star-PEG-alendronic acid hydrogels. Especially when aiming for bone tissue engineering, the 
injectability of the material is an important advantage. Without this, an open surgical procedure 
has to be carried out, which is highly invasive for the patient. Injectability of the physically cross-
linked star-PEG-alendronic acid hydrogels is likely to be promising. Moreover, these gels have 
self-healing properties, which easily allows them to remodel and to fill any shape or defect. 
Additionally, our initial studies with calcium releasing liposomes showed that the hydrogels can 
be made stimuli responsive, which allows on demand release of calcium. This is a step forward in 
developing hydrogels in which the time, site and dose of release can be precisely controlled.11-14
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Summary
Chapter 1 - Peptide- and protein based hydrogels
Hydrogels are three-dimensional, hydrophilic polymeric networks, capable of absorbing large 
amounts of water or biological fluids, up to thousand times their dry weight. They are insoluble 
due to the presence of cross-links between the constituents that form the polymeric network. 
An important hydrogel characteristic is the way in which cross-linking occurs, either chemically 
or physically. Chemically cross-linked hydrogels are formed via covalent bonds between the 
polymeric constituents. Advantageous about this cross-linking method is that it allows control 
over the mechanical properties of the formed hydrogels. A disadvantage is that chemical 
reactions often require the use of organic solvents and/or reagents, which hampers the use 
for biomedical applications. Physically cross-linked gels, on the other hand, are formed via self-
assembly in response to external stimuli such as temperature, pH or ionic strength. These gels do 
not depend on the additions of chemical reagents and moreover, can be made stimuli-response. 
This makes them promising for use as injectable material. A disadvantage is that physical cross-
linking methods often lead to gels with weak mechanical properties. The way in which cross-
linking occurs is an important factor for hydrogel formation, as it determines the mechanical 
properties of the gel, the biocompatibility and also influences hydrogel administration. Control 
over the cross-linking method leads to control over the hydrogel properties, which facilitates 
their clinical use. This thesis therefore focusses on several bio-inspired cross-linking methods for 
hydrogel formation, aiming to develop adaptive scaffolds for bone tissue engineering.
Chapter 2 - Physical cross-linking of star-PEG polymers using calcium-binding peptides
Bone tissue is composed of cells embedded in an organic matrix, consisting of collagen and 
the calcium-containing hydroxyapatite. An important criterion in the search for scaffolds for 
bone tissue engineering is the ability to induce apatite formation. Materials that mineralize 
bone tissue are usually non-collagenous proteins, with strong calcium-binding features. These 
calcium-binding motifs are abundantly present in nature, such as bone sialoproteins, calmodulin 
and alginate. Our aim was the development of physically cross-linked hydrogels as bone tissue 
engineering scaffolds, by adopting the strong calcium-binding features found in nature. We first 
synthesized several peptides that were abundant in negatively charged carboxylate groups for 
binding to Ca2+. Peptides such as Gly-Glu7-Gly (GE7G), G[LEELLEE]2G and the binding motifs 
from calmodulin were synthesized using solid phase peptide synthesis. The calcium-binding 
properties of these peptides were explored via analysis techniques such as circular dichroism 
spectroscopy (CD), dynamic light scattering (DLS) and isothermal calorimetry (ITC). The effect 
of calcium addition on the peptides secondary structure, the aggregation behaviour and the 
enthalpy of binding were determined. It was difficult to be conclusive about the ability of the 
peptides to bind calcium, as the analysis techniques mainly showed only weak effects upon 
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addition of calcium. Nevertheless, we decided to continue with our aim to develop calcium 
cross-linkable hydrogels by linkage of the peptides to star-shaped poly(ethylene)glycol (star-
PEG). Coupling of peptide GE7G to star-PEG was successful, affording the peptide-polymer 
construct star-PEG-GE7G. Synthesis of the polymer constructs with peptide G[LEELLEE]2 and 
with the calmodulin domains did not succeed, because the low solubility of these compounds 
hampered purification. Star-PEG-GE7G was therefore used to test the possibility to make a 
physically cross-linked hydrogel using calcium as cross-linker. Unfortunately, addition of calcium 
to star-PEG-GE7G did not result in gel formation. As the analysis techniques to determine the 
calcium-binding properties were also not convincing, we concluded that the interaction of 
calcium with the peptides is not strong enough to make physical connections between the 
polymers.
Chapter 3 - Soft PEG-hydrogels with independently tunable stiffness and RGDS-
content for cell adhesion studies
We switched our attention to chemically cross-linked gels and especially focussed on the 
biocompatibility of the cross-linking procedure. Interesting in this respect are the so-called 
click reactions. These water-based chemistries are fast, modular, high-yielding and, importantly, 
biocompatible. We studied the copper-free click reaction named strain promoted azide-
alkyne cycloaddition (SPAAC). Ring strained alkyne bicyclo[6.1.0]nonyne (BCN) and an azide 
were coupled to polymer star-PEG, to obtain star-PEG-BCN and star-PEG-N3, respectively. 
Upon mixing of these two polymers in water, the SPAAC reaction commenced, leading to 
hydrogel formation. Cross-linking took place without the need of additional chemicals or 
further processing. We aimed for developing soft hydrogels, to mimic the stiffness range of 
most mammalian organs (G’ = 100 – 10.000 Pa). Rheological analysis confirmed the soft nature 
of the SPAAC cross-linked gels, as elastic moduli of 25 Pa (10 mg/mL), 1192 (20 mg/mL) and 
2298 Pa (30 mg/mL) were obtained. This also showed that the mechanical properties of the 
gels could easily be tuned by varying the total polymer content. In order to be able to ensure 
biocompatibility, cell adhesion peptide RGDS was incorporated in the polymeric network. Cell 
adhesion studies were performing using a live/dead assay, which contains a fluorescent dye to 
colour living cells (green) and a dye for dead cells (red). Three different cell types originating 
from different tissues were utilized to get insight in how cells interact with their surroundings. 
We found a large number of green fluorescent cells for the bone marrow derived HOS cells 
on all RGDS-containing hydrogels (10 – 30 mg/mL). This means that HOS cells remained viable 
on all hydrogel surfaces, independent of the stiffness. Both cell lines derived from softer tissues 
(HeLa and 3T3 NIH fibroblasts) also showed nicely spread and viable cells on the 10 and 
20 mg/mL gels. Interestingly, cell adherence was clearly hampered on the stiffest hydrogel of 
30 mg/mL, shown by the significantly lower amount of adherent cells. Since stiffness is the 
only difference between the 10, 20 and 30 mg/mL gels, we conclude that this seems to be a 
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determining factor in cellular adhesion of HeLa cells and NIH 3T3 fibroblasts. Importantly, our 
research showed that SPAAC cross-linked RGDS-containing hydrogels are a good substrate for 
cellular adhesion.
Chapter 4 - A fast and activatable cross-linking strategy for hydrogel formation
We demonstrated that the SPAAC reaction is a valuable method for the formation of 
chemically cross-linked hydrogels. However, as we also observed, the SPAAC reaction is often 
hampered by slow reaction kinetics. Moreover, the reaction is not activatable, which is a desired 
property for injectable hydrogels and for other biomedical applications where spatiotemporal 
control of hydrogel formation is demanded. We therefore developed a new cross-linking 
method called strain-promoted oxidation-controlled cyclooctyne–1,2-quinone cycloaddition 
(SPOCQ). This method is based on the reaction between alkyne BCN and catechol DHPA (3,4 
dihydroxyphenylacetic acid), which proceeds after oxidation of the catechol to the quinone. We 
showed that hydrogel formation out of polymers star-PEG-BCN and star-PEG-DHPA proceeds 
extremely fast upon oxidation. Chemical oxidation using sodium periodate resulted in almost 
immediate gelation. Oxidation could also rapidly be performed using enzyme mushroom 
tyrosinase. By varying the enzyme concentration, the cross-linking rate could be controlled, 
as higher enzyme concentrations gave rise to lower gelation times. The SPOCQ reaction only 
commenced after addition of an oxidation agent, meaning that, for the first time, a fast and 
activatable cross-linking method for hydrogel formation is developed. Additionally, inspired 
by the large difference in reaction rate between SPOCQ and SPAAC, we hypothesized that 
we could use both reactions in one-pot. We indeed showed that both chemical cross-linking 
methods can be used in concert, SPOCQ for rapid hydrogel formation, and SPAAC for the 
simultaneous functionalization of the gel. 
Chapter 5 - SPAAC and SPOCQ cross-linked hydrogels as matrices for encapsulation 
of aligned peptide amphiphile fibres
Both chemical cross-linking methods SPAAC and SPOCQ were used in Chapter 5, in 
which we combined the hydrogel network with peptide amphiphile fibres. These fibres are 
composed of a hydrophobic aliphatic tail and a hydrophilic peptide sequence. We used peptide 
amphiphiles with a diacetylene moiety in the alkyl tail, to introduce fibre stability. These fibres 
can be polymerised using UV irradiation, leading to highly ordered alkyl tails. Apart from this 
self-assembly, certain peptide amphiphiles fibres can be aligned using a strong magnetic field 
to further organize them at a macroscopic level. This is especially interesting when the peptide 
amphiphiles contain peptide motif IKVAV, which is known to promote neurite outgrowth 
of several neuronal cell types. Aligning IKVAV containing fibres opens up the possibility to 
develop a biomaterial to control the directional growth of neuronal cells. In order to avoid 
fibre disassembly after alignment, we aimed for capturing the aligned IKVAV containing peptide 
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amphiphile fibres in a hydrogel network. We confirmed that the peptide amphiphile fibres can 
be aligned using a strong magnetic field, and showed proper alignment with a field strength of 20 
T. SPAAC cross-linking was first studied as polymeric matrix to fixate alignment. Unfortunately, 
the formation of the polymeric network occurred simultaneously with the alignment process, 
which thereby prevented proper alignment. We therefore continued with SPOCQ cross-
linking, which has the great advantage of being activatable. In fact, this showed its value, because 
magnetic alignment of the fibres could be achieved in presence of polymers star-PEG-BCN 
and star-PEG-DHPA, as it was not hindered by gel formation. After alignment, oxidizing agent 
sodium periodate was added, which diffused through the sample cell, to provide formation 
of the polymeric network around the aligned fibres. We confirmed that the fibres remained 
aligned, and were thus entrapped in a polymeric matrix. This hydrogel is an interesting material 
for further research aiming for controlling the directional growth of neuronal cells. 
Chapter 6 - Dual cross-linked hydrogels by combining chemical and physical cross-
linking
Our hydrogels cross-linked with SPAAC and SPOCQ showed that chemically cross-linked 
gels allow precise control over the mechanical properties. Physical cross-linking, on the other 
hand, have the advantage that gelation occurs upon application of an external trigger (pH, 
temperature, stress, ionic strength). A disadvantage of physically cross-linked hydrogels is that 
they usually have weak mechanical properties. By combining chemical and physical cross-linking, 
advanced hydrogels can be developed with improved mechanical properties. Before studying 
these dual cross-linked hydrogels, we first further studied the gel forming capacity of SPOCQ 
cross-linking. We showed that vitamin B2 can also be used as oxidizing agent, by making use of 
illumination with visible light. With biomedical applications in mind, we continued by performing 
cell adhesion studies with SPOCQ cross-linked hydrogels. Gels were functionalized with 
adhesion motif RGDS and proved to be good substrates for cell adherence, when oxidized by 
sodium periodate or vitamin B2. We next studied physical cross-linking, based on the strong 
interaction of bisphosphonate alendronic acid with calcium. Polymer star-PEG-alendronic acid 
rapidly formed ionically cross-linked hydrogels upon addition of calcium. We also showed that 
these gels display self-healing behaviour. We now continued with dual cross-linked gels, by 
combining our chemical cross-linking method SPOCQ with the physical cross-linking procedure 
using calcium. Rheological analysis showed that these dual cross-linked gels showed improved 
mechanical properties, compared to gels that were only chemically cross-linked. Finally, we 
also made the physically cross-linked gels stimuli-responsive, by incorporation of thermally 
triggerable calcium-releasing liposomes. In this way, the release of calcium can be controlled, 
which is promising for biomedical applications such as bone tissue engineering.
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Chapter 7 - Future perspectives
Hydrogels have great potential to be used in biomedical applications, such as tissue engineering 
and for the controlled delivery of drugs. In the final chapter, we focussed on the main challenges 
we need to overcome in order to boost the clinical use of hydrogels. We discussed the 
possibilities to make the hydrogels injectable. Both SPAAC and SPOCQ cross-linked gels are 
promising to study in this respect. Furthermore, the long term stability and degradability of the 
gels need to be investigated. An important guide when aiming for tissue engineering is mimicking 
of the extracellular matrix. Hydrogels are promising for creating this 3-D cellular environment, 
especially the gels containing the peptide amphiphile fibres as discussed in Chapter 5. The 
physical cross-linked gels from Chapter 6 are interesting to study as bone tissue engineering 
scaffolds, as alendronic acid can bind to bones via binding to calcium. Future studies on the 
hydrogels described in this thesis, should directly aim for biomedical applications, which will give 
our gels the opportunity to find their way in clinical use. 
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Hoofdstuk 1 - Peptide- en eiwit-gebaseerde hydrogels
Hydrogels zijn 3-dimensionale polymerische netwerken. Door hun hydrofiele karakter zijn 
ze in staat om grote hoeveelheden water of biologische vloeistoffen te absorberen, tot wel 
duizend keer hun eigen drooggewicht. De gels zijn onoplosbaar vanwege de aanwezigheid 
van cross-links (dwarsverbindingen) tussen de componenten die het polymerische netwerk 
vormen. Een belangrijk kenmerk van hydrogels is de manier waarop de cross-links ontstaan, wat 
zowel op een chemische als op een fysische manier kan plaatsvinden. Chemisch gecross-linkte 
hydrogels worden gevormd via covalente verbindingen tussen de polymerische componenten. 
Een belangrijk voordeel van deze cross-linkings methode is dat men controle heeft over de 
mechanische eigenschappen van de gevormde hydrogels. Een nadeel is dat de chemisch reacties 
vaak het gebruik van organische oplosmiddelen en/of reagentia vereisen, wat het inzetten van 
deze gels voor biomedische toepassingen verhindert. Fysische gecross-linkte hydrogels worden 
gevormd door zelf-assemblage van de polymerische componenten, in reactie op externe 
stimulansen, zoals temperatuur, pH of ionische sterkte. Deze gels zijn niet afhankelijk van de 
toevoeging van chemische reagentia. Ze kunnen zo worden ontwikkeld dat de vorming van de 
gel alleen plaats vindt als reactie op bepaalde stimulansen, wat deze hydrogels veelbelovend 
maakt als injecteerbaar materiaal. Een nadeel van fysische cross-linking is dat ze vaak gels geven 
met zwakke mechanische eigenschappen. De manier waarop cross-linking plaats vindt is een 
belangrijke factor in de vorming van hydrogels, aangezien het de mechanische eigenschappen 
bepaald, alsmede een invloed heeft op de biocompatibiliteit en op de mogelijkheden voor 
het toedienen van de gel. Controle over de cross-linkings methode leidt tot controle over 
de eigenschappen van de hydrogels, wat hun klinische gebruik vergemakkelijkt. Deze thesis 
richt zich op verschillende bio-geïnspireerde cross-linkings methoden voor het vormen van 
hydrogels, met als doel om deze in te zetten als adaptieve dragermaterialen voor het kweken 
van botweefsel.
Hoofdstuk 2 – Fysische cross-linking van ster-PEG polymeren met behulp van calcium-
bindende peptides
Botweefsel bestaat uit cellen die door een organische matrix omringd worden. Deze matrix 
bestaat uit collageen en het calcium-bevattende hydroxyapatiet. Een belangrijk criterium in 
de zoektocht naar dragermaterialen voor het kweken van botweefsel, is dat het materiaal de 
mogelijkheid moet bieden om apatiet vorming te induceren. Materialen die botweefsel kunnen 
mineraliseren zijn vaak niet-collagene eiwitten, met sterke calcium-bindende eigenschappen. 
Deze calcium-bindende motieven zijn veel voorkomend in de natuur, zoals bijvoorbeeld bot 
sialo eiwitten, calmoduline en alginaat. Ons doel was de ontwikkeling van fysisch gecross-
linkte hydrogels als dragermateriaal voor het kweken van botweefsel, met behulp van de 
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sterke calcium-bindende kenmerken uit de natuur. Eerst werden verschillende peptiden 
gesynthetiseerd, die rijk zijn in negatief geladen carboxylaat groepen, voor de binding aan Ca2+. 
Peptiden zoals Gly-Glu7-Gly (GE7G), G[LEELLEE]2G en de bindingsmotieven van calmoduline 
werden gesynthetiseerd met behulp van vaste-fase peptide synthese. De calcium-bindende 
eigenschappen van deze peptiden werden onderzocht via analyse technieken zoals circulair 
dichroïsme spectroscopie (CD), dynamische licht verstrooiing (DLS) en isotherme calorimetrie 
(ITC). Zodoende werd het effect van het toevoegen van calcium op de secundaire structuur 
van het peptide, het aggregatie gedrag en de bindingsenthalpie bepaald. Het bleek lastig om 
een conclusie te trekken over het vermogen van de peptides om calcium te binden, omdat de 
analyse technieken voornamelijk zwakke bindingseffecten lieten zien na toevoeging van calcium. 
Desondanks besloten we om door te gaan met ons doel om hydrogels te ontwikkelen die 
cross-linken onder invloed van calcium. Dit werd gedaan middels het koppelen van de peptiden 
aan stervormig poly(ethylene)glycol (ster-PEG). Het koppelen van peptide GE7G aan ster-PEG 
was succesvol en leidde tot het peptide-polymeer construct ster-PEG-GE7G. De synthese van 
de polymeer constructen met peptide G[LEELLEE]2 en met de calmoduline bindingsmotieven 
was niet geslaagd, omdat de lage oplosbaarheid van deze constructen de zuivering belemmerde. 
Daarom werd alleen ster-PEG-GE7G gebruikt om te testen of hiermee een fysisch gecross-
linkte hydrogel kon worden gemaakt, waarbij calcium de cross-linker is. Helaas resulteerde 
de toevoeging van calcium aan ster-PEG-GE7G niet tot de vorming van een gel. Omdat de 
gebruikte analyse technieken om de calcium-bindende eigenschappen te bepalen ook niet 
overtuigend waren, concluderen we dat de interactie van calcium met de peptides niet sterk 
genoeg is om fysische connecties tussen de polymeren te maken. 
Hoofdstuk 3 – Zachte PEG-hydrogels met onafhankelijk aanpasbare stijfheid en 
RGDS-hoeveelheid voor cel adhesie studies
We hebben onze aandacht verlegd naar chemische gecross-linkte gels en ons daarbij speciaal 
gericht op de biocompatibiliteit van de cross-linkings methode. Interessant hierbij zijn de 
zogenoemde click reacties. Deze op water gebaseerde chemische reacties zijn snel, aanpasbaar, 
geven een hoge opbrengst, en hebben als belangrijkste voordeel dat ze biocompatibel zijn. We 
hebben de kopervrije click reactie genaamd ‘spannings-gestimuleerde cycloadditie tussen een 
azide en een alkyn’ (SPAAC) bestudeerd. Ring gespannen alkyn bicyclo[6.1.0]nonyne (BCN) en 
een azide werden gekoppeld aan polymeer ster-PEG, om zo respectievelijk ster-PEG-BCN en 
ster-PEG-N3 te verkrijgen. Nadat deze twee polymeren in water werden opgelost en gemengd, 
startte de SPAAC reactie, welke resulteerde in de vorming van een hydrogel. Dit cross-linkings 
proces vond plaats zonder verdere handelingen en zonder dat er extra chemicaliën dienden 
te worden toegevoegd. We hebben ons als doel gesteld om zachte hydrogels te maken, die de 
stijfheid van de meeste organen van zoogdieren (G’ = 100 – 10.000 Pa) nabootsen. Analyse 
van de hydrogels met behulp van rheologie bevestigde het zachte karakter van de SPAAC 
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gecross-linkte hydrogels, aangezien elastische moduli van 25 Pa (10 mg/mL), 1192 (20 mg/mL) 
en 2298 Pa (30 mg/mL) werden verkregen. Dit liet ook zien dat de mechanische eigenschappen 
van de gels gemakkelijk kunnen worden aangepast, middels het variëren van de totale polymeer 
hoeveelheid. Om verzekerd te zijn van biocompatibele gels, werd cel adhesie peptide RGDS 
in het polymerisch netwerk ingebouwd. Cel adhesie studies werden uitgevoerd met een ‘live/
dead’ assay, welke twee fluorescente stoffen bevat, om levende cellen te kleuren (groen) en 
om dode cellen te kleuren (rood). Er werden drie verschillende celtypes gebruikt, afkomst 
van verschillende weefsels, om zo een beeld te krijgen van hoe cellen interactie hebben met 
hun omgeving. Op alle RGDS-bevattende hydrogels (10 – 30 mg/mL) werd een groot aantal 
groen fluorescerende cellen gevonden voor de van botweefsel afkomstige HOS cellen. Dit 
betekent dat de HOS cellen in leven blijven op alle hydrogel oppervlaktes, onafhankelijk van 
de stijfheid van de gel. Voor beide cel types die afkomstig zijn van zachtere weefsels (HeLa en 
3T3 NIH fibroblasten) werden mooi gespreide en levende cellen gevonden op de gels van 
10 en 20 mg/mL. Interessant bij deze studies was dat de cel adhesie duidelijk gehinderd werd 
op de stijfste hydrogel (30 mg/mL), welke een significant lager aantal aangehechte cellen liet 
zien. Aangezien stijfheid de enige factor is waarin de 10, 20 en 30 mg/mL hydrogels van elkaar 
verschillen, concluderen we dat dit de bepaalde factor lijkt in de cel adhesie van HeLa cellen en 
3T3 NIH fibroblasten. Belangrijk is dat dit onderzoek laat zien dat SPAAC gecross-linkte RGDS-
bevattende hydrogels een goed substraat zijn voor cellulaire adhesie.
Hoofdstuk 4 – Een snelle en activeerbare cross-linkings methode voor het vormen 
van hydrogels
We hebben laten zien dat de SPAAC reactie een waardevolle methode is voor de vorming 
van chemisch gecross-linkte hydrogels. Echter, wat we ook geobserveerd hebben, is dat de 
SPAAC reactie vaak gehinderd wordt door de langzame reactie kinetiek. Bovendien is de reactie 
niet activeerbaar, wat vaak een gewenste eigenschap is voor injecteerbare hydrogels en voor 
andere biomedische toepassingen waar controle op het moment van gelvorming noodzakelijk 
is. We hebben daarom een nieuwe cross-linkings methode ontwikkeld, genaamd ‘spannings-
gestimuleerde oxidatie gecontroleerde cycloadditie met behulp van een 1,2-quinone’ (SPOCQ). 
Deze methode is gebaseerd op de reactie tussen alkyn BCN en catechol DHPA (3,4 dihydroxy 
fenyl azijnzuur), welke plaatsvindt na de oxidatie van het catechol naar het quinone. We hebben 
laten zien dat de vorming van hydrogels uit polymeren ster-PEG-BCN en ster-PEG-DHPA 
extreem snel plaatsvindt na oxidatie. Chemische oxidatie met behulp van natrium periodaat 
resulteerde in bijna onmiddellijke gelvorming. Oxidatie kon ook snel worden uitgevoerd met 
behulp van enzym ‘mushroom tyrosinase’. Door het variëren van de enzym concentratie kon de 
cross-linkings snelheid worden gecontroleerd, omdat hogere enzym concentraties resulteerde 
in kortere tijden tot het vormen van de gel. De SPOCQ reactie vindt alleen plaats nadat 
het oxidatie middel is toegevoegd, wat betekent dat we, voor de eerste keer, een snelle en 
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activeerbare cross-linkings methode voor het vormen van hydrogels hebben ontwikkeld. Door 
het grote verschil in reactiesnelheid tussen SPAAC en SPOCQ werden we ook geïnspireerd 
om beide reacties in één pot uit te voeren. We hebben hierbij laten zien dat beide cross-linkings 
methoden samen kunnen worden gebruikt, SPOCQ voor het snelle vormen van hydrogels en 
SPAAC voor het simultaan functionaliseren van de gel. 
Hoofdstuk 5 - SPAAC en SPOCQ gecross-linkte hydrogels als matrices voor het 
vastzetten van uitgelijnde peptide amfifiele vezels
Beide chemische cross-linkings methoden SPAAC en SPOCQ werden gebruikt in Hoofdstuk 
5, waarin we het hydrogel netwerk hebben gecombineerd met peptide amfifiele vezels. Deze 
vezels zijn opgebouwd uit een hydrofobe alifatische staart en een hydrofiele peptide sequentie. 
We hebben peptide amfifielen gebruikt met een diacetyleen functionaliteit in de alkyl staart, 
om vezel stabiliteit te introduceren. Deze vezels kunnen worden gepolymeriseerd door 
middel van bestraling met UV licht, wat leidt tot een hoge mate van ordening van de alkyl 
staarten. Behalve deze zelf-assemblage, kunnen bepaalde peptide amfifiele vezels ook worden 
uitgelijnd in een sterk magneetveld, wat leidt tot een verdere ordening op macroscopisch 
niveau. Dit is vooral interessant wanneer de amfifiele vezels peptide domein IKVAV bevatten, 
omdat dit in staat is om de uitgroei van neurieten van bepaalde zenuwcellen te stimuleren. 
Het uitlijnen van IKVAV-bevattende vezels opent mogelijkheden om een biomateriaal te 
ontwikkelen die de groeirichting van zenuwcellen controleert. Om te voorkomen dat de vezels 
deassembleren nadat ze uitgelijnd zijn, was ons doel om de IKVAV bevattende vezels vast te 
zetten in een hydrogel netwerk. We hebben bevestigd dat de peptide amfifiele vezels kunnen 
worden uitgelijnd met behulp van een sterk magneetveld, aangezien er een nette uitlijning 
werd gevonden bij een veldsterkte van 20 T. SPAAC cross-linking werd als eerste bestudeerd 
als polymerische matrix om de uitgelijnde vezels in vast te zetten. Helaas vond de vorming 
van het polymerisch netwerk gelijktijdig plaats met het uitlijningsproces, waardoor de vezels 
niet naar behoren werden uitgelijnd. We gingen daardoor verder met SPOCQ cross-linking, 
welke als groot voordeel heeft dat het activeerbaar is. Dit liet zijn meerwaarde zien, omdat 
de magnetische uitlijning kon plaatsvinden in aanwezigheid van polymeren ster-PEG-BCN en 
ster-PEG-DHPA, maar niet gehinderd werd door de vorming van de gel. Na de uitlijning kon 
het oxiderende middel natrium periodaat worden toegevoegd, welke diffundeerde door het 
monster, en zorgde voor de vorming van een polymerisch netwerk rondom de uitgelijnde 
vezels. We hebben bevestigd dat de vezels uitgelijnd bleven, en zijn dus in staat om de uitlijning 
vast te zetten in een polymerische matrix. Dit levert een hydrogel op welke interessant is voor 
verder onderzoek naar het controleren van de groeirichting van zenuwcellen. 
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Hoofdstuk 6 – Dubbel gecross-linkte hydrogels door het combineren van chemische 
en fysische cross-linking 
Onze hydrogels gecross-linkt met SPAAC en SPOCQ hebben laten zien dat chemische cross-
linkings methoden de mogelijkheid bieden om de mechanische eigenschappen van de gels 
te controleren. Aan de andere kant hebben fysische cross-linkings methoden het voordeel 
dat de gelvorming plaats vindt als reactie op een externe trigger (pH, temperatuur, stress en 
ionische sterkte). Een nadeel van de fysisch gecross-linkte hydrogels is dat ze vaak zwakke 
mechanische eigenschappen hebben. Door het combineren van zowel chemische als fysische 
cross-linking, kunnen geavanceerde hydrogels worden ontwikkeld met verbeterde mechanische 
eigenschappen. Voordat we deze dubbel gecross-linkte gels bestuderen, kijken we eerst verder 
naar de gel vormingscapaciteiten van de SPOCQ reactie. We hebben laten zien dat vitamine 
B2 ook gebruikt kan worden als oxiderend middel, met behulp van bestraling met zichtbaar 
licht. Met biomedische toepassingen in gedachten, zijn we ook doorgegaan met de cel adhesie 
studies, nu met de SPOCQ gecross-linkte hydrogels. De gels werden gefunctionaliseerd met 
adhesie motief RGDS en hebben bewezen goede substraten voor celadhesie te zijn, wanneer 
ze geoxideerd zijn met natrium periodaat of vitamine B2. Hierna hebben we fysische cross-
linking bestudeerd, gebaseerd op de sterkte interactie van bisfosfonaat alendronine zuur met 
calcium. Polymeer ster-PEG-alendronine zuur vormde snel ionisch gecross-linkte hydrogels na 
de toevoeging van calcium. We hebben ook laten zien dat deze gels zelfhelend gedrag vertonen. 
We zijn daarna verder gegaan met de dubbel gecross-linkte gels, door chemische cross-linkings 
methode SPOCQ te combineren met de fysische procedure met calcium. Analyse met 
behulp van rheologie liet zien dat deze dubbel gecross-linkte gels verbeterde mechanische 
eigenschappen hebben in vergelijking tot gels met alleen chemische cross-linking. Tot slot 
hebben we de fysisch gecross-linkte gels ook zo ontwikkeld dat ze reageren op een externe 
stimulans. Dit hebben we gedaan door het toevoegen van temperatuur gevoelige, calcium 
vrijlatende liposomen. Op deze manier kan de afgifte van calcium worden gecontroleerd, wat 
veelbelovend is voor biomedische toepassingen zoals het kweken van botweefsel.
Hoofdstuk 7 – Toekomst perspectieven
Hydrogels hebben veel potentie om te worden gebruikt in biomedisch toepassingen, zoals 
voor het kweken van weefsels en in de gecontroleerde afgifte van medicijnen. In het laatste 
hoofdstuk hebben we ons gericht op de belangrijkste uitdagingen die we moeten overwinnen 
om het klinisch gebruik van hydrogels te stimuleren. We hebben de mogelijkheden besproken 
om hydrogels injecteerbaar te maken. Zowel SPAAC als SPOCQ gecross-linkte gels zijn 
veelbelovend om gebruikt te worden als injecteerbaar materiaal. Verder moet de stabiliteit 
over lange termijn en de degradeerbaarheid van de gels worden onderzocht. Een belangrijke 
richtlijn voor het kweken van weefsels is om de extracellulaire matrix na te bootsen. Hydrogels 
hebben potentie om deze 3-D cellulaire omgeving te creëren, zeker als ze peptide amfifiele 
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vezels bevatten, zoals besproken in Hoofdstuk 5. De fysisch gecross-linkte gels van Hoofdstuk 
6 zijn interessant om te bestuderen als dragermateriaal voor het kweken van botweefsels, 
omdat alendronine zuur kan binden aan botten, via de binding aan calcium. Toekomstige studies 
aan de hydrogels beschreven in deze thesis, zullen zich direct moeten richten om biomedische 
toepassingen, waardoor onze gels de kans krijgen om zich te bewijzen in klinisch gebruik.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Dankwoord    217
D
Dankwoord
Na vier jaar (of eigenlijk al bijna 5) is dit dan het moment om een van de leukste dingen van je 
boekje te schrijven, het dankwoord! En een belangrijk onderdeel ook, want er zijn veel mensen 
die ik wil bedanken voor de mooie bijdrage die ze hebben geleverd aan dit proefschrift.
Als eerste is dat uiteraard Dennis. Bedankt voor je enthousiaste begeleiding! Ik waardeer het 
erg dat ik altijd binnen kon lopen, en ook dat je regelmatig langs kwam op het lab om gewoon 
even te vragen hoe het gaat. Dat leverde dan vaak weer van die praktische tips op, waardoor 
ik weer nieuwe ideetjes had om vooruit te komen. Bedankt ook voor de hulp met ‘onze grote 
vriend’, de HPLC, die toch geregeld jouw technische kennis nodig had, en waardoor ik inmiddels 
ook weet wat een ferrule is.
Natuurlijk is Jan de volgende die ik graag wil bedanken. Het was vooral heel fijn dat je altijd 
de grotere lijn zag van het onderzoek. Je dacht eigenlijk al een paar stappen verder en zag al 
meteen veel mooie (publiceerbare) resultaten, wat mij enorm motiveerde. Ondanks dat het 
soms toekomstmuziek leek voor mij, was je vastberaden, en ben ik erg blij dat ik (zeker ook 
doordat ik wat langer mocht blijven) nu een mooi boekje heb kunnen schrijven!
Wat betreft begeleiding wil ik ook Sander Leeuwenburgh bedanken. Je maakte altijd even tijd 
als ik ergens mee in de knoop zat, en ik heb veel aan je expertise over hydrogels en rheologie 
gehad. Jouw inbreng van alendronic acid als nieuw calciumbindend motief, heeft gelukkig ook 
geresulteerd in de fysische hydrogels van hoofdstuk 6. Ook heb ik prettig kunnen samenwerken 
met verschillende mensen op de afdeling Biomaterialen, waaronder Reza Nejadnik, Timothy 
Douglas en Paula Lopez Perez. Paula, you always shared your expertise on hydrogels and 
alendronic acid and I enjoyed our conversations about research at the rheometer.
Graag wil ook de manuscript commissie, Alan Rowan, Rint Sijbesma en Kim Bonger, 
bedanken voor het kritisch lezen van mijn proefschrift. Voor hoofdstuk 5 had ik de eer om 
met een grote magneet te mogen werken, bedankt voor jullie expertise en hulp hierbij, Roger 
Rikken en Peter Christianen. Graag wil ik Floris van Delft bedanken voor de waardevolle 
discussies voor hoofdstuk 4 en voor je expertise over click chemie. Dit hoofdstuk kreeg door 
Ernst van Eck een mooie toevoeging, dank voor de hulp met magic-angle spinning NMR.
Zonder de vaste medewerkers van de afdeling, zou alles een stuk moeizamer gaan! Hans, 
geen enkel peptide is hetzelfde, en daarom kwam jouw uitgebreide kennis regelmatig van pas. 
Bedankt ook voor de organisatie op het lab, de peptide benodigdheden waren altijd prima op 
orde. Marieke, dank dat alles altijd zo prima geregeld was, maar vooral ook bedankt voor de 
gezelligheid! Ik kon altijd van alles bij je kwijt, wat toch wel opluchtte. Ook Desiree wil ik hier 
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zeker noemen, bedankt dat je zo begripvol bent en, ondanks alles, altijd interesse in mij toonde. 
Peter, even een bestelling plaatsen of iets bij je ophalen, duurde altijd langer dan gedacht, 
omdat het zo gezellig was om een praatje met je te maken! Jan Dommerholt, bedankt voor 
het bestellen van BCN, en uiteraard voor je bijdrage aan hoofdstuk 4. Peter van Galen en 
Helene, bedankt voor het onderhoud aan de LC-MS en HPLC. Ook wil ik Jacky en Paula 
bedanken voor de administratieve hulp.
Zonder financiële ondersteuning was dit onderzoek niet mogelijk geweest, daarom mag 
Agentschap NL niet ontbreken. Sybrand van der Zwaag en Annette Steggerda, dank 
voor jullie enthousiasme en interesse in mijn project, en voor de leuke activiteiten en symposia 
die jullie organiseerden!
Tijdens mijn promotie heb ik het voorrecht gehad om drie studenten te begeleiden. Addie 
Kusters, je begon met het moeizame werk aan hoofdstuk 2, maar legde uiteindelijk de basis 
voor hoofdstuk 3. Het was leuk om te zien hoeveel plezier je daarin had, en hoe netjes je 
de verschillende combinaties van polymeren voor SPAAC hebt uitgetest. Ook ben je gestart 
met de eerste celtesten, en hebben we dit kunnen uitbouwen tot een mooi artikel. Lindsey 
Lelieveld, je was er alleen voor de bachelorstage, maar was erg gemotiveerd, zelfs om ’s 
ochtends vroeg bij de handmatige ITC te proberen om luchtbellen te voorkomen. Een paar 
van jouw analyses heb ik kunnen gebruiken in hoofdstuk 2. Imke Pijpers, achter ideale student 
in het woordenboek vind je jouw naam zeker terug. Je kwam op het laatste stukje van mijn 
promotie, en terwijl ik door het hele land reisde, werkte jij zelfstandig aan je eigen hydrogels. Je 
was creatief in oplossingen vinden, onder andere om hydrogels onder UV licht te laten cross-
linken, en hebt daardoor een groot deel van het werk in hoofdstuk 6 uitgevoerd. Jammer dat 
de tijd op was! Je hebt hard gewerkt en ik vond het erg gezellig! 
Ik heb een hele gezellige tijd gehad in Nijmegen, wat natuurlijk komt door de collega’s! Vooral 
de peptide angels, Britta en Saskia, waren mijn ‘partners in crime’! Britta, je was de eerste 
die ik sprak, zelfs nog voordat ik begonnen was, en het was eigenlijk meteen goed! Ik kon 
altijd bij je terecht voor hulp met het onderzoek, maar ook zeker op persoonlijk vlak. Mooi 
om te zien dat je soms zo lekker nuchter bent, maar er wel altijd volledig voor gaat. Dank 
voor de gezellige etentjes, het samen organiseren van de Streepjesborrels, het shoppen, onze 
zangkunsten (Enrique!), mijn vraagbaak zijn voor allerlei Engelse vragen en, ondanks dat we nog 
net geen nieuwe ruggengraat gemaakt hebben, de prima samenwerking aan hoofdstuk 5! 
Saskia, zonder jou had ik nooit kennis gemaakt met de wondere wereld van cell-babies! Ik ben 
heel blij dat je mijn paranimf bent! Samen hebben we hard gewerkt aan hoofdstuk 3, wat echt 
met vallen en opstaan ging. Ik heb veel van je geleerd over in vitro studies, en denk graag terug aan 
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de gezellige momenten achter de confocal! Ik waardeer je positiviteit en doorzettingsvermogen, 
en mede daarom hebben we uiteindelijk toch de mooie beloning van een artikel voor elkaar 
gekregen. Heel fijn dat je er altijd voor me bent en we samen zoveel leuke dingen hebben 
kunnen doen! Dank je wel voor de leuke en lekkere etentjes, het knuffelen met nijntjes, de 
shoptripjes en altijd gezellige gesprekken!
Annika, zonder jou was hoofdstuk 4 er niet geweest! Heel gaaf dat je mijn paranimf bent! 
Onze samenwerking was top, we hebben in korte tijd onze SPOCQ gels in Advanced Materials 
gekregen, waarbij ik onze reactie na de submissie ‘Hij is niet afgewezen!’ nooit zal vergeten. 
Mooi om jouw talent om dingen te regelen en je fanatieke werkhouding te zien. Ik denk ook 
met plezier terug aan de hydrogel fotosessies, waarbij niet alle gels zo fotogeniek bleken. Danke 
schön voor de gezellige treinreizen naar Arnhem, etentjes, leuke ‘Wie is de Mol’-discussies en 
natuurlijk de Streuseltalers!
Wil ik hier natuurlijk ook even de ‘partners van’ noemen, René, Stijn en Arne, dank voor de 
gezellige avonden! Ruud, ondanks dat je nooit helemaal begrepen hebt dat Almere toch echt 
een stad is, vond ik het super gezellig om jou als bureau buurman te hebben! Ook had je altijd 
tijd om je even in de wereld van hydrogels te verdiepen en heb je zelf een prachtig boekje 
gemaakt! Dan zijn er nog veel andere mensen die ik wil bedanken voor hun hulp, tijd om even 
te overleggen en hun gezelligheid op het lab, tijdens de lunch (om 12:30 uur precies uiteraard) 
en tijdens borrels: Matthijs (mooi roze is niet lelijk), Marcel (lunch!), Joep, Nanda, Morten 
(Hot & Spicy zonder kaas), Mark, Mariëlle, Zhipeng, Petra, René B., Marjoke, Angelique, 
Lise, Lianne, Selma, Silvie, Jorgen, Stefan, Bram en de rest van vleugel 1! Rosa, thanks for 
the nice collaboration on the review. Ook waren er een aantal studenten die zeker hebben 
bijgedragen aan de gezellige sfeer op het peptide lab: Carim, Dennis en Pascal. Gelukkig heb 
ik ook veel cel studies mogen uitvoeren, waarbij ik fijne hulp heb gehad van Stéphanie en 
Liesbeth.
Naast alle mensen die ik in Nijmegen heb leren kennen, wil ik ook graag het thuisfront bedanken. 
Het was elk weekend heerlijk om in Almere te zijn, en de promotie-perikelen lekker in het 
zuiden achter te laten.
Lieve papa en mama, heel erg bedankt voor jullie steun! Ik keek er altijd erg naar uit om op 
vrijdag in de auto te stappen en naar jullie (en Boemel :P) te rijden! Ik vind het super dat jullie 
mij altijd weer hebben gemotiveerd. De ritjes terug naar Arnhem, met mijn hele auto vol bakjes, 
shopdagen met mama, en klusjes met papa in mijn huisje, ik zal er altijd met veel plezier aan 
terugdenken! Lieve Nils, scheikunde is voor jouw een compleet andere wereld, verder dan 
H2NX4 kom je niet (ik vraag me nog steeds af wat voor bijzonder element X is :P), maar je 
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was altijd geïnteresseerd in mijn wetenschappelijke avonturen. Ik vind het erg gezellig dat we nu 
‘buren’ zijn in Amsterdam! Angela, heel leuk om er zo’n gezellig schoonzus bij te krijgen. Super 
bedankt voor het prachtige ontwerp van de voorkant!
Lieve Mavis, Gerrit, Kimberly en Lindsey: naar Almere gaan betekende uiteraard ook een 
bezoekje aan jullie! Dank jullie wel voor de leuke weekenden, waar we het over van alles en 
nog wat hebben (en niet te vergeten vaak over lekker eten), en juist niet over wetenschap, wat 
mijn weekenden heerlijk ontspannen maakte! Ik ben blij met jullie, en de rest van de gezellige 
en gastvrije familie!
Een speciaal woordje ook voor mijn tante Pauline, je lieve appjes maken mij altijd blij! Ook 
stond ik vol trots op de Via Gladiola, om je te zien finishen na weer een succesvolle 4-daagse!
Dan tot slot, ondanks dat ik weet dat je dit cliché gaat vinden, zijn de laatste woorden toch echt 
voor jou! Lieve Marc, van mijn high-school lover, tot inmiddels ruim 10 jaar verder, maar het 
verveelt echt nooit! Dank je wel voor al je steun, ook al was het helaas vaak op afstand. Gelukkig 
heb je op mij gewacht in Amsterdam! Ik ben gek op je, en hoop nog lang met je samen te zijn!
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